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CHAPTER 1
GENERAL INTRODUCTION
Oxygen free radicals '
Oxygen free radicals are oxygen species with one or more unpaired electrons,
which are involved in many normal biological processes, like phagocytosis, eicosanoid
metabolism and enzymatic reactions. Antioxidants and antioxidant enzymes inhibit the
formation of radicals or reduce their reactivity^. However, any situation accompanied
by increased oxidative stress and/or decreased antioxidant defences, may lead to an
excess of free radicals and damage to biomolecules. In various clinical conditions,
involvement of oxygen free radicals has been suggested (reviewed in ref. 2). Halliwell
and Gutteridge^ pointed out, however, that the production of free radicals is usually
a consequence of disease. On the other hand, evidence has accumulated that oxygen
free radicals are involved in disease pathology of atherosclerosis and ischemia/-
reperfusion injury^.
Due to their short half-lives, relatively low concentrations, and the ethical and
logistical considerations in obtaining samples, however, the detection of free radicals
in human tissue with spin labels is usually not feasible^. Also, it should be realized
that production of free radicals does not mean that biomolecules will actually be
damaged.
Lipid peroxidation
Several oxygen free radicals are capable of initiating lipid peroxidation by removing
a hydrogen atom from a methylene group of an unsaturated fatty acid* (Figure 1.1).
Also non-radical reactive oxygen species, like hydrogen peroxide, may play a role in
lipid peroxidation^ Polyunsaturated fatty acids (PUFA) in membranes are a major
target of reactive oxygen species, since the presence of multiple double bonds
facilitates abstraction of a hydrogen atom, /n wfro studies have shown that after
hydrogen abstraction, the PUFA radicals undergo molecular rearrangement to form
conjugated dienes, and then take up oxygen to form peroxyl radicals'* (for an extensive
review of oxygen radical chemistry of PUFA, see also ref. 5). Peroxyl radicals can
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attack membrane proteins, but are also capable of abstracting a hydrogen atom from
another PUFA, and start a chain reaction while the peroxyl radical is converted to a
hydroperoxide. This chain reaction may be terminated by a chain-breaking antioxidant,
like vitamin E*. Peroxyl radicals may also be broken down to cyclic (endo)peroxides
when the presence of good hydrogen donators, like vitamin E or PUFA themselves,
is low^. Lipid hydroperoxides are fairly stable molecules under physiological conditions,
but their decomposition is catalyzed by transition metals and metal complexes^'*. The
subsequently formed alkoxyl and peroxyl radicals can re-initiate PUFA peroxidation,
and amplify the initial events \ Various end-products arise from breakdown of lipid
hydroperoxides and endoperoxides, like alkanes, alkenes, alkanals, and alkenals.
I-""
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Figure 1.1. Initiation and propagation of peroxidation of a polyunsaturated
fatty acid (PUFA) with three double bonds.
Genera/ /nfroducfion
The formation of many of these products has been used to monitor lipid
peroxidation^. However, some of these indices can be non-specific, and their
production may not necessarily be directly related to lipid peroxidation''. For example,
alkanes like ethane (from n-3 fatty acids) and pentane (from n-6 fatty acids) are only
minor end-products and their formation depends on the presence of transition metals
to decompose lipid peroxides*. Furthermore, these alkanes may arise through flushing
of adipose tissue, and pentane may be metabolized by the liver before its detection
in breath^. A frequently used method to quantify the degree of lipid peroxidation is the
detection of malondialdehyde (MDA) by the reaction with thiobarbituric acid (TBA).
MDA is usually formed from fatty acids with three or more double bonds, and the
amount of free MDA produced in most peroxidizing lipid systems would not give a
significant color yield in the TBA-test. The majority of the MDA detected in the TBA
test is formed from decomposition of lipid peroxides and further peroxidation during
the acid-heating stage of the test itself^®. In addition the TBA test is not specific for
MDA®. However, as yet no ideal method exists to assess lipid peroxidation in humans,
and results need to be interpreted with caution.
Peroxidation of low density lipoproteins
Lipid peroxidation is not only limited to cellular membranes, but also takes place
in, for example, lipoproteins. Steinberg ef a/.® have suggested that part of the etiology
of atherosclerosis may be explained by lipid peroxidation of low density lipoproteins
(LDL). This hypothesis, which has been supported by several other studies in recent
years, is depicted in Figure 1.2. Briefly, LDL in the intima of vessel walls, may be
oxidized when (1) oxidized lipids from within cells are transferred to LDL, (2) LDL lipids
are directly oxidized by LDL-cell contact, or when (3) reactive oxygen species are
generated within the cell and released into the medium, where oxidation of LDL lipids
occurs. Oxidized LDL then (Figure 1.2, I) increases the recruitment of circulating
monocytes, (II) inhibits the motility of resident macrophages to leave the intima, and
(III) the oxidized LDL is taken up more rapidly by macrophages, leading to the
formation of foam cells. In addition, oxidized LDL has a direct cytotoxic effect (IV),
leading to loss of endothelial integrity.
Chapter 7
Esterbauer ef a//° developed a technique to monitor the susceptibility of LDL to
oxidation /n v/fro. Briefly, LDL is isolated from plasma, and a fixed concentration of
LDL is oxidized with copper ions. Although the mechanism of copper-catalyzed
oxidation is not yet completely elucidated, copper probably generates radicals capable
of propagating lipid peroxidation by decomposing lipid hydroperoxides which are also
present in native LDL. The formation of conjugated dienes is monitored
spectrophotometrically at 234 nm (Figure 1.3). After addition of copper, antioxidants
contained in LDL are consumed, and during this lag phase the increase in conjugated
dienes is minimal. The lag phase is followed by the propagation phase, characterized
by rapid oxidation of polyunsaturated fatty acids. The rapid increase in conjugated
dienes reaches a maximum, after which the absorbance at 234 nm decreases again,
due to breakdown of the conjugated dienes.
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Figure 1.2. Four mechanisms by which oxidation of LDL may contribute to atherosclerosis
(see text). [Reprinted by permission of 777e New Eng/andJouma/of Med/c/ne, Steinberg
ef a/.", p. 919. Copyright 1989. Massachusetts Med/ca/ Soc/efy. All rights reserved]
The susceptibility of LDL to oxidation /n w/fro is studied under conditions where the
LDL is not protected by the interacting (water-soluble) antioxidant systems present in
the human body, and with copper as prooxidant. Nevertheless, /n wfrro copper-oxidized
LDL greatly resembles LDL extracted from human and rabbit atherosclerotic
lesions", and IgG isolated from these lesions recognizes copper-oxidized LDL but
not native LDL^. Moreover, Regnstrom efa/ .^ showed an inverse relation
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between the lag phase for copper-catalyzed LDL oxidation /n wfro and quantitative
estimates of global coronary atherosclerosis in humans. This technique may therefore
provide a useful tool to assess effects of interventions on LDL oxidizability.
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Figure 1.3. Formation of conjugated dienes during copper-catalyzed oxidation ol
LDL /n vrtro is monitored spectrophotometrically at 234 nm. The
lagtime before onset of rapid oxidation, the maximum rate of oxidation
during the propagation phase, and the maximum amount of dienes
formed, are used to described LDL oxidation characteristics.
Outline of this thesis
In situations in which oxidative stress is increased, and/or antioxidative protection
is decreased, lipids, proteins, carbohydrates, and DNA may be subjected to oxidative
damage. Antioxidative systems, like lipid-soluble antioxidants, antioxidant enzymes,
water-soluble antioxidants, and antioxidant proteins may protect biomolecules from
oxidative damage. This thesis focusses on the oxidative and antioxidative processes,
closely related to lipids, under mainly physiological conditions.
Firstly, the effect of dietary manipulation of fatty acids on lipid peroxidation of LDL
was studied (Chapter 2). The hypothesis for atherogenesis by Steinberg ef a/.®
suggests that the susceptibility of LDL to oxidation may be an important factor in
atherosclerosis. Since PUFA are highly susceptible to oxidation due to the presence
of multiple double bonds, diets were manipulated with fish oil, which contains a high
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degree of PUFA with 5 and 6 double bonds. Cosgrove ef a/.™ showed that the
/n wfro oxidizability of PUFA is linearly dependent on the number of double bonds, and
that the oxidizability of docosahexaenoic acid, with 6 double bonds, was 5 times
greater than the oxidizability of linoleic acid, with 2 double bonds. Therefore,
incorporation of these highly unsaturated fish oil fatty acids in LDL might increase their
susceptibility to oxidation.
In addition, the effects of dietary fish oil during strenuous physical exercise were
studied (Chapter 3). Several studies have indicated that dietary fish oils increase the
deformability of red blood cells^'^ and facilitate the transport of red blood cells
through capillaries^, leading to improved oxygen supply and exercise performance.
However, during exercise the production of free radicals increases^, and, especially
in combination with the high degree of unsaturation of fish oils, may increase lipid
peroxidation. Therefore, we have studied exercise performance and physical
characteristics of red blood cells, as well as copper-catalyzed oxidation of LDL /n w'fro
and plasma lipid-soluble antioxidant levels during intensive exercise.
During pregnancy, concentrations of various lipids increase in plasma. A previous
study at our department showed that levels of plasma phospholipid fatty acids, which
are rich in highly unsaturated PUFA with three or more double bonds, increased by
more than 50% during pregnancy^. We have studied whether the increase in fatty
acids, serving as substrate for lipid peroxidation, compromised antioxidant defences
(Chapter 4). Also, postpartum maternal and neonatal plasma antioxidant levels were
studied, since phospholipid fatty acid patterns were changed after delivery^, and the
stressful event of labor may be associated with free radical production.
Furthermore, there is considerable evidence that endothelial cell injury is involved
in the pathogenesis of pregnancy-induced hypertension (PIH)^°. Therefore, we
investigated whether a hypothesis of free radical and lipid peroxidation associated
pathogenesis of PIH was supported by altered antioxidant defences (Chapter 5).
As previously pointed out, oxygen free radicals may also be involved in disease
pathology of ischemia/reperfusion injury. Percutaneous transluminal coronary
angioplasty (PTCA) is a medical procedure associated with ischemia/reperfusion injury
in humans. During this procedure, a balloon catheter is inflated intraarterially to reduce
arterial stenosis in the heart. Reperfusion of the previously ischemic part, however,
suddenly increases the oxygen supply, and the balance between reactive oxygen
species, lipid peroxidation products, and antioxidative systems may become derailed.
6
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Since PTCA is the most routinely used technique under well standardized surgical
conditions, it might provide a good model for oxidative stress-related lipid peroxidation
in humans (Chapter 6).
The general conclusions emerging from these studies are discussed in Chapter 7.
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CHAPTER 2
Effects of fish oil and vitamin E supplementation on copper-
catalyzed oxidation of human low density lipoprotein /n wfro
Gerard S. Oostenbrug, Ronald P. Mensink & Gerard Homstra
Based on: European Jou/na/ 0/ C//n*ca/ Mrtrrt/on J994; 48:895-898.
ABSTRACT
The highly unsaturated fish oils have beneficial health effects, but may increase the
susceptibility of low density lipoproteins (LDLs) to oxidative modification. We, therefore,
investigated this potentially atherogenic effect and the influence of the natural antioxidant
vitamin E in humans.
Seven men received a daily supplement of 6 g of fish oil for 3 weeks; four of them
received an additional 300 mg of vitamin E. Four additional men received no supplements,
and served as controls. LDL was isolated before, during and after the supplementation period,
and oxidized /n w'fro with CuClj. Oxidation was measured spectrophotometrically by
continuously monitoring the formation of conjugated dienes at 234 nm.
After three weeks, the mean (± SD) amount of dienes formed /n wfro (oxidizability) had
increased in the fish oil group (20 ± 6 %; P=0.006 vs control group) and fish oil/vitamin E
group (18 + 4 %; P=0.008 vs control group), but not in the control group (1 ± 9 %).
The lagtime before onset of oxidation (oxidation resistance) had decreased by 22.7 ± 8.4
minutes (29 + 7 %) in the fish oil group, but had increased by 5.6 ± 14.6 minutes (6 ± 18 %)
in the fish oil/vitamin E group (P=0.008 between groups). These changes, however, did not
differ significantly from the decrease in the control group (7.5 ± 6.8 minutes or 11 ± 9 %;
P=0.10 vs fish oil group; P=0.12 vs fish oil/vitamin E group).
The rate of oxidation tended to be lower in the fish oil/vitamin E group, but differences
between groups did not reach statistical significance.
We conclude that in man, dietary fish oil increases the copper-induced oxidizability of LDL
/n w'fro, and that vitamin E may prevent this potentially adverse condition by increasing the
resistance against oxidative modification.
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INTRODUCTION ^
Reduction of plasma low density lipoproteins (LDL) can be achieved by replacing
saturated fatty acids in the diet with linoleic acid, the most common n-6
polyunsaturated fatty acid (PUFA)\ Increasing the proportion of dietary linoleic acid
causes an increase in the proportion of linoleic acid in the LDL particle^. This may
present an unfavorable condition, because LDL can be modified by oxidation of its
PUFAs*, and several studies have suggested that oxidatively modified LDL is more
atherogenic than native LDL (for reviews, see refs 5, 6, and 7).
So far, most studies have compared the effects on LDL oxidation /n v/fro of dietary
linoleic acid versus oleic acid, a monounsaturated fatty ac id^ '^° . Indeed it was
found that a linoleic acid rich diet increased the susceptibility of LDL to oxidation
/n v/fro. Less is known about the effect of dietary fish oil on LDL oxidation. Fish oils
are rich in n-3 PUFAs, which may be beneficial to human health^, but which may,
on the other hand, be very susceptible to oxidation because of their high degree of
unsaturation. The present study therefore tested the effects of a dietary fish oil
supplement on the susceptibility of LDL to copper-catalyzed oxidation /n v/fro.
Apart from its PUFA content, the antioxidant status of the LDL particle determines
the susceptibility to oxidation as well^'^•'*. We therefore also examined whether
supplementation with vitamin E, a natural, lipid-soluble antioxidant, could counteract
the expected decrease in LDL oxidation resistance caused by an increased intake of
dietary fish oil.
METHODS
Design, subjects and dietary supplements
Twelve male volunteers participated in this experiment. All were in good health,
and none was taking any medication known to affect serum lipids. The protocol and
aim of the study were fully explained, and all gave their written informed consent.
Approval for the study was obtained from the Medical Ethics Committee of the
University of Limburg.
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For three weeks, eight of the men received, three times per day, two capsules,
each containing 1 gram of a fish oil concentrate (ETOS, Zaandam, The Netherlands).
These capsules provided an additional 1.3 g of eicosapentaenoic acid (EPA; C20:5
n-3) and 0.8 g of docosahexaenoic acid (DHA; C22:6 n-3) per day (Table 2.1). Four
of these men also received a daily supplement of 300 mg (300 IU) of vitamin E
(dl-ot-tocopherol-acetate: "Ephynal 300" capsules, a generous gift of Hoffmann-La
Roche, Basel, Switzerland). Capsules were handed out weekly. The men were asked
to keep the capsules refrigerated, and to take out only the number necessary for one
day. The remaining four men did not receive any capsules and served as a control
group. All participants were urged not to change their habitual diets. On two
consecutive days, 1 or 2 men from each of the three experimental groups entered the
study on the same day. During the first week one man from the fish oil group withdrew
from the study for reasons of illness.
Body weights were recorded weekly, prior to blood sampling. The 11 participants
who completed the study were between 19 and 53 years of age (mean: 32 years).
Body weights at the start of the study, ranged from 66 to 85 kg (mean: 78 kg) and
body mass indexes from 17.6 to 27.3 kg/m* (mean: 23.2 kg/m*). Baseline plasma LDL
cholesterol levels ranged from 1.64 to 3.54 mmol/l (mean: 2.38 mmol/l). One
participant smoked.
Blood sampling and analysis
After subjects had fasted for 12 hours, blood samples from an antecubital vein
were obtained on days 1, 8, 15 and 22 in 10 ml vacutainer tubes with a final
concentration of 4.7 mmol/l K3EDTA when filled with blood ("Venoject", Terumo
Europe, Leuven, Belgium). Plasma was obtained after 15 minutes of centrifugation at
2000 g and 4 °C within one hour of venipuncture.
Isolation of LDL from fresh plasma was started on the same day by single spin
density gradient ultracentrifugation^. Sudan Black B to prestain the lipoproteins,
however, was not added because it interfered with the LDL oxidation analysis
(unpublished observations). All gradient solutions contained 1.0 g/l (2.7 mmol/l) of
Na2EDTA.2H2O to prevent initiation of oxidation of the LDL particle during isolation.
LDL (p=1.019-1.055 g/ml) was collected by aspiration, and 0.6 ml of each sample was
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immediately dialyzed for 24 hours against a 100-fold volume of dialysis buffer
(10 mmol/l KH2PO4, 0.15 mol/l NaCI, pH 7.4, 0.1 mg/l chloramphenicol)^, which was
made oxygen-free by purging with nitrogen. Samples collected on the same day were
dialyzed together in one buffer solution (60 ml buffer per sample). Dialysis was
performed at 4 °C in Visking V8 dialysis tubing (Radiometer Holland, Zoetemneer, The
Netherlands) under a nitrogen atmosphere in the dark. The buffer was changed once,
after 8 hours. Cholesterol concentrations in the LDL fractions were determined
colorimetrically, immediately after isolation (Monotest Cholesterol, Boehringer
Mannheim, Mannheim, Germany). After dialysis, samples were diluted with oxygen-
purged phosphate-buffered saline (PBS: 10 mmol/l KH2PO4, 0.15 mol/l NaCI, pH 7.4)
to a final concentration of 0.26 mmol cholesterol/I, and oxidation was initiated with
CuClg (final concentration 1.66 nmol/l) in a quartz cuvette. Oxidation of PUFAs was
measured spectrophotometrically by monitoring the formation of conjugated fatty acid
dienes at 37 °C*'^. The change in absorbance at 234 nm was recorded over a 5-hour
period, and the amount of dienes was calculated using a molar extinction coefficient
for conjugated dienes of £234= 29,500 l/mol/cm (for more detailed information, see ref.
12).
Oxidation of LDL /n vtfro was described by the maximum amount of conjugated
dienes formed, by the lagtime between the addition of copper to initiate oxidation and
the onset of rapid oxidation, and by the maximum rate of formation of conjugated
dienes during this rapid oxidation (propagation phase)^. Because samples from each
experimental group were present in each LDL isolation, dialysis, and oxidation run,
differences between the groups due to analytical variation were minimized.
Aliquots of plasma and LDL at baseline and at the end of the study were stored
at -80 °C for further analyses. Vitamin E levels in LDL were determined by high
performance liquid chromatography (HPLC)^. LDL (200 nl) was mixed with retinol
acetate (50 ul, 15 mg/l) as internal standard, ethanol (200 ul) and methanol (200 p.l).
Then n-hexane (0.5 ml) was added, the samples were vortexed for 1 minute, and
centrifuged at 4000 rpm (2700 g) for 5 minutes. The organic top phase was removed
and the extraction repeated. The pooled hexane phase was evaporated to dryness
under nitrogen. The residue was redissolved in 500 ul methanol, and an aliquot of 50
u.l was injected on a reversed phase precolumn (Hypersil ODS, 5 urn C-18, 75 mm *
4.6 mm I.D.; Chrompack, Middelburg, The Netherlands) followed by a reversed phase
column (Hypersil ODS, 5 |im C-18, 150 mm * 4.6 mm I.D.; Chrompack), and eluted
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with 99% methanol at a flow rate of 1.0 ml/min using a Spectroflow 400 pump
(Separations, H.I. Ambacht, The Netherlands). Detection wavelength (Spectroflow 783,
Separations) was set at 340 nm (retinol acetate) during the first 5 minutes, and at 280
nm (vitamin E) during the 5 minutes thereafter. Peak areas were calculated by a
Spectra-Physics 4400 integrator and calibrated against standard a-tocopherol solutions
(2.5, 5 and 10 mg/l in ethanol). Vitamin E levels were lipid-standardized using (LDL)
cholesterol values.
Due to limited amounts of LDL, no fatty acid composition of LDL could be
measured. It is conceivable, however, that the fatty acid composition of LDLs and
plasma phospholipids changed similarly during the study. The fatty acid composition
of plasma phospholipids was determined by gas chromatography. Briefly, total lipid
was extracted from 100 (il plasma samples with 3 ml methanolxhloroform (1:2, vohvol)
via a modified Folch method''^®. Dinonadecanoyl phosphatidylcholine (31 ng per
100 u.l plasma; Avanti, Alabaster, USA) was used as internal standard. Phospholipids
were separated from the total lipid extract with a Bond Elut NHg-aminopropyl column
(Rochrom, Rotterdam, The Netherlands)^, and then saponified and methylated with
14% boron trifluoride in methanol (Fluka Chemie AG, Buchs, Switzerland) at 100 °C
for 1 hour*°. The fatty acid methylesters were extracted with pentane, evaporated
to dryness, and redissolved in 50 uJ isooctane. Three microliters (split ratio of 1:40)
were then injected on a HP 5890 II gas chromatograph fitted with a 50 m, 0.25 mm
I.D., 0.12 jim film thickness, CP-Sil 5 CB non-polar capillary column (Chrompack),
using Ng as carrier gas. A standard mixture of fatty acid methylesters was used to
optimize the temperature programming, and to identify the fatty acid methylesters by
relative retention times. Fatty acids were quantified based on the peak areas relative
to the internal standard. To measure its fatty acid composition, the fish oil concentrate
was directly methylated, with trinonadecanoin as intemal standard, and the
methylesters were analyzed as described above.
All chemicals were purchased from Merck (Darmstadt, Germany) or Sigma
Chemical Company (Saint Louis, USA), unless otherwise indicated. Methanol used for
HPLC was of HPLC grade.
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Statistical analysis •
For LDL oxidation parameters, responses to the supplements were calculated per
subject as the changes from day 1 to days 8, 15 and 22, and for all other parameters
from day 1 to day 22. Thus, each subject served as his own control and interindividual
variation was excluded. Differences at baseline and differences in responses between
the experimental groups were examined by oneway analysis of variance using the
General Linear Models procedure of the Statistical Analysis System^. Pearson
correlation coefficients were calculated between various parameters at baseline.
Values are reported as mean ± SD.
RESULTS
No significant differences between the experimental groups were present at the
start of the study for any of the parameters studied (Table 2.1 and 2.2). Over the 3
weeks of the study, slight increases in body weight (0.6 ± 0.9 kg) and LDL cholesterol
(0.16 ± 0.24 mmol/l) were noticed. Changes, however, were not significantly different
between the groups.
Compliance to the supplements was confirmed by a significant increase in the
proportion of EPA (P<0.0001 vs control group) and DHA (P=0.0004 and P=0.0002 for
respectively the fish oil and the fish oil/vitamin E group vs the control group) in the
plasma phospholipids of the fish oil supplemented volunteers (Table 2.1), and by an
increase of vitamin E in LDL of the fish oil/vitamin E supplemented group (P<0.0001
vs both other groups; Table 2.2). The increase in the proportion of n-3 fatty acids was
accompanied by a decrease in the proportion of n-6 fatty acids. Although the total
amount of PUFAs was therefore similar in all groups, the total number of double bonds
contained in the PUFAs (PUFA unsaturation index) was higher in the two groups
receiving the fish oil supplement (P=0.003 and P=0.002 for respectively the fish oil and
the fish oil/vitamin E group vs the control group; Table 2.1).
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Table 2.1. Fatty acid composition of the fish oil concentrate and the effects on the fatty acid composition of plasma phosphoiipids
after three weeks of fish oil supplementation.
Plasma phospholipid fatty acids in experimental groups
Total saturates
Total monoenes
C18:1(n-9)
Total polyenes
n-3 polyenes
C20:5(n-3)
C22:5(n-3)
C22:6(n-3)
n-6 polyenes
C18:2(n-6)
C20:3(n-6)
C20:4(n-6)
C22:4(n-6)
C22:5(n-6)
Unidentified
Fish oil
concentrate
24.9
23.9
9.2
43.9
40.0
20.9
3.7
13.1
3.7
1.2
0.2
1.1
0.1
0.5
7.2
PUFA unsaturation indexf
Control
Baseline
45.3 ±0.6
11.2 ±1.1
7.3 ±1.1
41.8 ±1.5
5.4 ±0.9
0.6 ±0.2
1.0 ±0.1
3.5 ±0.6
36.3 ±2.1
21.4 ±3.1
3.6 ±0.6
9.9 ±2.2
0.4 ±0.1
0.3 ±0.0
1.6 ±0.2
119.1 ±5.7
Change
0.0 ±0.5
0.0 ±0.5
+0.3 ±0.5
0.0 ±0.5
+0.3 ±0.5
+0.2 ±0.2
0.0 ±0.1
0.0 ±0.3
-0.3 ±0.5
+0.3 ±1.8
+0.1 ±0.5
-0.6 ±1.7
0.0 ±0.0
0.0 ±0.0
0.0 ±0.2
-0.6 ±3.1
Fish
Baseline
oil
Change
grams per 100 grams fatty acids
44.6 ±0.6
11.5 ±1.9
7.6 ±1.4
42.0 ±1.4
4.9 ±1.5
0.4 ±0.2
0.9 ±0.2
3.3 ±1.3
36.9 ±2.1
22.9 ±1.5
2.3 ±0.5
10.5 ±2.0
0.4 ±0.1
0.3 ±0.0
1.9 ±0.2
117.4 ±8.4
+1.1 ±0.5
-0.9 ±0.4
-1.0 ±0.3
+0.1 ±0.5
+5.1 ±0.5
+2.7 ±0.3
+0.5 ±0.1
+1.9 ±0.6
-4.9 ±0.3
-2.6 ±1.3
-0.7 ±0.3
-1.3 ±1.7
-0.2 ±0.0
-0.1 ±0.0
-0.3 ±0.2
+12.0 ±4.4
c
c
b
b
b
b
a
a
Fish oil/Vitamin E
Baseline
45.3 ±1.0
, 12.6 ±0.8
8.7 ±1.0
40.2 ±1.1
4.5 ±0.8
0.6 ±0.2
0.9 ±0.1
2.7 ±0.6
35.5 ±1.4
22.2 ±2.3
3.0 ±0.5
9.0 ±0.9
0.4 ±0.0
0.2 ±0.0
1.8 ±0.3
110.6 ±2.0
Change
+0.4 ±0.7
-1.2 ±0.8
-1.2 ±1.3
+0.7 ±1.3
+4.8 ±1.0 "
+2.3 ±0.6 *
+0.4 ±0.2 "
+2.0 ±0.4 "
-4.0 ±1.7 "
-1.5 ±1.6
-1.0 ±0.4 •
-1.1 ±0.6
-0.2 ±0.0 '
-0.1 ±0.0 "
+0.1 ±0.2
+12.0 ±4.0 •
Eleven men received for three weeks a fish oil (n=3), fish oil plus vitamin E (n=4) or no supplement (control, n=4) to their habitual diets. Values
for phospholipid fatty acid composition are means ± SD. Asterisks indicate significant differences in change from control group (oneway analysis
of variance): a: P<0.01; b: P<0.001; c: P<0.0001. No significant differences were noticed at baseline between the three groups, nor in change
between the fish oil and fish oil/vitamin E group,
t Calculated as the sum of the percentage of each PUFA (moles/moles total fatty acids * 100%) multiplied with its number of double bonds.
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Table 2.2. Effects of fish oil supplementation, with or without vitamin E, on cholesterol levels
r cholesterol standardized vitamin E levels and copper-catalyzed oxidation of low
density iipoprotein (LDL) ;n v/fro.
• ' . • " • . • ; • . - • /
Control
LDL cholesterol (mmol/l)
baseline 2.48 ± 0.79
end 2.55 ± 1.00
change - " +0.07 ± 0.26
LDL vitamin E (mg
baseline
end
change
LDL oxidation:
Conjugated dienes
baseline
end
change
Lagtime (minutes)
baseline
end
change
Rate, max. (u.mol
baseline
end
change
vitamin E/mmol LDL
1.56 ± 0.62
1.70 ± 0.51
+0.14 ± 0.19
5 (limol dienes/mmol
129.0 ± 5.6
129.9 ± 9.4
+0.9 ±10.7"
i
76.2 ±20.7
. 68.4 ±24.3
-7.5 ± 6.8
Expenmental group
Fish oil
2.33
2.43
+0.10
cholesterol)
1.54
1.78
' +0.24
LDL cholesterol)
122.2
146.4
+24.2
76.6
53.9
-22.7
dienes/mmol LDL cholesterol/min)
2.22 ± 0.33 2.09
1.96 ± 0.40 2.31
-0.25 ± 0.71 +0.22
± 0.59
± 0.60
± 0.13
i+ 
i+
 
i+
po
p
fo
 
o
 
to
o
± 7.0
±15.4
± 8.6"
±13.4
± 7.1
± 8.4"
± 0.61
± 0.43
± 0.30
Fish oil/vitamin E
2.33
2.63
+0.31
1.18
2.90
+1.73
120.7
142.2
+21.6
79.3
84.9
+5.6
2.33
1.76
-0.57
± 0.73
± 0.56
+ 0.27
+ 0.19
± 0.28
± 0.19*
±10.8
±12.2
± 4.3"
± 9.7
±23.2
±14.6"
± 0.19
± 0.38
± 0.35
Values are means ± SD. Male subjects received no supplement (control group, n=4), or 6 g/day of a
fish oil supplement, without (fish oil group, n=3) or with (fish oil/vitamin E group, n=4) 300 Ul/day
vitamin E. Baseline values and changes over the 3 weeks of the study were compared by oneway
analysis of variance: superscripts b and c indicate significant differences from a-superscript: a vs b:
P<0.01; a vs c: P^O.0001.", n=3 for LDL vitamin E analysis (one sample lost during analysis).
Within one week, the amount of dienes formed during oxidation of LDL /n v/fro,
was higher in both groups on fish oil supplementation (Figure 2.1, top panel). After
three weeks, the amount of dienes in the fish oil group had increased by 20%
(24.2 ± 8.6 umol dienes/mmol LDL cholesterol; p=0.006 vs control group) and in the
fish oil/vitamin E group by 18% (21.6 ±4.3 umol dienes/mmol LDL cholesterol;
P=0.008 vs control group), while the change in the control group was less than 1%
(0.9 ± 10.7 nmol/mmol LDL cholesterol; Table 2.2).
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I I Control [ X 3 Fish oil Fish oil + Vitamin E
DIENES (umol/mmol cholesterol)
LAGTIME (min)
0 .5 ,
0 -
-0.5
RATE (dienes/min)
Weeks
Figure 2.1. Effect of fish oil and vitamin E supplementation on maximum amount of conjugated dienes
(top panel), lagtime before onset of oxidation (center panel), and maximum rate of diene
formation (bottom panel) during oxidation of human low density lipoprotein /n wfro. Results
are shown as mean changes relative to the start of the study. Changes are corrected for
unknown drifts with time as measured by the changes in the control group, which are set
to zero. *,# Significant difference (P<0.01): * vs control group, # vs fish oil group.
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Compared to the control group, the lagtime decreased in the fish oil group and
increased in the fish oil/vitamin E group (Figure 2.1, center panel). After three weeks,
the lagtime in the control group had decreased by 7.5 ± 6.8 minutes (11+9 %). The
lagtime in the fish oil group, however, had decreased by 22.7 ± 8.4 minutes (29 ± 7 %;
P=0.10 vs control group), whereas the fish oil/vitamin E group showed an increase of
5.6 ± 14.6 minutes (6 ± 18 %; P=0.008 vs fish oil group; P=0.12 vs control group;
Table 2.2).
The maximum rate of diene formation during oxidation decreased after 3 weeks
by 0.57 ± 0.35 |imol dienes/mmol LDL cholesterol/min in the fish oil/vitamin E group
(P=0.40 vs control group; P=0.07 vs fish oil group). Mean changes were -0.25 ± 0.71
in the control group and +0.22 ± 0.30 umol dienes/mmol LDL cholesterol/min in the
fish oil group (P=0.25 between groups; Table 2.2). Differences between groups were
not consistent throughout the study, but decreases were always most pronounced in
the fish oil/vitamin E group (Figure 2.1, bottom panel).
At baseline, no significant correlations were found between the cholesterol
standardized vitamin E concentration in LDL (n=10) and lagtime (r=0.304; P=0.39),
amount of dienes (r=0.490; P=0.15) or rate of diene formation (r=0.294; P=0.41).
DISCUSSION
The present study examined the effects of dietary fish oil and vitamin E on copper-
catalyzed /h wYro oxidation of human LDL. Three parameters were measured to
determine the extent of oxidation.
Maximum amount of conjugated dienes (oxidizability)
Increasing the dietary fish oil intake for three weeks caused a marked increase in
the amount of conjugated dienes formed during copper-catalyzed oxidation of LDL
;n wfro. This increased oxidizability of LDL was also found when the proportion of
dietary n-6 PUFAs (i.e. linoleic acid) was increased at the expense of oleic acid, both
in rabbits® and in man"^'™. Only a few studies looked at the effects of dietary n-3
18
F/s/7 o// supp/emenfaf/on and LDZ. ox/daf/on /n wrro
PUFAs on LDL oxidation /n w/ro. Nenseter ef a/.* analyzed LDL samples for lipid
peroxides after oxidation with copper for 1, 6, and 24 hours. The levels of lipid
peroxides in samples from two volunteers receiving a fish oil supplement did not differ
from samples from two volunteers receiving a com oil supplement, although the
unsaturation index of LDL was higher in the fish oil group. Due to the small number
of samples and the absence of baseline values, however, no final conclusion can be
drawn from this part of the study. Harats ef a/.^ found increased levels of
thiobarbituric acid reactive substances (TBArs) in native and /n wfro oxidized LDL of
fish oil supplemented volunteers as compared with not-supplemented volunteers.
Oxidation of LDL was performed by a fixed period of incubation with either copper or
smooth muscle cells. Additional dietary supplementation with vitamin E (fish oil +
vitamin E group) attenuated the increase in TBArs caused by the fish oil. In the
present study, vitamin E did not affect the maximum amount of dienes formed /n wfro,
but only increased the time needed to reach this maximum. Levels of TBArs (or other
oxidation products) after a fixed period of oxidation, however, may not necessarily
represent maximum levels. Indeed, two studies showed that supplementation with
vitamin E^, or probucol, another chain-breaking antioxidant^, decreased levels
of both TBArs and conjugated dienes in LDL measured after 3 hours of oxidation
/n wfro in PBS, but that maximum levels (after 5 or 8 hours of oxidation) were similar
to maximum levels in the placebo supplemented group. The lower pre-maximum
values in the vitamin E and probucol supplemented groups can (at least partly) be
explained by the significantly lower rate of oxidation in the vitamin E group (ref. 23,
lagtime not determined), and by a significantly longer lagtime in the probucol group
(ref. 24, rate of oxidation not determined). In a recent study of Lussier-Cacan
ef a/.^, the effect of dietary fish oil and the antioxidant probucol on copper-catalyzed
oxidation of LDL /n v/fro was studied. Six hypertriglyceridemic patients (3 with type III,
and 3 with type IV) received a low-saturated-fat, low-cholesterol diet with no
supplement, a fish oil supplement, and a fish oil plus probucol supplement in three
consecutive periods. TBArs were measured each hour during the 5 hours of oxidation,
and in the fish oil period, levels of TBArs in LDL were systematically higher as
compared with the not-supplemented period. Additional supplementation with probucol
drastically decreased the level of TBArs. Although a clear maximum was not reached
after 5 hours of oxidation, their data indicated that the propagation phase was near the
end, thus a further large increase of TBArs in the fish oil/probucol period seems
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Physical performance, red blood cell characteristics, plasma lipid-
soluble antioxidant concentrations and m wfro oxidation of low
density lipoproteins during exercise. The effects of fish oil and
vitamin E supplementation
Gerard S. Oostenbrug, Ronald P. Mensink, Max R. Hardeman, Tjeerd de Vries, Fred
Brouns & Gerard Homstra
Based on: 'Exere/se pe/formance, ery/nrocyfe c/u/acfensftcs, and //p/d peroxjdafron; effects of As/) o//
and fltam/n E" (sudm/fted).
ABSTRACT
Previous studies have indicated that fish oil supplementation increases red blood ceil
(RBC) deformability, which may improve exercise performance. Exercise alone, and the
combination with an increase in fatty acid unsaturation, however, may enhance lipid
peroxidation, and limit the potentially beneficial effects of fish oil supplementation. Therefore,
we investigated the effects of exercise and fish oil supplementation, without (FO) or with
vitamin E (FE), on RBC characteristics, plasma lipid-soluble antioxidant concentrations, and
/n v/fro oxidation of low density lipoproteins (LDL), and the effects of FO and FE on exercise
performance, in trained cyclists. RBC deformability appeared to decrease during endurance
exercise. After correction for hemoconcentration, plasma total tocopherol and carotenoid
concentrations decreased by 2.9% (P=0.012) and 4.5% (P=0.0008), respectively. Endurance
exercise did not affect the lagtime and rate of /n wfro oxidation of LDL, but the maximum
amount of conjugated dienes formed decreased by 1.2% (P=0.042). FO and FE did not affect
RBC characteristics or exercise performance. Both supplements decreased the rate of LDL
oxidation, and FE delayed oxidation. The amount of dienes, however, was not affected. The
supplements also did not change effects of exercise. We conclude that the changes observed
during endurance exercise may indicate increased oxidative stress. Fish oil supplementation
did not improve endurance performance, but also did not cause or augment adverse changes
in antioxidant concentrations or LDL oxidation during exercise.
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INTRODUCTION > T 'K*
Several studies have indicated that dietary fish oils increase the deformability of
red blood cells (RBC) as a result of the incorporation of the highly unsaturated fish oil
fatty acids in the membrane^. This may facilitate the transport of RBC through the
microcirculation^, leading to improved oxygen supply, reduced lactic acid production,
and improved exercise performance. In addition, exercise increases intravascular
hemolysis*, which may be counteracted by fish oil supplementation^.
However, incorporation of the highly unsaturated fatty acids in membranes
increases the membranes' susceptibility to lipid peroxidation®. Previously, we have
reported that the susceptibility to oxidation of low density lipoproteins (LDL) was
increased by fish oil supplementation, and that this potentially unbeneficial effect could
be counteracted by vitamin E .^ Lipid peroxidation may be especially important during
exercise, since exercise increases the formation of reactive oxygen species capable
of oxidizing unsaturated fatty acids leading to altered membrane characteristics (for
reviews, see Refs 8 and 9). Indeed, exercise™'"-^, and treatment of RBC
with malondialdehyde (MDA)^, a product of lipid peroxidation, have been shown to
decrease RBC deformability. Possible benefits of fish oil supplementation for athletes
may therefore be counteracted by increased susceptibility to oxidation of the RBC.
Therefore, we investigated the effects of exercise and fish oil supplementation, with
or without the antioxidant vitamin E, on RBC characteristics and lipid peroxidation, and
the effects of the supplements on exercise performance.
SUBJECTS AND METHODS
Study design
Twenty-four well-trained male athletes (aged 19 to 42 years), who were
experienced in cycling, entered the study between January 11 and 26, 1995. They
trained at least 2 times per week, and their 'maximal workload capacity' (W^^) on a
cycle ergometer (see below), exceeded 4 watt/kg body weight. All participants were
healthy as determined by a medical questionnaire. Written informed consent was
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received from each subject, and prior approval for the study was obtained from the
Medical Ethics Committee of the University of Limburg.
Participants were asked to abstain from intense physical activity for 36 hours prior
to the measurements, and were instructed not to use any antioxidant supplements
during and two weeks preceding the study. At the start of the study, W ^ ^ of each
participant was determined. Four to seven days later, the subjects performed an
endurance exercise test on a cycle ergometer, during which changes in hematological
variables, RBC characteristics, plasma viscosity, plasma antioxidant status, and LDL
oxidation were measured. For the next 3 weeks, 8 subjects (PLA group) received a
placebo supplement, 8 subjects (FO group) a fish oil supplement (6 g of Fish-EPA
daily), and 8 subjects (FE group) the fish oil supplement together with vitamin E
(Ephynal 300, 300 IU dl-a-tocopherol acetate daily). The three groups were stratified
for W^ax, and, as far as possible, one subject from each group was tested on the
same day. At the end of the study, exercise testing procedures were repeated.
Placebo capsules, containing micro-crystalline cellulose, were supplied by the
pharmacy of the Academic Hospital Maastricht (Maastricht, The Netherlands).
Fish-EPA capsules were a generous gift from Orthica (Weesp, The Netherlands), and
Ephynal 300 capsules from Hoffmann-La Roche (Basel, Switzerland). The fish oil
capsules contained (w/w) 17.6% EPA and 12.5% DHA, and only 0.12% vitamin E
(0.01% 5-tocopherol, 0.03% B+y-tocopherol, 0.08% a-tocopherol), as analyzed by gas
chromatography and HPLC respectively.
Exercise performance protocols
Max/ma/ worfc/oad capac/fy tesf
W^gj, was determined during an incremental cycle ergometer test with 3 min
intervals^. The workload corresponding to a plasma lactate concentration of 4
mmol/l (anaerobic threshold) was calculated assuming a linear change between the
two workloads corresponding to lactate concentrations just below and above this
value. Oxygen uptake was measured continuously using a computerized automatic
system (Oxycon Delta, Mijnhard, The Netherlands). All W^^ tests were performed
between 12.00 and 18.00 hour. W^^ of each subject, as measured the week before
supplementation started, was used for both the endurance exercise tests, before and
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after 3 weeks of supplementation. The second W^^ test, performed after 15 to 17
days of supplementation, was used to detect changes in W ^ ^ and plasma lactate
concentrations due to the supplements.
Endurance exerc/se tesf
Before and after the 3-week period of supplementation, subjects were asked to
perform a prefixed absolute workload on a linearly functioning cycle ergometer (Lode
Excalibur Sport, Lode, Groningen, The Netherlands), in as little time as possible. The
workload was based on 70% of the W^^ of each subject, and the workload output
depended directly on the pedalling frequency. During the test, subjects were only
informed about the cumulative achieved amount of work, as displayed by a 0 to 100%
indicator of the total workload. Time as well as pedalling frequency were blinded to the
subjects. Subjects were allowed to drink tap water ad //b/ft/m. The time needed to
complete the test was used as a measure of physical performance. This new validated
endurance exercise test, resembling a time trial of approximately 1 hour, has been
described in detail by Jeukendrup ef a/.^. All endurance exercise tests were carried
out between 8.30 and 11.00 hour.
Blood sampling
During the W^^ tests, an intravascular teflon catheter (Baxter, Utrecht, The
Netherlands) was positioned in a fore-arm vein. At the end of each workload step,
blood was collected in NagEDTA^HgO (f.c. 2 g/l), and kept on ice. After the test,
samples were centrifuged for 10 minutes at 1600 g and 4 °C, and plasma was stored
at -40 °C for lactate analysis later.
Before and immediately after each endurance exercise test, fasting free-flowing
antecubital venous blood was collected in two decapped KgEDTA-containing Monoject-
tubes (f.c. 1.5 g/l; Sherwood Medical, Ballymoney, Northern Ireland), while the subjects
were in supine position. Blood was also collected in heparin (f.c. 143 U.S.P. units/5
ml; Monoject-tubes, Sherwood Medical) for measurement of osmotic fragility of RBC.
Tubes were immediately closed after collection, and blood and anticoagulant were
carefully mixed. One tube with EDTA-anticoagulated blood was sent to Amsterdam
(ambient temperature), and analyzed the next day for RBC deformability and plasma
28
Exerc/se performance, ffs/i o// supp/emenfaf/on and //p/y perox/daf/bn
viscosity. Extensive pilot experiments demonstrated that such transport did not
significantly affect RBC deformability (results not reported). Hematological variables
were analyzed in the other EDTA-tube, which was then centrifuged for 10 minutes at
1300 g and 4 °C. Part of the fresh EDTA-plasma was used for LDL oxidation, and an
aliquot was stored at -80 °C for antioxidant analysis. RBC were immediately washed
for phospholipid fatty acid analysis.
Blood analyses
P/asma /acfate
EDTA-plasma, collected during W ^ tests, was analyzed for iactate (enzymatic
LDH method; LDH, No. 106984, Boehringer Mannheim, Mannheim) on a COBAS-BIO
centrifugal analyzer (F. Hoffmann-La Roche, Basel, Switzerland).
Hemato/og/ca/ variab/es, RSC cnaracferisf/cs, and p/asma v/scos/fy
Hematological variables were analyzed on a Coulter MD 18 (Counter, Miami, FL,
USA), and changes in blood and plasma volume during endurance exercise were
calculated using hematocrit (Ht) and hemoglobin (Hb) values^®.
RBC deformability was measured based on the ektacytometric principle using a
Laser-assisted Optical Rotational Cell Analyser, LORCA (R&R Mechatronics, Hoom,
The Netherlands)^. Briefly, 25 |il of EDTA-anticoagulated blood were suspended in
5 ml of a 5%-solution of polyvinylpyrrolidone (300 mOsm/l, Sigma Chemical Company,
Saint Louis, MO, USA). This sample was then subjected to several rotational speeds
at 21 °C, giving final shear stresses ranging from 0.30 to 53.35 Pascal (Pa). Laser
diffraction was used to follow the change of the RBC population from biconcave
towards an ellipsoid morphology under increased shear stress, and the deformability
(elongation index, El) of the RBC was calculated from the major and minor axis of the
ellipsoid diffraction pattern (Figure 3.1). Apart from the near-maximum values at 30 Pa
as previously used for evaluation of RBC deformability^^®, we also report values
at 0.95, 3 and 9.5 Pa, since, for example, rigidification of RBC with glutaraldehyde
decreases the elongation index only at lower shear stresses^. The rest of the EDTA-
blood was centrifuged for 10 minutes at 3000 g and room temperature, and the
viscosity of the plasma was measured in duplicate at a shear rate of 70/s using a
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Contraves LS 30 viscometer (Contraves, Zurich, Switzerland).
0.95 3 9.5 30
shear stress (Pa)
Figure 3.1. Change in diffraction pattern during
elongation of RBC exposed to
various shear stresses /n wf/u (log
scale). The elongation index (El) is
calculated from the major (A) and
minor (B) axis of the ellipsoid
diffraction pattern.
For measurement of the osmotic fragility of RBC, each week 16 solutions ranging
from 0.70% to 0.10% were prepared from a 1% salt solution (9.0 g NaCI/1, 1.71 g
NagHPO^HgO/l, 0.24 g NaHjPO^HgO/l, pH 7.4), and stored for a maximum of 5
days at 4 °C. To 5 ml of each solutions, 25 nl of fresh heparinized blood were added,
and carefully mixed. The samples were then left standing for 30 min at room
temperature, carefully mixed again, and centrifuged for 10 min at 600 g. The degree
of hemolysis (osmotic fragility) was determined by measuring the release of Hb in the
supernatant spectrophotometrically at 540 nm. Hemolysis in the 0.10% salt solution
was considered as 100%. Osmotic fragility in 5 salt solutions, demonstrating
approximately 5 to 90% hemolysis, was used for interpretation of the results.
Red b/ood ce// p/)osp/7o//p/d ferry ac/ds
RBC were washed twice with EDTA-containing saline (28.64 g NA2EDTA.2H2O/I,
7.00 g NaCI/1), and stored under nitrogen at -40 °C for a maximum of 4 days. After
thawing, phospholipids fatty acids were extracted from RBC, and analyzed by gas
chromatography as described by Foreman-van Drongelen^, with the modification
that fatty acids were separated on a BPX70 polar and a BP1 non-polar capillary
column (Scientific Glass Engineering, Austin, TX, USA). Fish oil from the capsules was
directly methylated with triheptadecanoin as internal standard. The fatty acid
composition of RBC phospholipids was expressed as weight percentage of total fatty
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acids (g/g * 100%), and the polyunsaturated fatty acid (PUFA) unsaturation index as
the sum of the molar percentage of each PUFA (mol/mol total fatty acids * 100%),
multiplied with its number of double bonds.
P/asma anf/ox/danfs ' •* '
EDTA-plasma was analyzed for retinol, tocopherols and carotenoids by HPLC with
simultaneous absorbance and fluorescence detection as described by Hess ef a/.^°,
with the modification that an internal standard (retinol acetate) was used, and
extraction of lipids was performed twice to improve recovery. Also, no ammonium
acetate was added to the mobile phase. All samples from one subject were analyzed
in the same analytical run, and the same number of subjects from each group was
present in each run. Chromatogram peak areas were calculated with the Gynkosoft
Chromatography Data System (Gynkotek, Germany), and calibrated against a mixture
of the various standard substances dissolved in ethanol/dioxane/acetonitrile (1:1:3).
Since pure phytofluene was not available, quantitative determination of this compound
was not possible. B-Tocopherol co-eluted with y-tocopherol, and they are therefore
reported together. The canthaxanthin standard eluted separately from the lutein
standard, but in plasma samples canthaxanthin concentrations were too low to be
chromatographically separated from the lutein peak. Therefore, concentrations of lutein
reported here may also include small traces of canthaxanthin.
Fish oil capsules were dissolved in ethanol/dioxane/acetonitrile (20 mg oil/ml), and
directly analyzed for tocopherols by HPLC.
a-Tocopherol (all-rac), Y-tocopherol, B-cryptoxanthin, lycopene, and B-carotene
standards were a generous gift from F. Hoffmann-La Roche (Basel, Switzerland).
Lutein, retinol (all-frans), 8-tocopherol and a-carotene were obtained from Sigma
Chemical Company, canthaxanthin from Fluka Chemie (Bomem, Belgium). Retinyl
acetate and all other chemicals were purchased from Merck (Darmstadt, Germany).
LDL /so/af/on and ox/daf/on /n v/fro
LDL was isolated from fresh EDTA-plasma immediately after collection by short-run
single spin density gradient ultracentrifugation. In a 4.9 ml OptiSeal polyallomer
centrifuge tube (Beckman Instruments, Palo Alto, CA, USA), 0.85 ml of a 0.49 g/ml
potassium bromide solution and 1.52 ml of plasma were gently mixed with a spatula.
This mixture was carefully overlayered with distilled water, containing 1 g/l
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NagEDTA^HgO, to the neck of the tube. The tube was then plugged, and centrifuged
for 1 hour at 80,000 rpm using a near vertical tube rotor (NVT-90, Beckman
Instruments) in an XL-80 ultracentrifuge (Beckman Instruments). The upper 0.6 ml was
removed, and the next 1.6 ml, containing LDL, was collected. EDTA was removed
from LDL samples by gel filtration, using two PD-10 Sephadex G25-M gel filtration
columns (Pharmacia, Roosendaal, The Netherlands) placed on top of each other, and
a nitrogen-purged mobile phase (PBS: 9.61 mmol/l NagHPO^ 1.56 mmol/l NaHgPC^,
0.154 mol/l NaCI, pH 7.4). The EDTA-free LDL, was kept under a nitrogen atmosphere
to prevent oxidation, and analyzed for its cholesterol content (Monotest Cholesterol,
Boehringer Mannheim, Mannheim, Germany).
Within 15 minutes after gel filtration, an aliquot of each sample was diluted in a
quartz cuvette with PBS (not purged with nitrogen) to a final concentration of 0.26
mmol cholesterol/I, and oxidation was initiated with CuC^ (f.c. 2 umol/l). Immediately
thereafter a second aliquot of LDL (0.26 mmol/I) was oxidized with 15 ^mol/l CuClg,
since at copper/cholesterol ratios over 1/20 (mol/mol) the copper concentration does
not affect LDL oxidation parameters anymore (unpublished observation). Oxidation of
PUFA at 37 °C was measured spectrophotometrically by monitoring the formation of
conjugated fatty acid dienes at 234 nm. The lagtime before rapid formation of
conjugated dienes was calculated from the intercept of linear lines through the point
of maximum rate of diene formation and the absorbance immediately after addition of
copper^. In addition, the time at which the maximum rate of oxidation was reached
(TFLJ was also determined. TR^ represents a combined effect of the lagtime and the
rate of oxidation.
Statistics
Effects of endurance exercise were examined before supplementation for all 24
subjects together by Student's paired two-tailed f-test. To evaluate the effects of the
supplements, responses were calculated for each subject as the changes in exercise
parameters and pre-endu ranee exercise biochemical values over the period of
supplementation. Differences in responses between the three experimental groups
were then compared by analysis of variance (ANOVA). The placebo group allowed us
to correct for possible drifts with time. Differences between the experimental groups
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in changes during exercise after supplementation as compared with changes during
exercise before supplementation, were also compared by ANOVA. Pearson correlation
coefficients (r) were calculated to evaluate the relationship between RBC deformability
and RBC osmotic fragility. Possible interference of the method of measurement of
RBC deformability by changes in blood cell concentrations during exercise was also
studied by computing Pearson correlation coefficients. The overall level of significance
was set at P<0.05. As between-group ANOVA involved three simultaneous
comparisons, between group levels of significance were set to P<0.017, according to
the Bonferroni method. All statistical analyses were performed using the Statistical
Analysis System (SAS Institute Inc., 1989). Values are reported as means ± SEM.
Although responses to exercise or supplementation may be given as percentages
change, statistics were always performed on absolute changes.
RESULTS
Effects of endurance exercise before supplementation
Body weights (mean, 73 kg; range, 64 to 92 kg) were similar in all groups
throughout the study. During the pre-supplementation endurance exercise test,
subjects lost on average 0.56 ± 0.07 kg (P<0.0001) of body weight, and consumed on
average 0.65 ± 0.06 liters of water.
Effecf of endurance exe/r/se on hemato/og/ca/ variab/es, p/asma wscos/fy, and RSC
cnaracferisf/cs
During the pre-supplementation endurance exercise test, the average RBC
concentration, total Hb, and Ht increased by 5.3 to 5.7%. The mean corpuscular
volume (MCV) and mean corpuscular hemoglobin concentration (MCHC) of the RBC
did not change. White blood cell (WBC) concentrations increased from 5.38 ± 0.16
* 10 /^1 before exercise to 7.48 ± 0.29 * 10^ /1 after exercise, an average increase of 39%
(P<0.0001). Platelet concentrations increased by 29%, from 202 ± 7 * 10 /^1 to 259 ± 10
* 10 /^1 (P<0.0001). Blood volume decreased by 5.0 ± 0.6 % during exercise, and
plasma volume by 9.0 ± 1.0 %.
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Table 3.1. Effect of endurance exercise on red blood cell characteristics and the modification by fish oil and vitamin E supplementation
" • • ' ' ' • • ' •
AFTER SUPPLEMENTATION
BEFORE SUPPLEMENTATION
pre-exercise
n=24
change
n=24
pre-exercise
n=8
PLACEBO
change
n=8
FISH OIL FISH OIL + VITAMIN E
pre-exercise
n=8
change
n=8
pre-exercise
n=8
change
n=8
Deformab/V/ty of red b/ood ce//s
shear (Pa) elongation index (El)
0.95 0.129 ±0.002 -0.005 ±0.003 0.139 ±0.008 -0.002 ±0.005 0.138 ±0.007 -0.007 ±0.003 0.132 ±0.006 +0.005 ±0.004
3 0.319 ±0.004 -0.005 ±0.002* 0.334 ±0.010 -0.005 ±0.007 0.332 ±0.007 -0.009 ±0.002 0.326 ±0.006 +0.004 ±0.004
9.5
30
0.490 ±0.002
0.582 ±0.002
Osmof/'c frag/My of red
salt solution
0.52%
0.49%
0.47%
0.45%
0.43%
3.1 ±0.5
17.3 ±1.6
37.0 ±2.8
68.5 ±2.3
87.4 ±1.2
-0.002 ±0.002
-0.003 ±0.001
b/ood ce//s
+0.3 ±0.3
+1.3 ±1.0
+1.1 ±1.9
+0.9 ±1.4
+0.3 ±0.7
0.503
0.586
5.8
24.2
41.7
68.1
84.5
±0.004
±0.002
±2.6
±6.5
±8.3
±6.3
±3.3
-0.003
+0.002
+0.7
+2.2
+2.7
+2.1
+1.8
±0.003
±0.002
±0.5
±1.2
±2.2
±2.8
±1.4
0.504 ±0.004
0.587 ±0.002
hemolysis (%)
4.1 ±0.9
22.7 ±4.3
43.0 ±5.1
74.0 ±3.9
90.9 ±3.3
-0.009
-0.002
+0.3
+0.9
+1.3
-0.2
-2.4
±0.002
±0.002
±0.4
±1.6
±2.5
±1.7
±2.7
0.497
0.585
4.8
24.5
45.8
76.3
90.9
±0.004
±0.003
±0.9
±3.6
±4.4
±2.6
±0.9
+0.002
+0.001
+1.3
+4.7
+4.2
+3.0
+1.3
±0.003
±0.001
±0.4
±1.3
±2.5
±1.2
±0.4
Subjects performed a time trial of approximately 1 hour on a bicycle ergometer, before and after supplementation with placebo, fish oil (6 g/day) or fish
oil (6 g/day) plus vitamin E (300 lU/day) for three weeks. Deformability and osmotic fragility of red blood cells were measured as described in "subjects
and methods". Values are means ± SEM.
* Before supplementation, changes during exercise were examined by Student's paired Mest: t . P<0.05. After supplementation, changes during exercise
in the 3 groups were compared by ANOVA, but no significant differences in change were noticed between the groups.
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Plasma viscosity increased from 1.46 ± 0.02 mPa-s before exercise to 1.52 ± 0.02
mPas after exercise, an average increase of 4.2% (P=0.005).
RBC deformability decreased during exercise (Table 3.1), but only the 1.6%
decrease at a shear rate of 3 Pa reached statistical significance (P=0.035). The
decreases in deformability correlated with increases in RBC concentration (e.g. at 3
Pa: r=-0.494, P=0.014; at 30 Pa: r=-0.454, P=0.026), but not with increases in WBC
concentration, platelet concentration, or plasma viscosity. Although the changes in
deformability also correlated with changes in plasma volume (3 Pa: r=0.455, P=0.025;
30 Pa: r=0.410, P=0.047), correlations with changes in blood volume (3 Pa: r=0.334,
P=0.110; 30 Pa: r=0.385, P=0.064) did not reach statistical significance.
The osmotic fragility of RBC (% hemolysis) was not significantly affected by
endurance exercise (Table 3.1). Interestingly, a high RBC deformability at low shear
stresses (0.95, 3, 9.5 Pa), but not at 30 Pa, was generally associated with a high
osmotic fragility. For example, Pearson correlation coefficients of the osmotic fragility
in a 0.47% salt solution versus RBC deformability at 3 Pa and 30 Pa were 0.477
(P=0.018) and 0.002 (P=0.992), respectively.
E/fecf o/ endurance exerc/se on p/asma anf/ox/dante
Plasma antioxidant concentrations, except for 5-tocopherol and B+Y-tocopherol,
increased significantly (P<0.0001) during endurance exercise. Retinol concentrations
increased by 10.1 ±0 .7%, a-tocopherol concentrations by 7.2 ± 0.7 %, and total
carotenoid concentrations by 4.8 ± 0.9 %. After correction for the decrease in plasma
volume in each subject, however, plasma antioxidant concentrations decreased
significantly, except for retinol (Table 3.2). Total tocopherol concentrations decreased
by 2.9 ± 1 . 1 % (P=0.012), and total carotenoid concentrations by 4.5 ± 1 . 2 %
(P=0.0008).
Effect of endurance exerc/se on LDL ox/daf/on /n v/fro
LDL was more rapidly oxidized /n wfro by the high copper concentration, as
compared with the low copper concentration. However, at both concentrations, the
lagtime before onset of rapid oxidation of LDL /n wfro, the maximum rate of oxidation,
and the time at which this maximum was reached (TR^) were not affected by
endurance exercise.
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Table 3.2. Effect of endurance exercise on plasma antioxidant concentrations, and the modification by fish oi and vltajriln E
supplementation i
AFTER SUPPLEMENTATION
BEFORE SUPPLEMENTATION
Retinol
Tocopherols
8-tocopherol
13+Y-tocopherol
a-tocopherol
Carotenoids
lutein
pre-exercise
n=24
1.82 ±0.06
25.1 ± 1.0
0.15 ±0.01
2.19 ±0.19
22.7 ± 0.9
1.89 ±0.10
0.51 ±0.02
B-cryptoxanthin 0.32 ±0.02
lycopene
a-carotene
B-carotene
phytofluene
0.61 ±0.06
0.07 ±0.01
0.38 ±0.03
0.58 ±0.07
change*
n=24
+0.004 ±0.020
-0.77 ± 0.28
-0.011 ±0.004
-0.162 ±0.035
-0.60 ± 0.26
-0.082 ±0.021
-0.026 ±0.006
-0.014 ±0.005
-0.022 ±0.007
-0.003 ±0.001
-0.017 ±0.004
-0.033 ±0.009
t
t
§
t
§
§
t
t
§
§
PLACEBO
pre-exercise
n=8
1.77 ±0.11
26.4 ± 2.2
0.17 ±0.03
2.79 ±0.44
23.4 ± 1.9
1.92 ±0.28
0.58 ±0.06
0.31 ±0.05
0.62 ±0.14
0.06 ±0.01
0.35 ±0.04
0.65 ±0.19
change
n=8
-0.043 ±0.026
-1.29 ± 0.52
-0.022 ±0.009
-0.283 ±0.097
-0.98 ± 0.42
-0.111 ±0.051
-0.030 ±0.009
-0.015 ±0.006
-0.044 ±0.028
-0.003 ±0.002
-0.018 ±0.008
-0.060 ±0.038
FISH OIL
pre-exercise
n=8
2.09 ±0.09
27.1 ± 1.7
0.18 ±0.02
2.40 ±0.30
24.5 ± 1.6
1.87 ±0.12
0.55 ±0.07
0.31 ±0.03
0.53 ±0.05
0.07 ±0.01
0.41 ±0.03
0.52 ±0.04
change
n=8
+0.011 ±0.025
-0.26 ± 0.23
-0.015 ±0.008
-0.121 ±0.028
-0.12 ± 0.22
-0.040 ±0.036
-0.016 ±0.008
-0.005 ±0.007
-0.012 ±0.011
-0.001 ±0.002
-0.006 ±0.010
-0.018 ±0.012
FISH OIL
pre-exercise
n=8
1.83 ±0.11
36.4 ± 2.6
0.09 ±0.01
0.75 ±0.09
35.5 ± 2.5
1.73 ±0.25
0.47 ±0.03
0.30 ±0.05
0.47 ±0.07
0.07 ±0.02
0.42 ±0.14
0.46 ±0.12
+ VITAMIN E
change
n=8
+0.031 ±0.016
-0.17 ± 0.42
0.000 ±0.001
-0.026 ±0.014
-0.15 ± 0.42
-0.028 ±0.014
-0.005 ±0.006
-0.003 ±0.002
-0.007 ±0.005
-0.003 ±0.001
-0.010 ±0.005
-0.014 ±0.006
Subjects performed a time trial before and after supplementation (for details, see Table 3.1 and text). Antioxidant concentrations are expressed in (imol/l
plasma. For phytofluene, chromatogram peak area are expressed in mV*min/^l plasma (amplification 100). Values are means ± SEM.
* Changes during exercise are adjusted for changes in plasma volume in each subject. Before supplementation, changes during exercise were
examined by Student's paired f-test: + P<0.05, ± P<0.01, § P<0.001. After supplementation, changes during exercise in the 3 groups were compared
by ANOVA, but no significant differences in change were noticed between the groups.
Table 3.3. Effect of endurance exercise on oxidation of LDL /n vff/o, and the modification by fish oil and vitamin E supplementation
AFTER SUPPLEMENTATION
Qx/daf/on
Lagt ime
Fornax
Dienes
BEFORE SUPPLEMENTATION
pre-exercise change
n=24 n=24
/ndt/ced w/tf? 2 /vmo//7 C1/C/2
66.4 ± 1.8 -0.5 ± 0.9
3.48 ± 0.08 -0.06 ± 0.05
95.0 ± 2.1 -0.5 ± 1.1
157.8 ± 2.3 -2.1 ± 1.0*
PLACEBO
pre-exercise
n=8
65.3 ±
3.48 +1
94.0 ±
156.6 ±
3.5
3.06
3.9
3.5
change
n=8
+3.4 ± 1.9
-0.02 ± 0.03
+4.0 ± 1.9
-1.1 ± 1.4
FISH
pre-exercise
n=8
59.7 ±
3.02 ± I
93.0 ±
159.2 ±
2.0
3.10
2.2
4.0
OIL
change*
n=8
-0.1 ± 1.8
+0.13 ±0.09
-0.9 ± 2.9
-1.4 ± 0.6
FISH OIL
pre-exercise
n=8
75.9 ± 4.0
2.66 ± 0.09
114.8 ± 5.0
162.1 ± 3.6
+ VITAMIN E
change*
n=8
-0.7 ± 1.8
+0.02 ± 0.06
-3.4 ± 2.9
-3.9 ± 1.6
Ox/c/af/on /nducecf vv/Y/i 75 p/noW
Lagtime
Dienes
59.0 ± 1.8
5.00 ±0.18
78.3 ± 2.2
154.4 ± 2.2
+1.4 ± 1.6
-0.18 ±0.20
+2.0 ± 2.3
-2.4 ± 1.1
56.0 ± 6.3 +4.8 ± 5.0 52.2 ± 3.6 -2.4 ± 1.7 65.1 ± 2.8 +1.6 ± 3.9
5.24 ± 0.36 -0.28 ± 0.45 4.46 ± 0.34 +0.20 + 0.22 3.92 ± 0.28 -0.41 ± 0.24
73.9 ± 7.3 +5.0 ± 6.0 73.9 ± 4.5 -3.3 ± 2.6 91.4 ± 3.8 +2.4 ± 5.0
153.7 ± 3.2 -1.6 ± 1.4 152.3 ± 3.0 -2.2 ± 1.4 157.9 ± 3.2 -4.6 ± 1.9
Subjects performed a time trial before and after supplementation (for details, see Table 3.1 and text). LDL (0.26 mmol cholesterol/l) was oxidized /n Wfro
with 2 and 15 nmol CuClg/l at 37 °C, and the formation of conjugated dienes was monitored spectrophotometrically at 234 nm. Lagtime before onset
of rapid oxidation and the time at which the maximum rate of diene formation was reached (TR^) are expressed in minutes, the maximum rate (R^ax)
in nmol/mmol LDL cholesterol/min, and the amount of conjugated dienes formed in nmol/mmol LDL cholesterol. Values are means ± SEM.
* Before supplementation, changes during exercise were examined by Student's paired f-test: t P<0.05. After supplementation, changes during exercise
in the 3 groups were compared by ANOVA, but no significant differences in change were noticed between the groups. . .
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The maximum amount of conjugated dienes formed during low-copper oxidation
/n v/fro decreased by 2.1 ±1.0 nmol/umol LDL cholesterol (P=0.042) during the pre-
supplementation endurance exercise test. A similar decrease was noticed in LDL
oxidized with the high copper concentration (Table 3.3).
Effects of fish oil and vitamin E supplementation
E/fecf of supp/ementef/on on ffi?C phospho//p/d fatty ac/cfe
Compliance to the fish oil supplements was confirmed by an increase in the
proportion of n-3 PUFA in RBC from 5.2% to 7.0% in the FO group (P<0.0001 vs PLA)
and from 5.2% to 7.6% in the FE group (P<0.0001 vs PLA) during the study (Table
3.4). The increase in EPA was larger in the FE group (P=0.001 vs FO), but other
indicators of compliance, like changes in DHA and intake of capsules, were similar.
Although increases in n-3 PUFA were accompanied by decreases in n-6 PUFA, the
degree of unsaturation was significantly increased after supplementation with fish oil
(Table 3.4).
E/ifecf of supp/emenfaf/on on max/ma/ wo/ff/oao' capacrty
Pre-stratification by W ^ ^ at the start of the study resulted in similar values of
5.0 ± 0.2, 4.9 ± 0.2, 5.0 ± 0.2 watt/kg in the PLA, FO, and FE group, respectively.
During the study, W^^ slightly improved in all groups (0.12 watt/kg or 2.5%), but no
significant differences between the groups were noticed.
At the start of the study, mean maximal oxygen consumption (VOg ^ ax) during the
test was 4.4 ±0.1 l/min, and did not differ significantly between the groups. After
supplementation, VOg,^ increased by 0.01 ± 0.09 l/min in the PLA, by 0.13 ± 0.13
l/min in the FO group, and by 0.15 ±0.09 l/min in the FE group. However, these
changes were not significantly different between the groups (P>0.3).
After PLA and FE supplementation, lactate concentrations appeared to increase
less rapidly during the W^^ test, as compared with the test at the start of the study.
In the PLA group, lactate concentrations of 4 mmol/l were reached at a workload of
3.77 ±0.17 watt/kg during the first test, and at 4.06 ±0.15 watt/kg during the second
test (change: +0.29 ± 0.08 watt/kg; P=0.022 vs FO). In the FE group these values
were 3.77 ± 0.22 and 3.99 ±0.15, respectively (+0.22 ± 0.08 watt/kg; P=0.074vsFO).
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Table 3.4. Fatty acid composition of the fish oil concentrate and the effects on the fatty acid composition of red blood cell phosphoHpkte
after three weeks of fish oil supplementation
Red blood cell phospholipid fatty acids in experimental groups
Total saturates
Total monoenes
Total polyenes
n-6 polyenes
C18:2(n-6)
C20:4(n-6)
n-3 polyenes
C20:5(n-3)
C22:6(n-3)
Unidentified
Fish oil
concentrate
25.9
26.5
39.7
3.8
1.2
1.1
35.7
17.6
12.5
7.9
Polyene unsaturation index
PLACEBO
baseline
47.9 ± 0.3
17.8 ±0.2
33.5 ± 0.2
28.4 ± 0.2
12.4 ± 0.4
10.7 ± 0.2
4.9 ± 0.2
0.5 ± 0.1
2.4 ± 0.2
1.0 ±0.1
102.1 ±0.9
change
grams per
-0.4 ± 0.2
-0.1 ±0.2
+0.4 ± 0.1
+0.3 ± 0.1
+0.2 ± 0.2
+0.1 ±0.1
0.0 ± 0.1
0.0 ± 0.0
0.0 ± 0.0
+0.1 ±0.1
+0.9 ± 0.5
FISH
baseline
100 grams fatty
47.4 ± 0.2
18.2 ± 0.4
33.4 ± 0.4
28.0 ± 0.4
12.2 ±0.3
10.4 ± 0.2
5.2 ± 0.2
0.5 ± 0.1
2.6 ± 0.1
1.0 ±0.1
102.4 ± 0.8
OIL
change
acids
+0.2 ±0.2
-0.2 ±0.1
+0.2 ±0.1
-1.7 ±0.2
-0.7 ±0.2
-0.5 ±0.1
+1.8 ±0.1
+0.8 ±0.1
+0.7 ±0.1
0.0 ±0.1
+3.5 ±0.6
*
t
*
*
*
t
FISH OIL
baseline
47.7 ± 0.3
17.7 ± 0.3
33.7 ± 0.2
28.3 ± 0.5
13.2 ± 0.4
10.0 ± 0.3
5.2 ± 0.3
0.5 ± 0.1
2.8 ± 0.2
1.0 ± 0.1
102.0 ± 0.6
+ VITAMIN E
change
-0.2 ± 0.3
-0.1 ± 0.1
+0.2 ± 0.2
-2.1 ± 0.3
-1.3 ± 0.2
-0.3 ± 0.1
+2.4 ± 0.1
+1.2 ± 0.1
+0.8 ± 0.0
+0.1 ± 0.1
+5.3 ± 0.4
*
*
t
*.§
*.§
t
t
Twenty-four athletes received for three weeks a placebo, fish oil (6 g/day), or fish oil (6 g/day) plus vitamin E (300 lU/day) supplement to their habitual
diets. Values for red blood cell phospholipid fatty acid composition are means ± SEM. Changes after supplementation in the 3 groups were compared
by ANOVA.
t'* Significant difference from change in placebo group: t P<0.01, ± P^O.0001.
§ Significant difference from change in fish oil group: P<0.01.
* Calculated as the sum of the percentage of each polyene (moles/moles total fatty acids * 100%) multiplied with its number of double bonds.
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In the FO group, however, lactate concentrations of 4 mmol/l were reached at similar
workloads in both tests (3.87 ± 0.20 and 3.89 ±0.19 watt/kg, respectively; change:
+0.01 ± 0.08 watt/kg). Since increases in lactate concentrations during the test may
have slightly deviated from linearity around the 4 mmol/l point, we also looked at
lactate concentrations at workloads just below (250 watt) and above (300 watt) this
point. At 250 watt, lactate concentrations in the PLA group were 0.80 ± 0.28 (P=0.085
vs FO) and in the FE group 0.68 ± 0.21 (P=0.166 vs FO) mmol/l lower during the
second test as compared with the first test, whereas they were only 0.19 + 0.22
mmol/l lower in the FO group. At 300 watt, these changes were -1.23 ± 0.41 (PLA,
P=0.107 vs FO), -1.46 ± 0.44 (FE, P=0.046 vs FO), and -0.32 ± 0.28 (FO) mmol/l.
Er/ecf of supp/emenfaf/on on endurance exerc/se performance
The average time to complete the endurance exercise test at the start of the study
was 55.9 ± 0.6 min (n=24). After supplementation, performances were similar in all
groups, and changed only by +0.11 ± 0.49, -0.23 ± 1.35, and -0.07 ±1.16 min in the
PLA, FO, and FE group, respectively (P>0.8 between groups).
£/fecf of supp/emenfaf/on on hemato/ogvca/ variab/es, p/asma wscos/fy, and
characteristics
After supplementation, RBC concentrations, Hb, Ht, MCV, and MCHC were similar
to values before supplementation. Average changes over the 3 weeks were no more
than 3%. Plasma viscosity decreased by 0.05 ± 0.03 mPa-s in the PLA group, by
0.09 ± 0.04 mPa-s in the FO group, and by 0.02 ± 0.03 mPa-s in the FE group.
Differences between treatments were not significant. Changes during exercise were
also similar in the three groups.
RBC deformability increased slightly during the study. Although the increases
during the study at lower stress rates appeared to be larger in the FO group,
differences between treatments were not statistically significant. A decrease in RBC
deformability during endurance exercise as seen before supplementation, was not
present anymore in all groups after supplementation. Differences between the groups
in changes during exercise, however, did not reach statistical significance (Table 3.1).
The osmotic fragility of RBC was not significantly affected by the supplements, nor
did they induce changes during exercise (Table 3.1).
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Effecf of supp/ementef/on on p/asma anf/ox/dante
Intake of the vitamin E capsules in the FE group was verified by an increase in the
mean plasma a-tocopherol concentration from 20.0 ± 1.0 to 35.5 ± 2.5 umol/l
(P<0.0001 versus other groups). This was accompanied by a non-significant decrease
in 8-tocopherol concentrations, and a significant decrease in 13+y-tocopherol
concentrations from 1.93 ± 0.25 to 0.75 ± 0.09 u.mol/1 (P<0.004 vs other groups).
Before supplementation, retinol concentrations in the FO group were non-significantly
higher than concentrations in the other groups. During the study, plasma retinol
concentrations changed by -0.02 ± 0.05 nmol/l in the PLA group, by +0.08 ± 0.06
^mol/l in the FO group (P=0.207 vs PLA), and by +0.15 ± 0.06 umol/l in the FE group
(P=0.041 vs PLA; P=0.390 vs FO). Carotenoid concentrations were also not affected
by the supplements.
Decreases in plasma antioxidant concentrations during endurance exercise were
smaller after FO and FE supplementation, than exercise-induced decreases after PLA
supplementation (Table 3.2). However, differences between the groups did not reach
statistical significance.
Effecf of supp/ementef/on on LDi. ox/daf/on /n v/fro
Before supplementation, LDL oxidation parameters were similar in all 3 groups. At
the end of the supplementation period, the lagtime during low-copper oxidation tended
to increase in the FE group as compared with the other groups (P=0.052 vs FO;
P=0.113 vs PLA; Figure 3.2). The rate of oxidation /n wYro, decreased by 0.52 ± 0.16
nmol dienes/mmol LDL cholesterol/min in the FO group (P=0.010 vs PLA), and by
0.82 ± 0.18 nmol/mmol in the FE group (P=0.0003 vs PLA; P=0.159 vs FO), whereas
the PLA group showed a slight increase (0.07 ± 0.08 nmol/mmol; Figure 3.2). TR^
remained unchanged in the PLA and FO group, but increased significantly in the FE
group (change: +15.0 ±5.7; P=0.007 vs PLA; P=0.040 vs FO; Figure 3.2). The
maximum amount of dienes formed ;n wfro did not change significantly during the
study, and no differences were therefore noticed between the groups (Figure 3.2).
Similar results were found for oxidation of LDL with a high copper concentration (figure
not shown).
After supplementation, changes in parameters of LDL oxidation during exercise,
if any, did not differ significantly between the groups (Table 3.3).
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Figure 3.2. Effect of placebo (open bars), fish oil (solid bars), and fish oil plus vitamin E (hatched
bars) supplementation on oxidation of LDL /n vrfro catalyzed by 2 nmol/1 of CuClj. Bars
indicate the mean change (& SEM) after three weeks of supplementation. Lagtimes and
the time of maximum rate (TRm) are expressed in minutes, the maximum rate of
oxidation (R max) in nmol/nmol LDL cholesterol/min, and the maximum amount of
conjugated dienes in nmol/jimol LDL cholesterol. Asterisks indicate significant
differences from change in placebo group (ANOVA): *, P^O.01; **, P<0.001.
DISCUSSION
The present study examined the effects of fish oil and vitamin E supplementation
on exercise performance, RBC characteristics, plasma lipid-soluble antioxidant status,
and ;n v/fro LDL oxidation.
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Effects of endurance exercise before supplementation .
Effecf of endurance exerc/se on nemafo/og/ca/ variaWes and /?SC characferisf/cs
During endurance exercise a hemoconcentration of approximately 5% was
observed, which was caused by a 9% reduction of the plasma compartment. At the
same time, RBC deformability slightly decreased, but the osmotic fragility was not
affected. The measured decrease in RBC deformability appeared to be related to
hemoconcentration, although Hardeman ef a/.^ showed that the elongation index does
not decrease with increasing numbers of RBC per ml of polyvinylpyrrolidone solution.
The increases in WBC, platelets and plasma viscosity during exercise did not correlate
with the decreases in RBC deformability, and it is therefore unlikely that these changes
have affected the measurement of RBC deformability.
Van der Brug efa/.^ measured the elongation index at 30 Pa, and found a
significant decrease of 0.7% after a combination of two cycling bouts and two running
bouts, with an average total duration of 140 min. After a 100-km race™, and after a
marathon", RBC deformability was also impaired, as measured by filterability of RBC
and whole blood, respectively. Others, however, did not find a decrease in RBC
deformability due to exercise as evaluated by RBC filterability after a marathon^ or
by relative blood vs plasma viscosity at high shear rates after a 1-h cycling
exercise^. Wood ef a/.** even found an increase in relative viscosity after a 3 to
6 hour cross-country run, performed at an altitude of 1700-3000 m. Conversely,
Guezennec ef a/.^ found a decrease in RBC filterability during a 1 hour cycling
exercise at a simulated altitude of 3000 m in a hypobaric chamber, but not at sea
level. However, the high variability of filtration techniques and the possibility of
analytical artefacts^'^ complicate comparison with the sensitive and reproducible
technique used in the present study.
In the present study, the change in RBC deformability was small (<2%), but
together with the 4.2% increase in plasma viscosity may have a significant effect on
whole blood viscosity, as demonstrated by van der Brug ef a/.^.
The unchanged osmotic fragility of RBC following exercise appears to be in conflict
with results from Smith ef a/.^, who reported a decrease. They suggested that this
decrease was caused by RBC dehydration, as indicated by a decrease in MCV and
an increase in RBC density. In the present study MCV did not change during exercise,
however.
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E/fecf 0/endurance exerc/se on p/asma anf/ox/dante ,
Plasma antioxidant concentrations increased during exercise, but after correction
for hemoconcentration, tocopherol and carotenoid concentrations decreased
significantly.
Comparable to the present study, an increase in plasma vitamin E was reported
after 3 times of 15 min of running exercise^. However, correction for
hemoconcentration neutralized this change. No changes in plasma vitamin E
concentration were found after a half-marathon^ or after 90 minutes of submaximal
cycling^, but these data were not adjusted for hemoconcentration. A decrease in
plasma vitamin E is therefore conceivable. Duthie ef a/.^ found an 18% increase in
plasma retinol concentration after a half-marathon, which was only partly explained by
the 6% decrease in plasma volume. Antioxidant concentrations, however, may have
been influenced by food intake during exercise, which was not allowed in our study.
It is unlikely that the loss of plasma tocopherols during exercise in the present
study was caused by a transfer to RBC^\ since it has been shown that RBC
vitamin E concentrations do not increase immediately after a half-marathon^. In
addition, Nair efa/.^ found no detectable concentrations of 13-carotene in RBC.
However, exercise-activated lipoprotein lipase^ may have caused a transfer of
tocopherols**^, and maybe also of carotenoids, from the circulation to tissues.
This might also explain why plasma concentrations of retinol, which is mainly
transported via a specific retinol binding protein, and much less via lipoproteins^, did
not decrease during exercise. However, others showed that vitamin E concentrations
in muscle tissue also decrease following exercise^.
Effecf of endurance exe/c/se on LDL ox/daf/on /n vrtro .
LDL oxidation /n v/fro was little affected by endurance exercise. The amount of
conjugated dienes formed ;n vrtro decreased after exercise by 1.2 ± 0 . 6 % , and
theoretically this indicates that the relative amounts of PUFA in the native LDL had
decreased^"". Recently, Sumikawa era//*® showed that exercise decreased the
proportion PUFA in RBC phospholipids of untrained subjects.
Exerc/se perfomjance, fen o// supp/emenfaf/on and //p/d perox/daf/on
Effects of fish oil and vitamin E supplementation
Effecr of supp/ementefron on exerc/se performance
Exercise performance as measured by validated exercise tests, was not
significantly altered by FO or FE supplementation in the present study. The maximum
workload capacity increased slightly during the study, but this was similar in all groups.
This small increase, however, was insufficient to improve endurance performance
during the time trial. In sedentary healthy female"*® and male'*" subjects, no effects
of fish oil supplementation on W ^ , ^ or VO2 max^'*° was found either. In well-trained
subjects, Leaf and Rauch^ found no improvement in treadmill performance after fish
oil supplementation. Although they found an increase in VOg ^ ax (predicted VOg ^^ ,
based on the treadmill performance) after daily supplementation with 6 g of fish oil, no
such increase was noticed after supplementation with 12 g/day. Analysis of covariance
between pre- and post-supplementation predicted VOg ^ax values, however, showed
no significant differences between the placebo, low (6 g/d), and high (12 g/d) fish oil
group. Therefore, results from this study are difficult to interpret.
Erfecf of supp/ementef/on on RSC characfer/stfcs
The approximately 2% increase in n-3 PUFA in membrane phospholipids of RBC
after fish oil supplementation did not affect RBC deformability. Results from other
studies investigating changes in RBC defonmability after fish oil supplementation are
conflicting. Earlier studies showed that, in young subjects, fish oil supplementation
increased whole blood^' and RBC^ filterability, but no control groups were used.
Recently, Kobayashi ef a/.^ also found an increase in whole blood filterability after
fish oil supplementation in healthy young subjects, but not in healthy middle-aged
subjects. Guezennec ef a/.^ reported that fish oil supplementation in young trained
subjects, as compared with non-supplemented young trained controls, improved
filterability of washed RBC after hypoxic exercise. Pre-exercise RBC filterability,
however, was not improved by fish oil supplementation^. A dose-response study also
showed no effect of supplementation with up to 6 g/day of n-3 ethyl ester fatty acids
on filterability of 10% RBC solutions'". ,
Results were not in agreement even when the proportion of n-3 fatty acids in
erythrocyte phospholipids increased similarly (the present study vs Refs 1 and 42; Ref
2 vs Ref 25). However, since not all studies were specifically designed to investigate
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the effect of fish oil per se, some of them lack a control group and data should be
viewed with caution.
Although decreases in RBC deformability during exercise appeared to be
prevented by vitamin E, this was not statistically significant. However, a protective
effect of vitamin E supplementation on RBC filterability was previously shown during
a high altitude ascent**.
The average osmotic fragility of RBC was not significantly altered by fish oil
supplementation, similar to results from Miller era/.*^. In contrast, Hagve efa/.^
reported a decrease in osmotic fragility after 2 weeks of fish oil supplementation, but
after 4 weeks of supplementation the fragility approached pre-supplementation values
again. They suggested that the initial decrease due to increased unsaturation of
membrane fatty acids, was followed by adaption, mediated by a change in
phospholipid sub-class distribution.
E/ifecf o/ si/pp/e/77e/7/a/yo/7 0/7 p/asma anf/ox/dante
FO supplementation did not affect plasma antioxidant concentrations. FO and FE
supplementation limited the loss of plasma antioxidants during exercise, but this was
not statistically significant. A decrease in plasma vitamin E concentrations after fish
oil supplementation has been reported^, but this was not confirmed in the present
study, or by others^. Also, no significant increase in plasma retinol and B-carotene
concentrations, as reported by Nair ef a/.^, were noticed. Additional vitamin E
supplementation, however, increased plasma a-tocopherol and decreased plasma
B+y-tocopherol concentrations, as has been found by others^®.
Effecf of supp/emenfaf/on on LDL ox/daf/on /n wfro
The lagtime during oxidation of LDL /n wfro was not affected by fish oil
supplementation, and was only non-significantly increased by additional vitamin E
supplementation. A previous study in sedentary male subjects^ showed a larger
increase in lagtime after FE supplementation as compared with subjects receiving FO
supplementation, who showed a decrease in lagtime. Recently, Suzukawa efa/.^
also found a decrease in lagtime after fish oil as compared with com oil
supplementation in drug-treated hypertensive subjects. A dose-response study by
Jialal ef a/."**, showed prolonged lagtimes in subjects supplemented with vitamin E,
but changes were only significant after 400 lU/day or more, and not after
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supplementation up to 200 lU/day. Lagtimes of EDTA-containing LDL, oxidized with
high copper concentrations, were already prolonged after supplementation with 25 to
50 lU/day^.
In the present study, both FO and FE supplementation reduced the rate of LDL
oxidation /n w/fro. This was not found in a previous study^, but recently also reported
by Suzukawa ef a/.'* .^ On the other hand, n-6 PUFA increase the rate of oxidation^.
Kleinveld ef a/.^ reported that the rate of oxidation of LDL /n i/tfro, correlated positively
with its n-6 PUFA content and negatively with its monoene content. Correlations with
n-3 fatty acids, however, were not investigated. Fish oil supplementation in the present
study also decreased the ratio of n-6 PUFA to monoenes in RBC phospholipids, and
the decrease in rate of oxidation may therefore be related to a similar change in LDL
fatty acids.
The decrease in rate of oxidation in the FO group hardly affected TR^. Additional
vitamin E supplementation, however, delayed oxidation of LDL, although the apparent
difference with the FO group was only of borderline significance.
Much to our surprise fish oil supplementation did not affect the amount of
conjugated dienes formed during LDL oxidation /n wfro, whereas a previous study^
showed a 20% increase after supplementation with a similar amount of fish oil. In
addition, the /n wfro formation in LDL samples of thiobarbituric acid reactive
substances after fish oil supplementation'*^, and of conjugated dienes after an n-6
PUFA rich diet as compared with a monoene rich dief^, were also increased.
Although the fast method of LDL preparation used in the present study was different
from the time-consuming method in the previous study^, comparison of the two
methods in six not supplemented sedentary volunteers showed no significant
difference in the amount of conjugated dienes formed /n w'fro (results not reported).
In conclusion, this study showed that exercise decreases RBC deformability,
causes consumption or a shift of plasma tocopherols and carotenoids, and decreases
the formation of conjugated dienes during oxidation of LDL /n wfro. These changes
support the theory that oxidative stress during exercise® may decrease RBC
deformability (for reviews, see Refs 4 and 9). Fish oil supplementation, with or without
vitamin E, does not improve RBC deformability or physical performance, but it also
does not compromise the plasma antioxidant status. Contrary to previous findings,
which indicated that fish oil supplementation increases LDL oxidation, this was not
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found in the present study. Moreover, fish oil supplementation decreased the rate of
oxidation /n vrfro, and additional vitamin E supplementation also delayed the time at
which this maximum was reached by a combined effect with a prolonged lagtime.
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CHAPTER 4
Maternal and neonatal plasma lipid-soluble antioxidant levels in
normal pregnancy, and the relationship with fatty acid unsaturation
Gerard S. Oostenbrug, Ronald P. Mensink, Monique D.M. Al, Adriana C. v.
Houwelingen & Gerard Hornstra
ABSTRACT
During pregnancy, maternal plasma levels of lipids, phospholipids, cholesterol, and
lipoproteins increase. Since the amount of the peroxidation-susceptible polyunsaturated fatty
acids also increases, antioxidant protection may become compromised during pregnancy. In
addition, the high degree of unsaturation of fatty acids in neonatal plasma may affect neonatal
antioxidant defences. Therefore, we studied maternal and neonatal plasma levels of various
antioxidants during normal pregnancy, and the relation with phospholipid fatty acid levels and
fatty acid unsaturation.
From the 1st to the 3rd trimester, plasma levels of tocopherols (5, B+y, and a) and lutein
increased by more than 40% (P<0.0001), B-carotene levels decreased by 19% (P<0.0001), and
levels of other carotenoids remained unchanged. Retinol levels decreased from the 2nd to the
3rd trimester, but returned to 1 st and 2nd trimester levels after delivery. After delivery, plasma
levels of S-tocopherol (P=0.006) and B+Y-tocopherol (P<0.0001) were lower than 3rd trimester
levels, whereas postpartum a-tocopherol and carotenoid levels were similar. As the
phospholipid polyunsaturated fatty acid unsaturation index (Ulg^ also increased during
pregnancy, antioxidant levels were adjusted for the change in Ul,^.. However, the
a-tocopherol/UI^ ratio still increased from the 1st to the 3rd trimester. Ratios for several
carotenoids and retinol, on the other hand, decreased during pregnancy. After delivery,
B+-^tocopherol/Ula(j,. ratios were lower than 3rd trimester levels, whereas retinol/Ulg^ ratios
were higher.
Umbilical cord plasma antioxidant levels and antioxidant/U^ ratios, except retinol/UI.,^,
were lower than maternal values (P<0.01). Significant and consistent cord vs maternal
correlations were noticed for plasma levels of B+y-tocopherol and several carotenoids, but not
for S-tocopherol, a-tocopherol, lycopene, and retinol.
In conclusion, although during pregnancy tocopherol levels increased concurrently with, or
more than, fatty acid unsaturation in phospholipids, the decrease in carotenoid/UI.,^ ratios
during gestation, the decrease in B+y-tocopherol after delivery, and the low neonatal tocopherol
and carotenoid levels may affect lipid peroxidation /n vivo, and further research is indicated.
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INTRODUCTION
Results from a large prospective survey have shown that the total amount of fatty
acids in plasma phospholipid increase by 51% from week 10 to week 40 of gestation^.
The largest increases were noticed in the concentrations of saturated (+57%) and
monounsaturated (+65%) fatty acids, but n-6 (+44%) and n-3 (+41%) polyunsaturated
fatty acids levels were also significantly increased. Since polyunsaturated fatty acids
are very susceptible to oxidation, the antioxidant status may become compromised
during pregnancy.
Several studies, however, have shown that plasma levels of the lipid-soluble
antioxidant vitamin E also increase during pregnancy^. Increases in plasma vitamin E
levels during pregnancy coincide with increased amounts of various plasma lipid
classes^, and plasma vitamin E levels standardized for plasma total lipid^,
cholesterol*^, or low density lipoprotein* levels appear to remain constant during
pregnancy. However, declining levels of triglyceride-standardized plasma vitamin E
levels during pregnancy have been reported as welP. Reports on vitamin A (retinol)
and total carotenoid levels during pregnancy are inconclusive^®, and information
about separate carotenoids during pregnancy is scarce. In addition, the degree of
unsaturation of the plasma lipids has not been taken into account.
At birth, umbilical vein plasma levels of vitamin E^°"^ , carotenoids^"^ and
retinol^"^ have been found to be very low as compared with maternal levels, but
levels of total lipid, lipoproteins, cholesterol, and triglycerides were low as well^°"^.
The previous prospective survey^ also found low levels of phospholipid fatty acids in
cord plasma, but showed that the relative amounts of highly unsaturated fatty acids,
like arachidonic acid and docosahexaenoic acid, were higher in umbilical vein plasma
phospholipids as compared with maternal plasma phospholipids.
Therefore, we have investigated plasma levels of tocopherol isomers, several
carotenoids, and retinol during the course of pregnancy and postpartum, and have
compared these levels with the degree of fatty acid unsaturation. In addition, plasma
lipid-soluble antioxidant levels and fatty acid unsaturation were measured in umbilical
cord plasma.
52
P/asma //p/d-so/t/We anf/ox/danf teve/s dunng no/ma/ pregnancy
METHODS
The samples from the large prospective survey* had been stored for 2 to 4 years
at -80 °C. Therefore, a pilot study was carried out first to check whether storage had
affected antioxidant concentrations.
Subjects
P//of sfudy.- Effect of storage on p/asma //p/d-so/ubte anf/ox/danf concenfraf/ons
Lipid-soluble antioxidant levels were studied in EDTA-anticoagulated plasma
samples, which had been stored for 5 years at -80 °C. Fifteen samples had been
obtained from women after 6 to 17 weeks of pregnancy. From 8 of these women, a
second sample was available, collected 4 to 13 weeks after the first sample, but
before 27 weeks of gestation. These 23 samples were compared with samples
recently collected from 11 women during the first two trimesters of pregnancy, to
check whether antioxidant concentrations in samples stored for 5 years are still within
the normal range for antioxidant levels during early and mid gestation. Before analysis,
the recently collected samples had been stored for 5 months at -80 °C.
Ma/n sfudy: P/asma //p/'d-so/uo/e anf/ox/danf /eve/s during non-na/ pregnancy
EDTA-anticoagulated plasma samples were obtained from a large study in which
140 pregnant women originally entered^. After analysis of the phospholipid fatty acid
patterns performed for that study, 38 complete sets of 1st, 2nd, and 3rd trimester
plasma samples, 33 postpartum samples and 28 concurrent umbilical vein plasma
samples were available for antioxidant analysis. The women were of Caucasian race,
had singleton pregnancies, were normotensive, had no metabolic, cardiovascular,
neurological or renal disorder, and did not develop gestational diabetes. The 1st, 2nd,
and 3rd trimester plasma samples were collected at 14, 22, and 32 weeks of
gestation, respectively. Postpartum and umbilical vein (cord) plasma samples were
taken immediately after delivery \ Before antioxidant analysis, plasma samples had
been stored at -80 °C for 2 to 4 years.
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Plasma antioxidants
Plasma was analyzed for tocopherol isomers, carotenoids and retinol by HPLC on
a Inertsil ODS-2, C-18 reversed phase column (GL Sciences, Tokyo, Japan), with
68% acetonitrile/22% tetrahydrofuran/7% methanol/3% distilled water (v/v/v/v) as
mobile phase, as described by Hess ef a/.^ with slight modifications (Chapter 3).
Fluorescence detection was used for the tocopherol isomers, 5-tocopherol,
G+ytocopherol, and a-tocopherol, for the carotenoid phytofluene, and for retinol.
Simultaneously, the carotenoids, lutein, (3-cryptoxanthin, lycopene, a-carotene and
B-carotene, were detected by absorbance. In the main study, all samples from one
subject and her neonate were analyzed in the same analytical run. Chromatogram
peak areas were calculated with the Gynkosoft Chromatography Data System
(Gynkotek, Germany), and calibrated against a mixture of the various standard
substances dissolved in ethanol/dioxane/acetonitrile (1:1:3). In postpartum plasma
samples, maternal as well as cord, an unknown component was detected with a
retention time slightly less than that of S-tocopherol, and, therefore, partly overlapping
the 8-tocopherol peak. As this sometimes did not allow good calculation of peak areas,
all 5-tocopherol concentrations in the main study were based on peak heights instead.
Since pure phytofluene was not available, quantitative determination of this compound
was not possible. On a reversed phase column, Q-tocopherol co-elutes with
y-tocopherol, and they are therefore reported together. The canthaxanthin standard
eluted separately from the lutein standard, but in plasma samples canthaxanthin levels
were too low to be chromatographically separated from the lutein peak. Therefore,
concentrations of lutein reported here may also include small traces of canthaxanthin.
In 4 samples from the pilot study, an unknown peak prevented correct quantitative
determination of lutein, and lutein values of these samples are not reported. Twelve
analyses of the stock mixture of antioxidants in 6 runs showed coefficients of variation
ranging from 2.4% to 3.6% for the various antioxidants. The mean (± SEM) recovery
of the internal standard retinyl acetate added to plasmas was 101 ± 0.6%, and the
detection limit in plasma samples was 0.003 u.mol/1 for all antioxidants.
cc-Tocopherol (all-rac), Y-tocopherol, (3-cryptoxanthin, lycopene, and (3-carotene
standards were a generous gift from F. Hoffmann-La Roche (Basel, Switzerland).
5-Tocopherol, lutein, a-carotene and retinol (all-frans) standards were obtained from
Sigma Chemical Company, and canthaxanthin standard from Fluka Chemie (Bornem,
Belgium). All other chemicals were purchased from Merck (Darmstadt, Germany).
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Plasma phospholipid fatty acids •*•
Details of the plasma phospholipid fatty acid analysis have been reported before \
Briefly, lipids were extracted from plasma using a modified Folch method. Then, the
phospholipids were separated on aminopropyl bonded silica columns, and saponified.
The fatty acids were transmethylated with boron trifluoride methanol, and quantified
on a non-polar capillary column. Fatty acid unsaturation was estimated by calculating
the absolute polyene unsaturation index (U l ^ ) as the sum of the micromolar
concentration of each polyunsaturated fatty acid (polyene) in the phospholipids
multiplied with its number of double bonds. The relative degree of unsaturation was
estimated by the relative polyene unsaturation index. This index was calculated as the
sum of the percentage of each polyene (moles/moles total fatty acids * 100%)
multiplied with its number of double bonds.
Statistics
In the pilot study, lipid-soluble antioxidant levels in all plasma samples were plotted
together by gestational age, as previous studies have shown that plasma vitamin E
levels increase linearly during gestation*'^. Trends during gestation were evaluated
by computing linear regression coefficients and Pearson correlation coefficients (r)
between gestational age and antioxidant levels. Samples from the same subject
collected at different gestational ages were considered as independent samples. Mean
antioxidant levels in plasma samples stored for 5 years and in recently collected
samples, were compared by Student's f-tests.
In the main study, the four serial maternal samples collected during the 1st, 2nd
and 3rd trimester and postpartum, were compared by repeated measures analysis of
variance (ANOVA) using least-squares estimates of marginal means for unbalanced
designs. Levels were evaluated as compared with levels in the 1st trimester, and as
compared with levels in the previous trimester. As this involved five simultaneous
comparisons, the level of significance between moments of sampling was set to
P<0.01. Postpartum maternal and cord samples were compared by paired Student's
f-test and Spearman correlation coefficients (R,.). To study whether the neonatal
antioxidant status was related to maternal antioxidant levels before delivery, Spearman
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correlation coefficients were also computed between neonatal values and matemal
values during each trimester. Spearman correlation coefficients were preferred since
in one or two sets of matemal and neonatal plasma samples, antioxidant levels were
considerably higher than in the other sets, which largely affected Pearson correlation
coefficients. Values are reported as means ± SEM. All statistical analyses were
performed using the Statistical Analysis System (SAS Institute Inc., 1989).
RESULTS
Pilot study: Effect of storage on plasma lipid-soluble antioxidant concentrations
Most lipid-soluble plasma antioxidant levels in recently collected samples were not
significantly different from levels in samples stored for 5 years (Figure 4.1 and 4.2).
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Figure 4.1. Maternal plasma 5-tocopherol, B+y-tocopherol, o-tocopherol, and
retinol levels (nmol/l) in samples stored for five years (circles) and
in recently collected samples (X). Results are depicted by
gestational age, and trends during gestation are shown by solid
regression lines, when statistically significant (see text).
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However, mean plasma cryptoxanthin levels in samples stored for 5 years (0.26 ± 0.03
u.mol/1) were significantly (P=0.035) lower than levels in recently collected samples
(0.51 ± 0.10 (imol/l). Consistent with previous reports, plasma levels of tocopherols
were higher in samples of later gestational age. Regression coefficients for antioxidant
levels between 6 and 27 weeks of gestation, indicated a weekly increase of 0.005
Hmol 5-tocopherol (r=0.359, P=0.034), 0.089 (xmol 3+y-tocopherol (r=0.360, P=0.033),
0.900 umol a-tocopherol (r=0.698, P<0.0001), and a weekly decrease of 0.020 |imol
retinol (r=-0.498, P=0.002). Lutein levels also tended to increase by 0.009 n.mol/week
(r=0.349, P=0.054). For plasma levels of the other carotenoids no significant inclining
or declining trends during the first 6 months of gestation were noticed (Figure 4.2).
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Figure 4.2. Maternal plasma phytofluene, lutein, cryptoxanthin, lycopene,
a-carotene, and B-carotene levels in samples stored for five years
(circles) and in recently collected samples (X). Antioxidant levels
are given in (xmol/l, except for phytofluene levels which is given in
arbitrary units. Results are depicted by gestational age, and trends
during gestation are shown by solid regression lines, when
statistically significant (see text).
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Main study: Plasma lipid-soluble antioxidant levels during normal pregnancy
AH women delivered full term neonates between 37 and 42 weeks of gestation.
Birth weights ranged from 2655 to 4310 kg, and of the neonates studied 13 were
females and 15 were males.
- •- Plasma levels of tocopherols and lutein increased from the 1 st trimester to the 2nd
trimester, as was also found in the pilot study, and from the 2nd trimester to the 3rd
trimester (Table 4.1). From the 1st to the 3rd trimester, 5-tocopherol levels increased
by 74%, B+Y-tocopherol by 42%, cc-tocopherol by 45%, and lutein levels by 42%
(P<0.0001). The intermediate levels in the 2nd trimester were also significantly
different from the 1st trimester for 13+y-tocopherol (P=0.006) and lutein (P=0.0006),
and different from trimester 1 and 3 for a-tocopherol (P<0.0001). B-Carotene levels
decreased during pregnancy, and levels in the 3rd trimester were 19% lower than
levels in the 1st trimester (P=0.002). Plasma levels of the other carotenoids did not
significantly change during pregnancy (Table 4.1). Plasma retinol levels were similar
during the 1st and 2nd trimester, but were significantly reduced during the 3rd
trimester (P<0.0001 vs other moments of sampling; Table 4.1).
Immediately after delivery, plasma a-tocopherol and lutein levels remained
increased, but S-tocopherol (P=0.006 vs 3rd trimester) and 13+y-tocopherol (P<0.0001
vs 3rd trimester) levels were lower than levels in the 3rd trimester, and similar to 1st
trimester levels. Postpartum plasma levels of other carotenoids were similar to prenatal
levels, except for lower lycopene levels as compared with the 1st trimester (P=0.0004;
Table 4.1). Postpartum retinol levels were similar to levels during the 1st and 2nd
trimester, and were significantly higher than levels during the 3rd trimester (P<0.0001).
All fatty acids in the phospholipid fraction increased during pregnancy as well. For
saturated and monounsaturated fatty acids, the increase became less strong towards
the 3rd trimester. Phospholipid linoleic acid levels, however, increased constantly
between each trimester, whereas the increases in n-3 fatty acids appeared to be
confined to the first part of gestation. The increase in polyunsaturated fatty acids in
phospholipids resulted in an increase in the absolute polyene unsaturation index
(Ulabs) during pregnancy, but the relative polyene unsaturation index decreased, since
the increase in polyenes was less than the increase in other fatty acids (Table 4.2).
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Table 4.1. Maternal plasma antioxidant levels during normal pregnancy, and concurrent neonatal plasma antioxidant levels
Tocopherols
8-tocopherol
B+ftocopherol
oc-tocopherol
Carotenoids
lutein
R-cryptoxanthin
lycopene
a-carotene
B-carotene
phytofluene
Retinol
1st trimester
n=38
30.10 ±1.05
0.17+0.01
2.70 ±0.16
27.23 ± 0.97
1.70 ±0.09
0.49 ± 0.03
0.24 ± 0.03
0.63 ± 0.04
0.06 ± 0.01
0.29 ± 0.02
0.62 ± 0.05
1.37 ±0.04
2nd trimester
n=38
36.62 ±1.10*
0.21 ±0.02
3.20 ± 0.20 "
33.20 11.02*
1.74 ±0.08
0.59 ± 0.04 *
0.28 ± 0.03
0.56 ± 0.03
0.06 10.00
0.26 ± 0.02
0.59 10.04
1.34 10.04
3rd trimester
n=38
42.59 11.29*-"
0.24 ± 0.02 *
3.59 ± 0.25 *
38.77 11.19*-"
1.78 10.08
0.67 ± 0.04 *
0.26 10.02
0.58 10.04
0.05 10.00
0.23 ± 0.02 *
0.68 10.05
1.11 10.04*'"
postpartum
n=33
41.30 11.78*
0.17 1 0 . 0 1 '
2.74 10.19'*
38.40 11.73 *
1.71 ±0.12
0.64 10.04 *
0.27 10.03
0.48 10.03 *
0.06 10.01
0.27 10.05
0.61 10.05
1.33 10.07 "
cord
n=28
7.98 10.274 *
0.05 10.007 *
0.49 10.043 *
7.71 10.346®
0.28 10.029 *
0.15 10.017*
0.04 10.005 '
0.04 10.005 *
0.01 10.001 *
0.03 10.004 *
0.00 - 0.04 *••
0.67 10.036 •
C/PP
(%)
2 1 %
30%
20%
22%
18%
26%
19%
9%
19%
16%
54%
Plasma collected from pregnant women during each trimester of pregnancy and immediately postpartum, were analyzed for lipid-soluble antioxidant
levels. Concurrent umbilical vein plasma samples (cord) were analyzed as well. C/PP expresses the average ratio of cord vs postpartum maternal
levels. Values are means ± SEM. Plasma antioxidant levels are expressed in nmol/l, except for phytofluene levels which chromatogram peak areas
are expressed in mV*min/nl plasma (amplification 100).
*•*: significantly different from 1 st trimester: a, P<0.01; b, P<0.001 (repeated measures ANOVA).
* ' " : significantly different from previous in line: c, P<0.01; d, P<0.001 (repeated measures ANOVA).
* significantly different from maternal postpartum levels: e, P<0.001 (Student's paired f-test).
*, only 5 cord samples contained detectable concentrations of phytofluene (range is given).
Table 4.2. Fatty acid composition of maternal plasma phosphoflpids during normal pregnancy, and neonatal fatty acid composition
1st trimester
n=38
2nd trimester
n=38
3rd trimester
n=38
postpartum
n=33
cord
n=28
OFP
Total fatty acids
saturates
monoenes
C18:1 n-9
polyenes
n-6
C18:2
C20:4
n-3
C20:5
C22:6
Polyene unsaturation bidex
absolute t
relative ±
5284
2419
563
405
2113
1824
1116
480
281
27.6
200
6452
122
±143
± 70
± 17
± 14
± 61
+ 55
± 38
± 18
± 12
± 2.5
± 10
±192
± 1
6271
2880
709
520
2446
2105
1296
515
330
30.1
237
7443
119
±198 '
± 94 '
± 28 '
± 22 '
± 75 '
± 69 '
± 44 '
± 21 '
± 15 '
± 2.9
± 11 '
±235 '
± 1 *
' 6699
 3110
 768
 567
 2607
 2267
 1451
' 512
 328
23.7
> 242
' 7766
' 116
±150
± 74
± 21
± 17
± 57
± 52
± 37
± 17
± 13
± 2.1
± 10
±178
± 1
b,c
b,c
b,c
b,c
b
b,c
b,d
b
b
b
b,d
6365
3003
755
556
2423
2105
1307
492
306
23.0
228
7300
114
±213 '
±103 '
± 25 '
± 20 '
± 86 '
± 76 '
± 52 '
± 23
± 19 '
± 3.0
± 15 '
±274 '
± 1 *
' 2096
• 1047
' 235
 140
' 789
' 648
•' 166
326
' 132
5.2
 116
• 2935
' 140
±
±
±
±
±
±
±
±
±
±
±
±
±
62 '
32 '
9 '
6 '
23 '
20 '
8 '
11 '
5 '
0.4 *
4 *
81 •
1 •
' 36%
' 38%
' 34%
' 27%
' 35%
• 34%
• 15%
 70%
» 48%
' 30%
' 56%
» 39%
' 123%
Plasma collected from pregnant women during each trimester of pregnancy and immediately postpartum, were analyzed for phospholipid fatty acids
levels. Concurrent umbilical vein plasma samples (cord) were analyzed as well. C/PP expresses the average ratio of cord vs postpartum maternal
levels. Values are means ± SEM. Plasma phospholipid fatty acid levels are expressed in nmol/l. Maternal levels were compared by repeated
measures analysis of variance (ANOVA) using least-squares estimates of marginal means for unbalanced designs:
••**: significantly different from 1st trimester: a, P<0.01; b, P<0.001 (repeated measures ANOVA).
"' **: significantly different from previous in line: c, P<0.01; d, P<0.001 (repeated measures ANOVA).
* significantly different from maternal postpartum levels: e, P<0.001 (Student's paired f-test).
t Calculated as the sum of the micromolar concentration of each polyene multiplied with its number of double bonds.
t Calculated as the sum of the percentage of each polyene (moles/moles total fatty acids * 100%) multiplied with its number of double bonds.
Table 4.3. Ratio of plasma lipid-soluble antioxidant levels to phospholipid absolute polyunsaturated fatty acid index in normal pregnancy
Tocopherols
8-tocopherol
B+y-tocopherol
a-tocopherol
Carotenoids
lutein
G-cryptoxanthin
lycopene
a-carotene
B-carotene
phytofluene
Retinol
1 st trimester
r
4.671
0.026
0.421
4.223
0.270
0.076
0.037
0.099
0.010
0.047
0.096
0.217
1=38
+
±
±
±
±
±
±
±
±
±
±
±
0.089
0.002
0.024
0.078
0.015
0.005
0.004
0.007
0.001
0.004
0.007
0.008
2nd
4.973
0.030
0.437
4.507
0.242
0.082
0.038
0.078
0.008
0.036
0.081
0.186
trimester
n=38
±
±
±
±
±
±
±
±
+
±
±
±
0.107
0.003
0.079
0.099
0.013
0.005
0.004
0.005
0.001
0.003
0.006
0.008
a
a
a
b
b
b
3rd trimester
r
5.481
0.031
0.463
4.987
0.232
0.086
0.034
0.076
0.007
0.030
0.089
0.145
1=38
±
+
±
+
±
±
±
±
±
±
±
±
0.102
0.002
0.029
0.094
0.011
0.005
0.003
0.004
0.001
0.002
0.006
0.006
b,d
b,d
b
b
b
b,c
b,d
postpartum
n=33
5.668
0.024
0.380
5.264
0.236
0.088
0.038
0.067
0.008
0.036
0.086
0.185
+
±
±
±
±
±
±
±
±
±
±
+
0.148
0.002
0.024
0.147
0.014
0.005
0.004
0.005
0.001
0.005
0.007
0.008
b
d
b
b
a
b
a
b
b,d
2.764
0.016
0.167
2.627
0.093
0.052
0.014
0.014
0.003
0.011
0.000
0.228
cord
n=28
±
±
±
±
±
±
±
±
±
±
-
±
0.076
0.002
0.012
0.081
0.009
0.006
0.001
0.001
0.000
0.001
0.012
0.011
f
e
f
f
f
f
f
f
f
f
\ f
e
Ratios of plasma lipid-soluble antioxidant to phospholipid absolute polyunsaturated fatty acid index were studied in plasmas from pregnant women
during each trimester of pregnancy and immediately postpartum. Ratios in concurrent umbilical vein plasma samples (cord) were calculated as well.
Values are means ± SEM.
"•'*: significantly different from 1st trimester: a, P<0.01; b, P<0.001 (repeated measures ANOVA).
*• •*: significantly different from previous in line: c, P<0.01; d, P<0.001 (repeated measures ANOVA).
• significantly different from maternal postpartum levels: e, P<0.001 (Student's paired f-test).
*, only 5 cord samples contained detectable concentrations of phytofluene (range is given).
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The changes in plasma a-tocopherol and lutein levels during pregnancy appeared
to coincide with these changes in phospholipid fatty acid levels, but no such relation
was evident for the other antioxidants. Nonetheless, plasma a-tocopherol to U^s
ratios still increased by 20% (P<0.0001) during pregnancy (Table 4.3). On the other
hand, ratios for lycopene (-16%, P<0.0001), a-carotene (-21%, P=0.0002), (3-carotene
(-33%, P<0.0001) and retinol (-33%, P<0.0001) decreased during pregnancy.
After delivery, 5-tocopherol/Ulafc. (P=0.023), a-tocopherol/UI.^ (P=0.036) and the
ratios of the carotenoids/Ulg^ (P>0.017) were similar to ratios in the 3rd trimester, but
B+Y-tocopherol/Ulabs ratios were significantly decreased (P=0.0005; Table 4.3).
Postpartum, retinol/Ulab«, ratios were significantly increased as compared with 3rd
trimester ratios (P<0.0001), but were still lower than ratios in the 1st trimester
(P<0.0001).
All cord samples had significantly lower levels of antioxidants than concurrent
maternal samples (P<0.0001). Average cord levels of tocopherols and carotenoids
were 9% to 30% of maternal levels (Table 4.1). Although postpartum B+y-tocopherol
levels in maternal plasma significantly correlated with levels in cord plasma (Table
4.4), this was not the case for 5-tocopherol and a-tocopherol. Consequently, total
tocopherol levels also did not correlate. With the exception of lycopene, carotenoid
levels in maternal and cord plasma correlated significantly. In only 5 of 28 cord
samples small traces of phytofluene could be detected, and correlation analysis was
therefore not performed. Cord retinol levels were on average 54% of maternal levels,
but cord and maternal postpartum levels did not correlate. For B+y-tocopherol, lutein,
B-cryptoxanthin, and B-carotene neonatal levels also consistently correlated with
maternal levels before delivery (Table 4.4). The highest correlation coefficients were
found between neonatal and 3rd trimester maternal levels.
Total, saturated, monounsaturated, and n-6 polyunsaturated phospholipid fatty acid
levels in cord plasma were on average 32 to 36% of maternal plasma levels. For n-3
fatty acids, the mean cord/maternal ratio was 47%. However, large differences
between the various fatty acids were present (Table 4.2). The relative phospholipid
polyene unsaturation index was 23% higher in cord plasma than in maternal plasma,
due to a higher proportion of polyunsaturated fatty acids. However, the concentration
of total phospholipid fatty acids was lower in cord plasma. Consequently, the absolute
polyene unsaturation index was on average 39% of maternal postpartum values.
Nonetheless, ratios of the tocopherols to U l ^ and carotenoids to U l ^ were
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significantly lower in cord samples than in postpartum maternal samples (Table 4.3).
s ratios, however, were significantly higher than postpartum matemal ratios.
Table 4.4. Spearman correlation coefficients between neonatal and maternal
plasma antioxidant levels during pregnancy and postpartum
Cord antioxidant
Tocopherols
5-tocopherol
(3+Y-tocopherol
a-tocopherol
Carotenoids
lutein
13-cryptoxanthin
lycopene
a-carotene
B-carotene
Retinol
Maternal levels
1st
trimester
-0.004
0.219
0.592 *
0.079
0.430 "
0.686"
0.411"
0.346
0.274
0.500"
-0.054
2nd
trimester
-0.078
0.153
0.518"
0.011
0.604"
0.555 *
0.489 "
0.295
0.141
0.644*
-0.132
during gestation
3rd
trimester
-0.097
0.407 "
0.663 *
-0.069
0.795 *
0.812'
0.764 =
0.328
0.381
0.718 =
0.128
post-
partum
-0.286
0.369
0.585"
-0.152
0.461 "
0.528 "
0.569 "
0.287
0.515"
0.510"
0.183
• statistically significant Spearman correlations: a, P<0.05; b, P<0.01; c, P<0.001.
DISCUSSION
This study investigated matemal plasma antioxidant levels during pregnancy and
its relationship with neonatal antioxidant levels. In addition, antioxidant levels were
analyzed in relation to fatty acid unsaturation of plasma phospholipids. A pilot study
was performed first to check whether storage of plasma affected lipid-soluble
antioxidant concentrations. Only B-cryptoxanthin concentrations appeared to be
affected by storage for several years, since concentrations in samples stored for 5
years (pilot study) as well as samples stored for 2-4 years (main study) were
considerably lower than concentrations found in recently collected samples (pilot
study). Since two recently collected samples contained very high levels of
B-cryptoxanthin, comparison between samples stored for 5 years and recently
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collected samples was repeated with a non-parametric Kruskal-Wallis test (not shown).
However, the difference between median (3-cryptoxanthin levels in the two groups of
samples was also statistically significant. Therefore results with respect to this
antioxidant should be viewed with caution.
Plasma total tocopherol levels increased significantly during pregnancy, as has
been reported for vitamin E "^^ . Vitamin E is a generic descriptor for tocopherol and
tocotrienol isomers, and usually reflects a-tocopherol concentrations, the isomer
predominantly present. This increase was still present when tocopherol levels were
adjusted for the increase in plasma unsaturation as estimated by the phospholipid
polyene unsaturation index.
Others have reported constant plasma vitamin E levels during pregnancy, when
standardized for total lipid^, cholesterol^, or low density lipoprotein^ concentrations,
while triglyceride-standardized vitamin E levels decreased during pregnancy^. The
larger increase in triglycerides, however, may be less important in view of potential
oxidative stress, since the degree of unsaturation in triglycerides is relatively
low'" '". The course of tocopherol levels during pregnancy found in the present
study indicates that the increase in phospholipid fatty acids during pregnancy, with
emphasis on polyenes, did not compromise the vitamin E status.
Al ef a/J suggested that the increase in plasma phospholipid fatty acids levels
likely was a consequence of increased mobilization from maternal stores. Plasma
vitamin E levels may have been affected by a similar mechanism, although the
increases were larger than the increases in phospholipid fatty acid levels. However,
most carotenoid and retinol levels did not increase with phospholipid lipid levels during
pregnancy, and the antioxidant/Ula^ ratio for these antioxidants decreased. Although
this may have affected the antioxidant status, Davidge ef a/.^ ° reported that the
antioxidant capacity of serum to inhibit autoxidation of brain homogenates /n //fro,
steadily increased during pregnancy. Other studies, in which only total carotenoid
levels were measured, have shown an increase^ or no change® during pregnancy.
This discrepancy may be due to the predominance of certain carotenoids in the
populations studied, since in our study lutein levels increased and B-carotene levels
decreased during pregnancy (Table 4.1). In the present study, retinol levels were only
decreased during the 3rd trimester as compared with the 1 st and 2nd trimester and
postpartum, results comparable to those of Darby ef a/A Morse ef a/.®, however,
found no change in plasma vitamin A during pregnancy, whereas Panth ef a/.^
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reported higher vitamin A levels at mid-gestation, as compared with early and late
gestation, in low socio-economic class Indian women. Panth ef a/.^  suggested that the
decline during late gestation was due to the poor nutritional status of the women, or
increased transfer of retinol across the placenta. In our study, the women were well-
nourished, but increased placental transfer may explain the sudden decrease during
the 3rd trimester. However, it is unclear why this decrease was then no longer present
after delivery. - ':•••
Several studies have investigated whether the changes in antioxidant levels during
pregnancy were sufficient to prevent peroxidation of the increased levels of
polyunsaturated fatty acids, but results are conflicting. Although all found an increase
in vitamin E during pregnancy, Wang ef a/.^ found no increase in thiobarbituric acid
reactive substances (TBArs), whereas lioka ef a/.^ reported a significant increase
in lipid hydroperoxides. Uotila ef a/.* found increased levels of serum conjugated
dienes, only during the 2nd trimester, while serum levels of TBArs decreased non-
significantly during pregnancy and fluorescent chromolipids did not appear to change.
Postpartum, oc-tocopherol and carotenoid levels were similar to levels after 32
weeks of gestation. This was previously also found for vitamin E^ , whereas others
have reported that the increase in maternal a-tocopherol levels during gestation
continued until b i r th^ . Our study, however, showed that 6- and 6+Y-tocopherol
levels were lower immediately after delivery as compared with levels in the 3rd
trimester. In a previous study in which oxidative stress was studied in patients
undergoing percutaneous transluminal coronary angioplasty, we also noticed a
decrease in only 8- and B+y-tocopherol levels in low density lipoproteins 2 days after
the procedure, but no decrease in a-tocopherol levels^. However, in the present
study the period between 3rd trimester sampling and partus is too long to substantiate
conclusions about possible (oxidative) stress during labor.
Cord plasma of newboms contained lower antioxidant levels than maternal plasma,
as has already been reported for vitamin E, (3-carotene, total carotenoids, and
r e t i n o f * ' ^ ^ ' ^ . Cord levels were also lower than maternal levels during early
gestation, and levels found in men (Chapter 3). Although it has been suggested that
the lower vitamin E levels in newboms are due to low total lipid^ or low density
lipoprotein^ levels, in the present study cord total phospholipid fatty acid-standardized
tocopherol and carotenoid levels (results not shown) and U l ^ adjusted ratios were
still significantly lower than maternal values. Consistent with our results, Jagadeesan
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ef a/.™ found a lower vitamin E/cholesterol ratio in cord plasma as compared with
matemal plasma, whereas the lower neonatal vitamin E/cholesterol ratio in another
study^ was not statistically significant. Retinol levels in cord plasma were about half
of maternal levels, and retinol/Ulats ratios were significantly higher. It is unknown
whether increased placental transfer during late gestation, as suggested by Panth
ef a/.^, may explain the relative high cord levels of retinoi as compared with the other
antioxidants and phospholipid fatty acids.
Lipid-soluble antioxidants act as important radical scavengers in lipophilic
compartments, like membranes, but several other compounds may also contribute to
antioxidant defences^^. Vitamin C (ascorbic acid) in plasma is an effective
scavenger of aqueous peroxyl radicals^. Although vitamin E belongs to the first line
of antioxidant defence against lipid-soluble peroxyl radicals^, vitamin C is capable
of regenerating oxidized vitamin E^'^, while being consumed. Contrary to lipid-soluble
antioxidant levels, however, vitamin C levels in umbilical vein plasma are higher than
levels in maternal plasma"^. Nonetheless, the total antioxidant capacity of serum to
inhibit autoxidation of brain homogenates is lower in neonates than in adults^. On
the other hand, the total free radical trapping ability of plasma is similar in term
neonates and adults'*^, and a low"** as well as high^ degree of lipid
peroxidation has been reported in newboms.
For total tocopheroi (vitamin E), cord levels did not correlate with matemal levels,
in agreement with other reports™'^. Shah ef a/.^, however, reported a significant
con-elation between cord and matemal levels in low-income and high-income Indian
subjects. Although matemal levels in this study were only 60% of levels in the present
study, average cord levels were similar or higher. In fact, in groups with high (40-50
umol/l; refs 2, 5, the present study) or low (23-27 u.mol/1; refs 23, 25, 36) matemal
levels at delivery, cord levels appear to be similar (ranging from 8 to 9, and 6 to 10.5
Hmol/I, respectively). This may indicate that vitamin E levels in cord blood are only
influenced by matemal levels when these maternal levels are low. This is also
supported by the higher correlation coefficient found in the low-income group with
lower vitamin E levels, as compared with the high-income group^. Interestingly,
B+y-tocopherol levels in cord and matemal plasma were well-correlated. The reason
for the differences in neonatal/maternal correlation between the tocopheroi isomers
remains unclear however.
For several carotenoids, cord plasma levels correlated with maternal levels, and
correlation coefficients were highest with 3rd trimester levels. Although this may
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indicate that these carotenoids are concentration-dependently transferred from the
mother to the child, this does not appear to be the case for lycopene, since correlation
coefficients for this carotenoid were not significant. The low child/mother ratio for
lycopene (9%) as compared with the other carotenoids (16 to 26%), also suggests a
different transfer or metabolism of lycopene. Furthermore, the apparent absence of
phytofluene in cord samples indicates that this carotenoid is not transferred from
maternal to cord plasma at all. The absence of phytofluene in cord samples was not
due to lack of sensitivity, since we are able to detect phytofluene levels which are
1000 times as low as average maternal levels. This, together with the observed
differences in responses of some carotenoids during pregnancy, indicates that
measurements of total carotenoid ^ . ^ or only R-carotene^ levels may not correctly
reflect responses of all carotenoids.
Retinol levels in cord and maternal plasma did not correlate, as has been reported
in Scandinavian ^ , US Navajo^, and Brazilian^ populations. Studies from India^
and Egypt^, however, reported a significant correlation between cord and maternal
levels. Although average maternal retinol levels were lower in the latter studies (0.8-
1.1 |imol/l) as compared with our study and refs 12,15, and 16 (1.3-1.7 umol/l), Shah
ef a/ /" found a higher correlation coefficient in a high-income group with higher retinol
levels, as compared with the low-income group.
Although the pregnancies were essentially uncomplicated, two women developed
mild pregnancy-induced hypertension. Re-analysis of the data excluding these two
women did not significantly affect trends during pregnancy, or maternal/neonatal
comparisons. A comprehensive comparison between plasma lipid-soluble antioxidant
levels in pregnancies complicated with pregnancy-induced hypertension and levels in
uncomplicated pregnancies is described in Chapter 5.
In summary, this study showed that during pregnancy the increase in plasma
phospholipid fatty acid levels, and thus in peroxidation-susceptible polyunsaturated
fatty acids and unsaturation index, was accompanied by an equal or even larger
increase in tocopherol levels, but that carotenoid levels did not increase concurrently.
Furthermore, B+y-tocopherol levels decreased after delivery, and umbilical cord levels
of tocopherols and carotenoids were lower than maternal levels, even after correction
for the lower fatty acid unsaturation found in neonates. Additional studies are
necessary to demonstrate whether these changes in antioxidant status affect lipid
peroxidation ;n wVo.
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CHAPTER 5
Pregnancy complicated with pregnancy-induced hypertension:
maternal and neonatal plasma lipid-soluble antioxidant levels and its
relationship with fatty acid unsaturation
Gerard S. Oostenbrug, Ronald P. Mensink, Monique D.M. Al, Adriana C. v.
Houwelingen & Gerard Homstra
ABSTRACT
It has been suggested that the plasma antioxidant status may be decreased in women
with pregnancy-induced hypertension (PIH). However, results are inconclusive, and only a
limited number of antioxidants have been studied. Therefore, we have compared plasma
levels of vitamin E isomers, several carotenoids, and vitamin A during the 3rd trimester and
postpartum in 23 women with PIH and their neonates, with levels in 23 matched controls with
uncomplicated pregnancies. Most (19) women with PIH, however, had diastolic blood
pressures under 110 mm Hg throughout pregnancy, and can be classified as mild cases.
In the 3rd trimester of pregnancy, lipid-soluble antioxidant levels were similar in women
with PIH and controls. In the control group, B+y-tocopherol levels decreased on average by
5% (P=0.038) from the 3rd trimester to postpartum. In the PIH group, however, plasma levels
of 5-tocopherol, B+y-tocopherol, lutein, a-carotene, and 13-carotene decreased by 15% to 26%
(P<0.02). As compared with changes in the control group, B+y-tocopherol, lutein, and
a-tocopherol levels in the PIH group decreased significantly (P<0.03). At the same time, the
absolute phospholipid polyunsaturated fatty acid unsaturation index ( U L ^ decreased in the
PIH group, as compared with the control group.
The ratios of B+y-tocopherol and lutein to U l ^ decreased in the control group from the 3rd
trimester to postpartum, but ratios for several other antioxidants decreased in the PIH group
as well. As compared with controls, however, these decreases did not reach statistical
significance. Umbilical vein plasma antioxidant levels were similar after complicated and
uncomplicated pregnancies.
In conclusion, these findings do not support the hypothesis that plasma lipid-soluble
antioxidant levels in the mother and the child are affected by mild PIH. However, this study
does not exclude the possibility that antioxidant levels may be more affected in women with
severe PIH.
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INTRODUCTION " f
Recently, ft has been suggested that many of the clinical and pathophysiological features
of pregnancy-induced hypertension (PIH) might be explained by an imbalance between lipid
peroxidation and antioxidant status (review by Walsh'). Especially the role of the lipid-soluble
antioxidants, like vitamin E, is emphasized'. They stabilize biological membranes and protect
them from oxidative damage. Indeed, during the 3rd trimester of pregnancy, the antioxidant
capacity of serum to inhibit autoxidation of brain homogenates^, and plasma vitamin E
levels'*, were significantly lower in women with severe PIH as compared with uncomplicated
pregnancies. However, Uotila ef a/.* reported increased rather than decreased vitamin E
levels during severe PIH. In women with mild PIH, plasma vitamin E levels during the 3rd
trimester were not increased^*. On the other hand, the total peroxyl radical-trapping capacity
(TRAP) of plasma shortly before delivery was higher in women with mild or severe PIH^.
Therefore, these studies are inconclusive with respect to the plasma antioxidant status in PIH.
After delivery, plasma vitamin E levels were similar in women with mild or severe PIH, as
compared with uncomplicated pregnancies®. The antioxidant capacity of serum to inhibit
autoxidation of brain homogenates, however, was decreased in women with severe PIH*.
Umbilical cord plasma and serum vitamin E levels were also similar after complicated and
uncomplicated pregnancies®'^ . However, cord plasma vitamin A levels were lower after
pregnancies complicated with PIH®.
Reports on other lipid-soluble antioxidants during PIH are scarce and also
inconclusive®®-®. In addition, we have previously shown that plasma levels of the separate
isomers of vitamin E and various carotenoids, do not change uniformly during pregnancy
(Chapter 4), and further analysis of these isomers is indicated. Therefore, we have studied
levels of three vitamin E isomers, several carotenoids, and vitamin A in women with PIH and
their neonates. In addition, we have compared these levels with the degree of fatty acid
unsaturation of phospholipids. There is considerable evidence that endothelial cell injury is
involved in the pathogenesis of PIH™, and phospholipids form important components of cell
membranes. Furthermore, the high degree of fatty acids with three or more double bonds in
phospholipids'' makes them highly susceptible to peroxidation, and fatty acid peroxidation
may have consequences for membrane integrity^.
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METHODS
Sftydy popu/af/on -
This prospective study was initially set up to examine the essential fatty acid status of
mother and child^. Informed consent was received from each participant, and prior approval
for the study was obtained from the Medical Ethics Committee of the University of Limburg.
The cohort consisted of pregnant women with a diastolic pressure (DBP) lower than 90 mm
Hg, and who did not suffer from cardiovascular, neurological, renal or metabolic disorders at
entry for the study, which was before week 16 of gestation. Only women who intended to
deliver at the hospital and had singleton pregnancies were included. After delivery, medical
records were checked, and women with a DBP of 90 mm Hg or more on two consecutive
measurements with an interval of at least of 4 hours, one measurement of 110 mm Hg or
more after 20 weeks of gestation, or an increase of at least 25 mm Hg during pregnancy, were
classified as PIH™. These women were matched for parity and hospital with three women
with uncomplicated pregnancies (controls). Venous plasma samples were collected during the
1st, 2nd, 3rd trimester, and immediately after delivery. Postpartum, umbilical cord (vein)
plasma was collected as well.
After phospholipid fatty acid analysis for that study, 23 sets of samples from women with
PIH and their concurrent neonates were available for antioxidant analysis. Only maternal
samples from the 3rd trimester (approximately 32 weeks of gestation) and maternal and
neonatal postpartum samples were analyzed, because of the reported differences between
PIH and uncomplicated pregnancies with regard to plasma antioxidant levels and plasma
antioxidant capacities during this period of pregnancy (see introduction). For each PIH patient,
1 matched control was randomly selected from the 3 available controls per patient. Until
analysis, plasma samples had been stored for 2 to 5 years at -80 °C. For further details see
ref. 13.
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Plasma antioxidants ..,, • :.
EDTA-anticoagulated plasma was analyzed by HPLC for the vitamin E isomers,
5-tocopherol, B+ytocopherol and a-tocopherol, for the carotenoids, lutein, 13-cryptoxanthin,
lycopene, a-carotene and B-carotene, and for retinol (vitamin A), as described in Chapter 4.
All 5-tocopherol concentrations were based on chromatogram peak heights, as an unknown
peak in postpartum samples sometimes prevented good calculation of peak areas. Since pure
phytofluene was not available, quantitative determination of this compound was not possible
(for further details, see Chapter 4). All samples from one subject, her neonate, and the
samples from the matched control were analyzed in the same analytical run. Storage of
plasma at -80 °C for 5 years was shown not to affect lipid-soluble antioxidant concentrations
(Chapter 4). Between-run coefficients of variation for a mixture of standards ranged from 1.1%
to 2.2% for the various antioxidants. The mean (± SEM) recovery of the internal standard
retinyl acetate added to plasmas was 97 ± 0.5%, and the detection limit in plasma samples
was 0.003 jimol/l for all antioxidants. - . . . •
Plasma phospholipid fatty acids
Details of the plasma phospholipid fatty acid analysis have been reported before". Briefly,
lipids were extracted from plasma using a modified Folch method. Then, the phospholipids,
separated on aminopropyl bonded silica columns, were saponified, and their fatty acids were
transmethylated with boron trifluoride methanol. Fatty acids were separated by gas-liquid
chromatography on a non-polar capillary column, and identified by flame ionization detection
and authentic standards". To quantify peak areas, a standard solution of l-a-dinonadecanoyl
lecithin was added to each plasma sample before extraction. The absolute phospholipid
polyene unsaturation index ( U l ^ was calculated as the sum of the micromolar concentration
of each polyunsaturated fatty acid in the phospholipids multiplied with its number of double
bonds. The relative polyene unsaturation index was calculated as the sum of the percentage
of each polyene (moles/moles total fatty acids * 100%) multiplied with its number of double
bonds.
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Statistics
Paired Student's f-tests were used to compare clinical parameters and 3rd trimester plasma
values in the PIH group with those in the control group. Since the changes in phospholipid
polyunsaturated fatty acids from the 3rd trimester to postpartum were significantly different
between PIH and uncomplicated pregnancies^, paired Mests were also used to evaluate the
changes from 3rd trimester to postpartum within each group, and between the two groups.
Furthermore, calculation of these changes made it possible to correct data for intrinsic
differences. Paired f-statistics were also computed to compare umbilical cord plasma levels
in the PIH group with those in the control group, and to compare cord levels with maternal
postpartum levels. Pearson correlation coefficients were calculated between DBP and
antioxidant levels for all subjects grouped together, and between changes in these parameters
from the 3rd trimester to postpartum. The level of significance was set to P<0.05. Values are
reported as means ± SEM. All statistical analyses were performed using the Statistical
Analysis System (SAS Institute Inc., 1989).
RESULTS
In the control group, aged 29.2 + 0.9 years, 7 smoked, and their mean DBP at entry was
67.0 ± 1.6 mm Hg. In the PIH group, aged 28.0 ± 0.6 years (P=0.257 vs controls), 3 smoked,
and their DBP at entry was 72.0 ± 1.7 mm Hg (P=0.026 vs controls). In both groups, 19
women were nulliparae at entry, and 4 women delivered their second baby. During pregnancy,
the mean maximum DBP in the control group was 75.3 ± 0.8 mm Hg, and in the PIH group
99.8 ± 1.7 mm Hg (P<0.0001 vs controls). In the control group, 10 male and 13 female infants
were bom after 278.7 ± 1.5 days of gestation, with an average birthweight of 3285 ± 99 g, and
in the PIH group, 14 male and 9 female infants after 274.8 ± 3.3 days of gestation (P=0.243
vs controls), who weighed on average 2969 + 153 g (P=0.046 vs controls). In both groups,
one woman gave birth by cesarean section. Although plasma antioxidant (Chapter 4) and
phospholipid fatty acid^ levels change during pregnancy, values were not adjusted for
gestational age, since the average duration of pregnancy was similar in both groups.
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Table 5.1. Plasma lipid-soluble antioxidant levels in women with uncomplicated pregnancies and women wHh pregnandlee
complicated with pregnancy-induced hypertension :
Tocopherols
8-tocopherol
(3+y-tocopherol
a-tocopherol
Carotenoids
lutein
(3-cryptoxanthin
lycopene
a-carotene
f3-carotene
phytofluene
Retinol
3rd trimester
42.42 ±1.24
0.19 ±0.02
3.16 ±0.25
39.06 ±1.31
1.89 ±0.10
0.64 ±0.04
0.31 ±0.03
0.62 ±0.05
0.07 ±0.01
0.25 ±0.03
0.70 ±0.06
1.08 ±0.05
control group
postpartum
43.53 ±1.55
0.17 ±0.01
2.78 ±0.22
40.57 ±1.48
1.85+0.11
0.65 ±0.04
0.29 ±0.05
0.60 ±0.06
0.07 ±0.01
0.25 ±0.03
0.66 ±0.05
1.06 ±0.07
change
+1.109 ±1.106
-0.022 ±0.016
-0.380 ±0.172 •
+1.510 ±1.097
-0.040 ±0.073
+0.003 ±0.030
-0.012 ±0.041
-0.025 ±0.034
-0.001 ±0.008
-0.006 ±0.020
-0.045 ±0.041
-0.023 ±0.073
3rd trimester
43.04 ±2.38
0.22 ±0.03
3.44 ±0.38
39.38 ±2.26
1.95 ±0.13
0.66 ±0.05
0.34 ±0.05
0.65 ±0.05
0.06 ±0.01
0.24 ±0.02
0.76 ±0.08
1.09 ±0.05
PIH group
postpartum
39.38 ±2.64
0.15 ±0.01
2.36 ±0.33
36.87 ±2.41
1.59 ±0.14
0.54 ±0.04
0.29 ±0.05
0.52 ±0.07
0.05 ±0.01 ,
0.19 ±0.02
0.60 ±0.10
0.99 ±0.07
change
-3.660 ±1.643
-0.067 ±0.025
-1.083 ±0.266
-2.510 ±1.578
-0.356 ±0.113
-0.129 ±0.040
-0.047 ±0.036
-0.124 ±0.061
-0.010 ±0.003
-0.046 ±0.014
-0.160 ±0.101
-0.099 ±0.073
«,t
a
b,t
t
b,t
b,t
a
b
b
Plasma lipid-soluble antioxidant levels (nmol/l) were studied in the 3rd trimester of pregnancy, and immediately postpartum, in women with
uncomplicated pregnancies (control group, n=23), and women with pregnancies complicated with pregnancy-induced hypertension (PIH group,
n=23). Phytofluene levels are reported as chromatogram peak areas (mV*min/(.il plasma, amplification 100). Values are means ± SEM.
• * Changes from the 3rd trimester to postpartum were examined by paired Student's t-tests: a, P<0.05; b, P<0.01.
* Differences between the control and PIH group for mean levels in the 3rd trimester, as well as for changes from the 3rd trimester to postpartum,
were examined by paired Student's t-tests: P<0.05. . - , . • « .
Table 5.2. Plasma phospholipid fatty acid composition and polyene unsaturation index in women with uncomplicated pregnancies
and in women with pregnancies complicated with pregnancy-induced hypertension
Total fatty acids
saturates
monoenes
C18:1 n-9
polyenes
n-6
C18:2
C20:4
n-3
C22:6
Polyene unsaturation
absolute
relative
3rd trimester
6238 ±155
2994 ± 79
802 + 26
548 ± 20
2442 ± 61
2126 ± 50
1373 ± 37
478 ± 21
296 ± 15
222 ± 12
index*
7235 ±211
116 ± 1
control group
postpartum
6561 ±178
3192 ± 86
838 ± 30
577 ± 25
2530 ± 71
2199 ± 68
1372 ± 54
525 ± 24
306 ± 13
229 ± 11
7591 ±219
116 ± 1
change
+322 ±155 *
+198 ± 75 "
+36 ± 29
+29 ± 23
+88 ± 60
+73 ± 54
-1 ± 41
+47 ± 13 * .
+10 ± 12
+7 ± 9
+356 ±180
-0.1 ± 0.8
3rd trimester
6389 ±241
3078 ±114
797 ± 48
547 ± 37
2514 ± 91
2175 ± 80
1386 ± 58
485 ± 30
317 ± 16
233 ± 11
7492 ±287
117 ± 1
PIH group
postpartum
6147 ±343
3001 ±164
803 ± 50
554 ± 40
2342 ±135
2015 ±116
1203 ± 67
510 ± 39
304 ± 20
231 ± 13
7181 ±430
117 ± 1
change
-242 ±234
-76 ±118
+6 ± 38
+7 ± 30
-172 ± 84
-160 ± 74
-183 ± 47
+26 ± 23
-13 ± 13
-2 ± 9
-311 ±260
-0.8 ± 0.9
t
t
*
a,*
c,*
t
The fatty acid composition of plasma phospholipids (|xmol/l) were studied in women with uncomplicated pregnancies (control), and women with
pregnancies complicated with pregnancy-induced hypertension (PIH). Samples were collected as described in table 5.1 Values are means ± SEM.
* Calculated as the sum of the micromolar concentration of each polyene multiplied with its number of double bonds (absolute), and as the sum
of the percentage of each polyene (moles/moles total fatty acids * 100%) multiplied with its number of double bonds (relative).
*•''•' Changes from the 3rd trimester to postpartum were examined by paired Student's t-tests: a, P<0.05; b, P<0.01; c, P<0.001.
*•* Differences between the control and PIH group for mean levels in the 3rd trimester, as well as for changes from the 3rd trimester to
postpartum, were examined by paired Student's t-tests: t . P<0.05; ±, P<0.01.
C/?apfer5
In the 3rd trimester of pregnancy, plasma antioxidant levels were similar in the PIH
and control group (Table 5.1). In the control group, B+ytocopherol levels decreased
on average by 5% (P=0.038) from the 3rd trimester to postpartum. Changes in levels
of the other antioxidants were not statistically significant. In the PIH group, however,
plasma levels of total tocopherol decreased on average by 8% (P=0.036), 5-tocopherol
by 21% (P=0.013), 8+ytocopherol by 26% (P=0.0005), total carotenoid by 16%
(P=0.005), lutein by 15% (P=0.004), lycopene by 16% (P=0.052), a-carotene by 15%
(P=0.005), and B-carotene by 15% (P=0.003). The decrease in 13+y-tocopherol levels
in the PIH group was significantly more pronounced than the decrease in
6+y-tocopherol levels in the control group (P=0.042). The decreases in total
tocopherol, total carotenoid, and lutein levels in the PIH group were also significantly
different from the changes in the control group (P=0.015, P=0.021, and P=0.013,
respectively). Although the changes in a-tocopherol levels within each group did not
reach statistical significance, the decrease in the PIH group was significantly different
from the increase in the control group (P=0.024). However, no significant correlations
were found between antioxidant levels and DBP, or between changes in these
parameters from the 3rd trimester to postpartum.
Mean phospholipid fatty acid levels during the 3rd trimester were similar in the PIH
and control group (Table 5.2). From the 3rd trimester to postpartum, total phospholipid
fatty acid levels in the control group increased by 6% (P=0.049). This was due to an
increase in saturated fatty acid levels of 7% (P=0.015) and arachidonic acid
(C20:4 n-6) levels of 10% (P=0.002). In the PIH group, phospholipid n-6 polyenes
decreased by 8% (P=0.042), due to a decrease in linoleic acid (C18:2 n-6) levels by
13% (P=0.0009). Significant differences between the change in the control group and
change in the PIH group were noticed for phospholipid total fatty acid levels (P=0.028),
saturated fatty acid levels (P=0.036), polyenes levels (P=0.007), n-6 poiyenes levels
(P=0.009), and linoleic acid levels (P=0.004). From the 3rd trimester to postpartum,
the absolute polyene unsaturation index (Ulg^) increased by 5% in the control group
(P=0.061), and decreased by 5% in the PIH group (P=0.245). These changes were
significantly different between the two groups (P=0.014). The relative polyene
unsaturation index, however, did not change significantly from the 3rd trimester to
postpartum.
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Table 5.3. Ratio of plasma lipid-soluble antioxidant levels to phospholipid absolute polyunsaturated fatty acid index in women with
uncomplicated pregnancies and in women with pregnancies complicated with pregnancy-induced hypertension
Tocopherols
5-tocopherol
B+7-tocopherol
a-tocopherol
Carotenoids
lutein
13-cryptoxanthin
lycopene
a-carotene
B-carotene
phytofluene
Retinol
3rd trimester
5.912 ±0.163
0.028 ±0.003
0.449 ±0.039
5.435 ±0.158
0.263 ±0.012
0.090+0.006
0.042 ±0.004
0.085 ±0.006
0.009 ±0.001
0.036 ±0.004
0.096 ±0.008
0.152 ±0.007
control group
postpartum
5.784 ±0.195
0.024 ±0.002
0.375 ±0.033
5.385 ±0.179
0.245 ±0.014
0.086 ±0.006
0.039 ±0.007
0.077 ±0.006
0.009 ±0.001
0.034 ±0.004
0.086 ±0.006
0.141 ±0.010
change
-0.128
-0.004
-0.074
-0.050
-0.018
-0.004
-0.003
-0.008
-0.001
-0.002
-0.010
-0.011
±0.129
±0.003
±0.026 *
±0.125
±0.010
±0.004
±0.006
±0.004 "
±0.001
±0.002
±0.006
±0.011
3rd trimester
5.780 ±0.177
0.030 ±0.004
0.462 ±0.050
5.288 ±0.180
0.262 ±0.020
0.091 ±0.008
0.047 ±0.008
0.084 ±0.006
0.008 ±0.001
0.032+0.003
0.098 ±0.010
0.150 ±0.007
PIH group
postpartum
5.581 ±0.130
0.020 ±0.002
0.319 ±0.036
5.242 ±0.128
0.231 ±0.020
0.079 ±0.007
0.044 ±0.008
0.073 ±0.008
0.007 ±0.001
0.028 ±0.003
0.083 ±0.013
0.149 ±0.012
change
-0.199
-0.009
-0.143
-0.046
-0.031
-0.012
-0.002
-0.011
-0.001
-0.004
-0.015
-0.001
±0.151
±0.004
±0.038
±0.142
±0.013
±0.005
±0.006
±0.007
±0.001
±0.002
±0.012
±0.012
a
b
a
a
a
Ratios of plasma lipid-soluble antioxidant to phospholipid absolute polyunsaturated fatty acid index were studied in the 3rd trimester of pregnancy,
and immediately postpartum, in women with uncomplicated pregnancies (control), and women with pregnancies complicated with pregnancy-
induced hypertension (PIH). Values are reported as means ± SEM.
"* Changes from the 3rd trimester to postpartum were examined by paired Student's t-tests: a, P<0.05; b, P<0.01.
Differences between the control and PIH group for mean levels in the 3rd trimester, as well as for changes from the 3rd trimester to postpartum,
were examined by paired Student's t-tests, but no significant differences were noticed.
Table 5.4. Maternal and cord plasma lipid-soluble antioxidant levels after uncomplicated pregnancies and pregnancies complicated
with pregnancy-induced hypertension
Tocopherols
8-tocopherol
B+y-tocopherol
a-tocopherol
Carotenoids
lutein
B-cryptoxanthln
lycopene
a-carotene
B-carotene
phytofluene
Retinol
Maternal
43.53 ±1.55
0.17 ±0.01
2.78 ±0.22
40.57 ±1.48
1.85 ±0.11
0.65 ±0.04
0.29 ±0.05
0.60 ±0.06
0.07 +0.01
0.25 ±0.03
0.66 ±0.05
1.06 ±0.07
control group
Cord"
7.374 ±0.483
0.053 ± 0.006
0.471 ±0.048
6.662 ±0.484
0.250 ±0.029
0.131 ±0.028
0.043 ±0.004
0.041 ±0.003
0.008 ± 0.001
0.028 ±0.002
0.000 - 0.005*
0.617 ±0.056
C/M%
17.2 ±1.4
30.8 ±3.2
18.1 ±1.8
16.7 ±1.4
14.0 ±1.3
20.2 ±3.0
17.3 ±1.6
8.4 ±1.0
13.3 ±1.5
13.4 ±1.6
62.6 ±5.4
Maternal
39.38 ± 2.64
0.15 ± 0.01
2.36 ± 0.33
36.87 ± 2.41
1.59 ± 0.14
0.54 ± 0.04
0.29 ± 0.05
0.52 ± 0.07
0.05 ± 0.01
0.19 ± 0.02
0.60 ±0.10
0.99 ± 0.07
K I H group
Cord"
7.860 ±0.602
0.045 ±0.006
0.479 ±0.041
7.477 ±0.584
0.259 ±0.023
0.126 ±0.013
0.057 ±0.009
0.041 ±0.003
0.007 ±0.001
0.027 ±0.002
0.000-0.010*
0.616 ±0.047
C/M%
21.6 ±2.0
30.0 ±2.6
24.9 ±2.4"
21.7 ±1.9
17.1 ±1.3
23.7 ±1.7
20.4 ±1.3
9.6 ±0.9
17.0 ±1.7
16.5 ±1.9
73.1 ±9.8
After uncomplicated (control) pregnancy, and pregnancy complicated with pregnancy-induced hypertension (PIH), maternal and concurrent cord
plasma were collected immediately after delivery, and analyzed for antioxidanl levels (nmol/l). Phytofluene levels are reported as chromatogram
peak areas (mVmin/nl plasma, amplification 100). C/M% expresses the average ratio of cord vs maternal levels. Values are reported as
means ± SEM.
" Differences between cord and maternal plasma antioxidant levels within each group were examined by paired Student's t-tests, and all cord
plasma antioxidant levels were significantly lower than maternal levels: P<0.001.
* Differences between control and PIH were examined by paired Student's t-tests: P<0.05.
* Cord plasma levels of phytofluene are given as ranges, since only small traces were detected in 11 control and 7 PIH cord samples
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From the 3rd trimester to postpartum, ratios of (3+y-tocopherol and lycopene to
Ulgts decreased by 9% (P=0.010 and P=0.044, respectively) in the control group
(Table 5.3). In the PIH group, d-tocopherol/UI.^ ratios decreased by 17% (P=0.023),
B+y-tocopherol/Ulabs by 23% (P=0.001), lutein/Ulgbs by 11% (P=0.022), and
13-carotene/Ulabs by 9% (P=0.046). However, these decreases did not significantly
differ from the changes in the control group (Table 5.3).
Umbilical vein plasma antioxidant levels were significantly lower than maternal
postpartum levels (Table 5.4), but no significant differences between the control group
and PIH group were noticed. Cord/maternal ratios for tocopherols and carotenoids
varied from 8% for lycopene to 31% for 5-tocopherol levels, and except for
5-tocopherol, these ratios were higher in the PIH group than in the control group.
However, only the higher cord/maternal ratio for B+^tocopherol in the PIH group
(25%) reached statistical significance (P=0.030) as compared with the ratio in the
control group (18%). This significant difference was mainly caused by the non-
significant lower maternal plasma levels in the PIH group as compared with the control
group, and hardly by a difference in cord plasma levels.
Total, saturated, monounsaturated, and n-6 polyunsaturated fatty acid levels in
cord plasma phospholipids were similar after PIH and uncomplicated pregnancies
(results not shown). Cord plasma n-3 polyunsaturated fatty acid levels in phospholipids
were significantly higher after PIH (P=0.005), mainly due to higher docosahexaenoic
acid (C22:6 n-3) levels (P=0.006). The relative polyene unsaturation index was also
higher after PIH (142) than after uncomplicated (135) pregnancies (P=0.012).
However, U l ^ as well as antioxidant/Ulg^ ratios (not shown), were similar in cord
plasma from the PIH and control group.
DISCUSSION
In this study, we have examined 3rd trimester and postpartum antioxidant levels
in plasma from women with pregnancies complicated with PIH, and from women with
uncomplicated pregnancies. In addition, umbilical vein levels in concurrent neonates
were studied.
Mean 3rd trimester maternal plasma antioxidant levels were not significantly
different between the PIH group and controls. Comparable vitamin E (total tocopherol)
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levels in women with mild PIH as compared with controls, were also reported by
others"''*. In women with severe PIH, decreased^ as well as increased plasma
vitamin E levels'* have been reported. Power analysis showed that the number of
subjects in the present study were sufficient to detect differences as reported in these
latter studies"*'*. However, in our study, only 4 of 23 women with PIH had a maximum
DBP of 110 or more, one of the criteria for severe PIH in those studies^*. Therefore,
our study cannot be compared with these studies, and the discrepancy with respect
to vitamin E levels in women with severe PIH remains to be investigated. Another
research group also reported that vitamin E levels in women with PIH were decreased
as compared with controls. However, in one study^ average plasma vitamin E levels
in PIH and controls were 6.3 umol/l and 11.4 ujnol/l, respectively, whereas in a recent
study^ levels were 46.5 and 88.0 umol/l, respectively. This large discrepancy
between these studies, and with the present study, limits the use of these results for
comparison. Uotila ef a/.* considered the possibility that vitamin E levels may not
reflect general antioxidant status, and that a shortage of other antioxidants might
prevail in lipid compartments. Our study, however, also showed no difference in
plasma levels of various other lipid-soluble antioxidants during the 3rd trimester in
complicated and uncomplicated pregnancies. These result are consistent with previous
reports on B-carotene levels in P IH^ . Plasma retinol levels were also similar in the
two groups during the 3rd trimester, which does not agree with results from
Jendryczko era/.®, who reported that retinol levels may be decreased throughout
pregnancy in women with PIH. .
In the present study, several antioxidant levels decreased from the 3rd trimester
to postpartum in the PIH group, whereas only B+y-tocopherol levels decreased in the
control group. The decrease in plasma B+y-tocopherol levels was also found in
another group of women with uncomplicated pregnancies studied at our department
(Chapter 4). In agreement with the present study, plasma levels of other lipid-soluble
antioxidants also did not change from the 3rd trimester to postpartum during
uncomplicated pregnancy in the previous study, except for 5-tocopherol levels which
decreased (Chapter 4). Although the decrease in 13+y-tocopherol levels may be a
result of (oxidative) stress during labor, the period between 3rd trimester sampling and
partus is too long to substantiate this. Furthermore, the reason why only
B+ytocopherol levels decrease from the 3rd trimester to postpartum, and levels of
other lipid-soluble antioxidants do not, is unclear. However, in patients undergoing
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percutaneous transluminal coronary angioplasty, a medical procedure associated with
oxidative stress, we also noticed a decrease in concentrations of the less abundant
tocopherol isomers in low density lipoproteins (LDL), 2 days after the procedure, but
no decrease in LDL a-tocopherol concentrations (Chapter 6).
The decreases in B+y-tocopherol, total tocopherol, a-tocopherol, total carotenoid,
and lutein levels from the 3rd trimester to postpartum in the PIH group were
significantly different from the changes in the control group. However, at the same
time, the peroxidation-susceptible polyunsaturated fatty acids in phosphoiipids, and
thus the Ulabg, also decreased, as compared with the control group. Nonetheless,
B+y-tocopherol/Ulaijg ratios still decreased significantly from the 3rd trimester to
postpartum in both groups, which is consistent with previous results (Chapter 4). In the
control group, lycopene/Ulgjjg ratios also decreased from the 3rd trimester to
postpartum. Furthermore, within the PIH group, ratios for several antioxidants
decreased significantly, despite the decreased in UL^, although these decreases were
not significantly different from changes in the control group. Possibly, a future study
with more cases of severe PIH may show whether the decreases in maternal
antioxidant/Ulgbs ratios from the 3rd trimester to postpartum are substantial in
pregnancies complicated with PIH.
Results from this study do not indicate that the status of lipid-soluble antioxidants
in the neonate is affected by PIH complications in the mother, since cord plasma
antioxidant levels and antioxidant/UI.^ ratios in both groups were similar. For vitamin
E, these findings agree with previous reports^, but Uotila ef a/.®, have found lower
cord plasma retinol levels after pregnancies complicated with PIH.
Vitamin E is regarded as one of the most important antioxidants in lipophilic
compartments, like membranes. However, the water-soluble antioxidant vitamin C may
have a sparing effect on vitamin E by regenerating the oxidized form''*'™. Although
Mikhail ef a/.^  found decreased plasma levels of vitamin C during the 3rd trimester in
women with PIH, Uotila ef a/.^  reported similar levels just before delivery in women
with and without PIH. In women with PIH, Uotila ef a/.^  also found increased plasma
levels of uric acid and unidentified antioxidants, both contributing to higher TRAP
levels. Conversely, Davidge ef a/.* reported a lower antioxidant capacity of serum to
inhibit autoxidation of brain homogenates in women with PIH, and they suggested that
the increase in serum antioxidant capacity, as seen during uncomplicated pregnancies,
is absent in women with PIH. However, in the present study, 3rd trimester plasma
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tocopherol levels in the PIH group were consistent with increases seen during
uncomplicated pregnancies (Chapter 4), and plasma vitamin C levels in women with
or without PIH are similarly increased as compared with nonpregnant controls^.
In summary, this study showed that maternal plasma lipid-soluble antioxidant levels
during the 3rd trimester were similar in pregnancies complicated with mild PIH and
uncomplicated pregnancies. From the 3rd trimester to postpartum, however, plasma
levels of several antioxidants decreased in the PIH group as compared with controls.
At the same time, plasma unsaturation, as estimated by the phospholipid polyene
unsaturation index, decreased as well. Nonetheless, the PIH group showed significant
decreases in antioxidant/Ula^ ratios for several antioxidants, although the differences
with changes in the control group did not reach statistical significance. Neonatal lipid-
soluble antioxidant levels in plasma were unaffected by maternal PIH.
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CHAPTER 6
Percutaneous transluminal coronary angioplasty as model for lipid
peroxidation-associated oxidative stress in humans
Gerard S. Oostenbrug, Ronald P. Mensink, Frits W.H.M. Bar & Gerard Homstra
Based on: Free flad/'ca/ S/o/ogy /n Wedfc/ne (Vn press/
ABSTRACT
Animal studies have suggested that myocardial ischemia/reperfusion causes oxidative
stress. We therefore examined whether routinely performed percutaneous transluminal
coronary angioplasty (PTCA) might be a human ischemia/reperfusion model for oxidative
stress-induced lipid peroxidation. Fasting antecubital venous blood was sampled from 13
patients on the moming of PTCA, and 2 days after PTCA. Venous and coronary arterial blood
were sampled just before and 10 minutes after the first balloon inflation. Samples were
analyzed for plasma and LDL lipid hydroperoxide levels, /n wfro oxidation of LDL, and LDL
antioxidant levels. Lipid hydroperoxide levels in plasma and LDL remained unchanged
throughout the study. During the first 10 minutes of PTCA, the lagtime during oxidation of LDL
/n v/Yro did not change, but the maximum rate of oxidation decreased in venous and arterial
samples (Wilcoxon signed rank test: P<0.002). At the same time, total tocopherol levels in
LDL significantly increased by 6.3% (P=0.048) in arterial, but not in venous samples. Total
carotenoid levels increased by 3.8% (P=0.127) in arterial samples and decreased by 2.9%
(P=0.040) in venous samples. Forty hours after PTCA, LDL oxidation parameters and LDL
antioxidant levels were similar to baseline, except for about 17% lower levels of 5-tocopherol
(P=0.037) and y-tocopherol (P=0.014). Our results, therefore, do not support that PTCA in
humans is associated with oxidative stress-induced lipid peroxidation.
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I N T R O D U C T I O N ' V=i ,,'
Animal studies have suggested that, after a period of ischemia, the reintroduction
of oxygen during reperf usion of the heart causes oxidative stress. Oxygen-derived free
radicals, for example, were detected during myocardial reperfusion after mechanically
induced ischemia in isolated rabbit and rat^ hearts, and open-chest dogs^. These
hazardous free radicals can interact with polyunsaturated fatty acids (PUFAs)*,
thereby generating lipid hydroperoxides and aldehydes, which may cause cellular
damage^. Evidence for free radical and lipid peroxidation-associated oxidative
stress is supported by studies showing that antioxidants and antioxidant enzymes
reduce ischemia/reperfusion injury in ex wVo organ and /n wVo animal studies^®.
However, measurement of parameters of lipid peroxidation in isolated animal hearts
during ischemia/reperfusion are conflicting^".
Oxidative stress following ischemia/reperfusion in humans has mainly been
investigated during surgery under variable conditions''^. Percutaneous
transluminal coronary angioplasty (PTCA) is the most routinely used technique for
mechanical revascularization of obstructed coronary arteries, and surgical conditions
are often well-standardized. Therefore, PTCA may present a usable model for
oxidative stress in humans. Indeed, free radicals were detected during PTCA in human
plasma samples^*.
Lipid peroxidation-associated oxidative stress during PTCA in humans has usually
been demonstrated by measuring thiobarbituric acid reactive substances (TBArs) in
plasma^^. The TBArs assay measures malondialdehyde (MDA), one of the many
degradation products of lipid hydroperoxides. Although improved in recent years, the
low specificity of this assay for MDA, the numerous non-lipid TBA-positive materials,
and the fact that part of the MDA is formed /n v/fro due to the extreme conditions
needed for the reaction of MDA with TBA, have limited the value of this assay for
quantifying lipid peroxidation (reviewed in Ref. 17). Furthermore, not all studies
found increased levels of TBArs after PTCA^^ . Therefore, we decided to
investigate lipid peroxidation during and after PTCA using an assay directly measuring
lipid hydroperoxides in plasma under moderate conditions. In addition, interaction of
free radicals with PUFAs in low density lipoproteins (LDLs) may lead to oxidatively
modified LDL, and detection of modified LDL may indicate oxidative stress. Therefore,
oxidative modification of LDL was investigated as well, by measuring its lipid
hydroperoxide and antioxidant content, and its susceptibility to oxidation /n vrfro.
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PATIENTS AND METHODS
Patients and procedure
Thirteen patients (1 female, 12 males) with stable angina pectoris enrolled in this
study after angiographically detected occlusion of a coronary artery. All regular
medications were continued, including acetylsalicylic acid, calcium antagonists, 6-
adrenoceptor antagonists, and nitrates. Informed consent was received from each
patient, and prior approval for the study was obtained from the Medical Ethics
Committee of the University of Limburg.
Day 1
t t
VO V1 V2
A1 A2
10 min
Day 2 Day 3
Figure 6.1. Design of the study. Thirteen patients underwent PTCA according to a standard
protocol. Venous blood was sampled on the morning of PTCA (VO) and two days
thereafter (V3). Just before PTCA, venous (V1) and arterial (A1) blood was sampled,
and repeated ten minutes after the first balloon inflation (V2 and A2). During these ten
minutes, 1 to 3 dilations were performed, and the procedure was completed for 10
patients. In two patients a fourth angioplasty was performed after these ten minutes,
and for one patient a total of 12 dilations was necessary.
On the morning of PTCA, a fasting venous blood sample was taken from a fore-
arm (VO), one hour after oral administration of 80 mg acetylsalicylic acid. Four to
seven hours after VO, PTCA was performed according to a standard protocol.
Preceding PTCA, local anaesthesia with lidocaine was given. The catheter was
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inserted by the femoral route. After administration of heparin (i.v. 10,000 IU), a venous
sample (V1) was taken from a intravascular teflon cannula, which was placed in an
antecubital vein during the entire procedure. At the same time, an arterial sample
proximal to the lesion (A1) was taken from the coronary guiding catheter. Then,
nitroglycerin (i.e. 200 |ig) was administered, and the first balloon inflation was started.
Additional nitroglycerin was given during the procedure if cardiac instability occurred
as indicated by electrocardiography. Ten minutes after the first balloon inflation, again
a venous and an arterial sample were taken (V2 and A2). During these ten minutes,
the PTCA procedure was continued according to normal routine protocol. In 10 of 13
patients the procedure was completed within these ten minutes. After the procedure,
patients were kept under observation, and received standard hospital meals during this
period. Approximately 42 hours after PTCA (48 hours after VO), a final fasting venous
blood sample was drawn from a fore-arm (V3), again one hour after oral administration
of 80 mg acetylsalicylic acid. The design is schematically presented in Figure 6.1. Two
patients were discharged from the hospital before a V3-sample was taken. One patient
died the night before the V3-sampling.
Blood collection
Seven ml of blood were collected into decapped Monoject-tubes (Sherwood
Medical, Ballymoney, Northern Ireland) containing 15 mg ethylenediaminetetraacetic
acid, tripotassium salt (K3EDTA). Tubes were immediately closed after collection, and
blood and EDTA were carefully mixed. Plasma was obtained after 15 minutes of
centrifugation at 2000 g and 4 °C, within one hour of collection. Plasma for lipid
hydroperoxide analysis was stored at -80 °C.
Blood analyses .
P/asma and LDL //p/d hydroperox/des
Lipid hydroperoxide levels in plasma and LDL (see below) were analyzed with a
commercially available kit, based on the reaction with a methylene blue derivative
(MCDP) (Determiner LPO-CC, Kamiya Biomedical Company, Thousand Oaks, CA,
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USA). The reaction is catalyzed by hemoglobin added to the reaction mixture, and the
formation of methylene blue is measured spectrophotometrically at 675 nm. The
method was modified to measure low concentrations, and analyses were performed
using a COBAS BIO centrifugal analyzer (F. Hoffmann-La Roche, Basel, Switzerland).
Briefly, 12 fxl of plasma were mixed with 75 nl of reagent 1, containing ascorbic
oxidase and lipoprotein lipase. After incubation for 6 minutes at 30 °C, 130 u.l of
reagent 2 (MCDP and hemoglobin) were added. Absorbance at 675 nm was measured
after another 12 minutes of incubation at 30 °C. The analyzer was completely shielded
from light to prevent destabilization of the reagents. A hydroperoxide calibration curve
was obtained by diluting the supplied cumene hydroperoxide standard solution (50
|imol/l) to 1, 2 and 3 umol/l with distilled water. These calibration samples were
present in each run. All plasma samples were analyzed in duplicate. The between-run
coefficient of variation for the 3 calibration samples ranged from 8.6% to 10.2% (14
runs). The average difference between duplicate measurements of plasma samples
(n=104) was 9.0 + 9.5%. Levels were lipid-standardized (u.mol/mmol cholesterol)
using cholesterol levels.
LDL /so/af/on and ox/daf/on
LDL was isolated from fresh plasma immediately after collection by single spin
density gradient ultracentrifugation^°. Sudan Black B to prestain the lipoproteins,
however, was not added because it interfered with the LDL oxidation analysis. All
gradient solutions contained 1.0 g/L of NagEDTA^HgO to prevent initiation of oxidation
of the LDL particle during isolation. The 5 samples from each patient collected on the
same day (V0, A1, V1, A2, V2) were centrifuged in the same run. LDL (p=1.019-1.055
g/ml) was collected by aspiration, and 0.6 ml was stored at -80 °C for analysis of
antioxidants and lipid hydroperoxides. The remaining LDL was used for oxidation
studies: LDL of the first 5 samples (V0, A1, V1, A2, V2) was stored under a nitrogen
atmosphere for two days at 4 °C, and then processed together with the sixth sample
(V3). EDTA was removed from LDL samples by gel filtration. To this end, 1.3 ml of
LDL was diluted with 1.5 ml nitrogen-purged phosphate-buffered saline (PBS: 10
mmol/l KH2PO4, 0.15 mol/l NaCI, pH 7.4). Then, two PD-10 Sephadex G25-M gel
filtration columns (Pharmacia, Roosendaal, The Netherlands) were placed on top of
each other and equilibrated with nitrogen-purged PBS. Finally, 2.5 ml of the LDL-
dilution was applied to the upper column and eluted with 5.5 ml nitrogen-purged PBS
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in two volumes of 2.75 ml. The last eluent of 2.75 ml, containing the EDTA-free LDL,
was kept under a nitrogen atmosphere. A previous experiment showed that the
percentage removal of EDTA using this method was approximately 99.8%. The
concentration of EDTA was determined by mixing 5 (il of LDL eluent with 390 u.1 0.33
mmol/l iron-phenanthroline. Iron-phenanthroline was freshly prepared by adding
FeSO^HgO to 1,10-phenanthroline monohydrochloride monohydrate in PBS. After
1 hour of incubation at 25 °C, the decrease in absorbance at 510 nm, due to the
competition of EDTA with iron for the phenanthroline molecule, was compared with
that of standard solutions of EDTA in PBS. Before and after the gelfiltration,
cholesterol concentrations in LDL were determined, using a enzymatic colorimetric test
kit (Monotest Cholesterol, Boehringer Mannheim, Mannheim, Germany). Within 15
minutes after gelfiltration, samples were diluted with PBS (not purged with nitrogen)
to a final concentration of 0.26 mmol cholesterol/l, and oxidation was initiated with
CuClg (final concentration: 15 nmol/l). Oxidation of PUFAs was measured
spectrophotometiicaliy by monitoring the formation of conjugated fatty acid dienes at
37 °C in a quartz cuvette. The change in absorbance at 234 nm was recorded over
a 4-hour period, and the amount of dienes was calculated using the molar extinction
coefficient for conjugated dienes ( 6334= 29,500 l/mol/cm)*\
LDL anfox/danfs
LDL was analyzed for levels of tocopherols and carotenoids by a method slightly
modified from Hess efa/.^. LDL (250 nl) was mixed for 10 seconds with retinol
acetate (25 jil, 4.5 mg/l) as internal standard, distilled water (250 nl), ethanol (250 u.l)
and methanol (250 u.l). Then n-hexane (1 ml) was added, the samples were shaken
for 10 minutes, and centrifuged at 2000 g for 10 minutes. The organic top phase was
removed and the extraction procedure repeated. The two hexane phases were pooled,
and evaporated to dryness under nitrogen. Residues were redissolved in 60 u.l
ethanol/dioxane (1:1) by shaking for 10 minutes, and then 90 jil acetonitrile were
added. One hundred microliters were injected (Promis II injection system; Spark
Holland, Emmen, The Netherlands) on a Inertsil ODS-2, 5 nm C-18, 50 mm * 4.6 mm
I.D. precolumn, followed by a Inertsil ODS-2, 5 urn C-18, 150 mm * 4.6 mm I.D.
column (GL Sciences, Tokyo, Japan), and eluted with 68% acetonitrile/22%
tetrahydrofuran/7% methanol/3% ammonium acetate (10 g/l) at a flow rate of 1.0
ml/min (Gynkotek model 300 pump; Gynkotek, Germering, Germany). The mobile
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phase was passed through a 0.2 urn regenerated cellulose filter (Sartorius,
Goettingen, Germany) before use, and degassed on-line using a GT-103 metal free
degassing device (Separations, H.I. Ambacht, The Netherlands). All samples from
each patient were analyzed in the same analytical run. Detection of carotenoids at 450
nm was carried out with an Applied Biosystems 785A absorbance detector (Applied
Biosystems, Maarssen, The Netherlands). Simultaneously, fluorescence detection
(Jasco 821 -FP; Japan Spectroscopic Company, Hachioji City, Japan) was used for
detection of retinol acetate (excitation at 330 nm, emission at 470 nm: 0-6.5 min),
tocopherol isomers (excitation at 298 nm, emission at 328 nm: 6.5-13 min) and
phytofluene (excitation at 349 nm, emission at 480 nm: 13-23 min)^. Peak areas were
calculated with the Gynkosoft Chromatography Data System (Gynkotek, Germany),
and calibrated against a mixture of the various standard substances in ethanol/-
dioxane/acetonitrile (1:1:3). The concentration of the separate standard solutions was
determined spectrophotometrically using molar extinction coefficients reported in
literature^'^'^. Molar extinction coefficients used were for: retinol acetate 50.9
(326 nm), 8-tocopherol 3.52 (298 nm), 6 and y-tocopherol 3.81 (298 nm), a-tocopherol
3.26 (292 nm), lutein 128 (445 nm), canthaxanthin 127 (470 nm), cryptoxanthin 131
(452 nm), lycopene 185 (472 nm), a-carotene 150 (440 nm), and (3-carotene 137
l/mmol-cm (ethanolic solutions). Since pure phytofluene was not available, quantitative
determination of this compound was not possible. B-Tocopherol co-eluted with
y-tocopherol. Previous reports on (3-tocopherol levels in plasma vary between
'negligible'^, 9%*® or 20%^ of y-tocopherol levels. B-Tocopherol levels in LDL are
unknown. The canthaxanthin standard eluted separately from the lutein standard, but
in LDL samples canthaxanthin concentrations were too low to appear as a separate
peak. Therefore, concentrations of lutein reported here may also include
canthaxanthin. Levels of LDL antioxidants were lipid-standardized (nmol/mmol
cholesterol) using LDL cholesterol levels. Tocopherol (a, (3,7 and 5), B-cryptoxanthin,
lycopene, and a- and 3-carotene standards were a generous gift from F. Hoffmann-La
Roche (Basel, Switzerland). Lutein was obtained from Sigma Chemical Company
(Saint Louis, USA), and canthaxanthin from Fluka Chemie (Bornem, Belgium). Retinol
acetate and all other chemicals were purchased from Merck (Darmstadt, Germany).
Acetonitrile, tetrahydrofuran and methanol used for HPLC were of HPLC grade.
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Short-term (V2 minus V1; A2 minus A1) and longer-term (V3 minus VO) effects of
PTCA, as well as differences in short-term effects between arterial and venous
samples (V2-V1 minus A2-A1) were examined by Wilcoxon signed rank tests
(Statistical Analysis System, SAS Institute Inc., 1989). Spearman correlation (r)
coefficients were calculated between values in venous (V1) and arterial (A1) samples,
and differences were compared by Wilcoxon signed rank tests. Spearman correlation
coefficients were also computed to assess the relationship between lipid hydroperoxide
levels in plasma and LDL, and between various parameters when applicable. Non-
parametric tests were chosen because of the relatively small number of subjects.
Results are given as means± SD. s : r
RESULTS
Basic and clinical characteristics
The 13 patients were between 43 and 71 years of age (mean: 58 years), and
between 155 and 190 cm tall (mean: 174 cm). Body weight ranged from 59 to 95 kg
(mean: 80 kg), and body mass index from 20 to 30 kg/m* (mean: 26 kg/m*). Five
patients did not smoke, two had stopped smoking, and six smoked on average 19
cigarettes per day (range: 7-30 cigarettes). The average length of the coronary artery
lesions was 11 mm (range: 2 to 20 mm), causing a 90% (range: 80 to 99%) narrowing
of the affected arteries, as determined by qualitative assessment. Eight patients
required PTCA in the left anterior descending artery (LAD), one patient in the right
coronary artery (RCA), and four in the circumflex branch (RCX). One balloon inflation
was performed in 4 patients, two in 4 patients, three in 2 patient, four in 2 patients,
and twelve dilations in 1 patient. Each dilation was sustained for on average 1 minute.
After PTCA, the average degree of stenosis was reduced to 21% (range: 5 to 70%).
There was no apparent relation between the clinical characteristics and lipid
hydroperoxide levels, LDL oxidation /n v/fro, or LDL antioxidant levels. No significant
baseline differences were noticed between samples from the 5 non-smokers and the
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6 smokers, except for lower levels of LDL tocopherols in smokers (3468 ± 319 versus
4357 ± 445 nmol/mmol cholesterol in non-smokers, Wilcoxon rank-sum test: P=0.046).
Responses to PTCA as described below, however, were similar in smokers and non-
smokers.
Short-term effects of PTCA
P/asma and LDL //p/d hydroperox/des
Table 6.1. Short-term effect of PTCA on plasma and LDL lipid hydroperoxide levels, and LDL
oxidation /n wfro in venous and arterial samples.
Sample V1 or A1
(n=13«)
V2orA2
(n=13")
Change
(AV.AA)
L/p/d hydroperox/des ftymoW77mo/ crjo/estero/^
Plasma
LDL
LDL ox/daf/on
Lagtime
(min)
Dienes
(nmol/mmol LDL-C)
Rate
(dienes/min)
venous
arterial
venous
arterial
venous
arterial
venous
arterial
venous
arterial
0.24
0.32
0.95
1.03
62.1
61.7
137.3
137.4
3.81
3.88
±0.17
±0.52
±0.23
±0.25
±11.1
±10.6
± 9.2
± 8.1
±0.63
±0.53
0.30 ± 0.55
0.25 ± 0.21
1.02 ± 0.25
0.98 ± 0.23
63.0 ± 9.9
61.0 ± 12.4
136.9 ± 8.8
137.0 ± 7.6
3.54 ± 0.47
3.57 ± 0.54
0.07 ±
-0.07 ±
0.07 ±
-0.05 ±
0.91 ±
-0.77 ±
-0.35 ±
-0.42 ±
-0.28 ±
-0.31 ±
0.40
0.38
0.19
0.17
3.83
6.12
2.50
4.05
0.29 t
0.22 t
Just before PTCA, venous (V1) and arterial (A1) blood samples were taken, and analyzed as described
in 'Methods'. Ten minutes after the first balloon inflation, again a venous (V2) and arterial (A2) sample
were taken, and the changes (AV.AA) as compared with respectively V1 and A1 were calculated.
Values are means ± SD. * n=12 for LDL lipid hydroperoxides. Short-term changes were analyzed by
signed rank test, t : P<0.002. No significant differences between venous and arterial samples were
noticed. LDL-C = LDL cholesterol.
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* Just prior to PTCA, the mean plasma lipid hydroperoxide level was 0.24 ± 0.17
u.mol/mol cholesterol in venous samples, and 0.32 ± 0.52 nmol/mol in arterial samples.
Ten minutes after the first balloon inflation, levels remained essentially similar, both
in venous and arterial plasma (Table 6.1). Lipid hydroperoxide levels in LDL also
showed no effect of ballooning (Table 6.1). However, levels in LDL were much higher
(irrespective of standardization for cholesterol), and did not correlate with levels in
plasma at any point of sampling (r= -0.32 to +0.51, p>0.09, n=9-12).
LDL ox/c/af/on /n v/fro
The lagtime before onset of rapid oxidation^, and the amount of dienes formed
during copper-catalyzed oxidation of LDL /n w'fro, were similar just before PTCA and
10 minutes after the first balloon inflation, in both venous and arterial samples (Table
6.1). During this period, however, the maximum rate of diene formation had decreased
by 0.28 ± 0.29 u.mol/mmol LDL cholesterol/min or 6.7 + 6.2 % (P=0.002) in venous
samples, and by 0.31 ± 0.22 nmol/mmol/min or 7.9 ± 5.1 % (P=0.0002) in arterial
samples (Table 6.1). The maximum rate of oxidation did not correlate with antioxidant
levels. Although there was a significant correlation between the maximum rate of
oxidation and the (preformed) lipid hydroperoxide levels in the original LDL solution
obtained before PTCA (V1: r=0.70, P=0.017; A1: r=0.87, P=0.0005), this correlation
was not found between the short-term changes of both parameters.
LDL anf/'ox/ctente
During the ten minutes after the first balloon inflation, cholesterol-standardized
a-tocopherol levels in LDL increased significantly in arterial samples by 192.2 ± 291.5
nmol/mmol cholesterol or 6.3 ± 9.4 % (P=0.033), but not in venous samples (Table
6.2). A similar trend was seen for B+y-tocopherol (arterial increase: 15.2 ±27.0
nmol/mol or 6.2 ± 10.2 %, P=0.068). Arterial 5-tocopherol increased non-significantly
by 1.0 ± 2.2 nmol/mol or 6.8 ± 18.7 % (P=0.146).
Cholesterol-standardized total carotenoid levels (without phytofluene) in LDL
decreased in venous samples (5.8 ±10.1 nmol/mmol cholesterol or 2.9 ± 4.4 %, P=
0.040), but only the small change in the B-carotene level (-1.8 ±3.4 nmol/mmol
cholesterol or -2.7 ± 3.8 %, P=0.033) reached statistical significance. The decreases
in venous (3-cryptoxanthin (1.0 ± 1.9 nmol/mmol cholesterol, P=0.057) and lycopene
(1.6 ± 2.7 nmol/mmol cholesterol, P=0.057) levels were of borderline significance. As
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with tocopherol levels, all carotenoid levels in arterial samples increased, but these
increases did not reach statistical significance. The increase in arterial a-carotene
(1.1 ± 2.8 nmol/mmol cholesterol) levels was of borderline significance (P=0.057). For
most carotenoids, the short-term responses in venous samples were in opposite
direction from those in arterial samples (Table 6.2). These differences in change reach
statistical significance for all carotenoids except for lutein + canthaxanthin.
Table 6.2. Short-term effect of PTCA on cholesterol-standardized LDL antioxidant levels in
venous and arterial samples.
Sample V1 or A1
(n=13)
V2orA2
(n=13)
Change
(AV.AA)
C/io/estero/-stendarcfeeaf LDL anfox/danfc (VimoWnmo/ cno/esfera/;
Total tocopherols
6-Tocopherol
6+y-Tocopherol
a-Tocopherol
Total carotenoids"
Lutein"
B-Cryptoxanthin
Lycopene
a-Carotene
B-Carotene
Phytofluene"
venous
arterial
venous
arterial
venous
arterial
venous
arterial
venous
arterial
venous
arterial
venous
arterial
venous
arterial
venous
arterial
venous
arterial
venous
arterial
3865
3755
20
20
365
358
3480
3376
247
238
40
39
30
29
75
72
18
17
85
81
98
93
±598
±682
± 8
± 8
±224
±231
±527
±579
±119
±111
± 10
± 9
± 13
± 13
± 43
± 41
± 16
± 16
± 62
± 59
± 95
± 92
3836
3963
21
21
363
373
3453
3569
241
249
39
40
29
30
73
75
17
18
83
86
98
101
±641
±640 *
± 8
± 8
±223
±230
±571
±579 *
±120
±127
± 10
± 9 *
± 14
± 14
± 43
± 43
± 16
± 18*
± 62
± 67 *
± 96
±106
-28.6
208.4
0.3
1.0
-2.1
15.2
-26.8
192.2
-5.8
11.1
-1.0
0.8
-1.0
1.2
-1.6
2.9
-0.4
1.1
-1.8
5.0
0.0
7.9
±173.1
±316.3 t *
± 1.7
± 2.2
± 21.0
± 27.0
±152.6
±291.5 t *
± 10.1 f
± 26.3 *
± 2.1
± 3.5
± 1.9
± 4.1 *
± 2.7
± 7.2 *
± 1.0
± 2.8 "
± 3.41
± 11.7 "
± 4.4
± 16.9 "
a, sum of specified tocopherols or carotenoids (phytofluene not included); b, lutein levels may
include small amounts of canthaxanthin; c, phytofluene levels are presented in peak area/nmol LDL
cholesterol. Values are means ± SD.
t , short-term changes were analyzed by signed rank test: P<0.05.
* and **, significant differences between venous and arterial values, *, P<0.05; **, P<0.01.
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Longer-term effects of PTCA , . .
On the second day after PTCA (V3), lipid hydroperoxide levels and LDL oxidation
parameters were similar to values at the start of the study (VO) (Table 6.3). Most
cholesterol-standardized antioxidant levels in LDL were also comparable to levels at
VO, except that 5-tocopherol and B+y-tocopherol levels had decreased by 4.5 ± 5.0
nmol/mmol cholesterol (16.4 + 20.9%, P=0.037) and 96.2+109.7 nmol/mmol
cholesterol (17.5 ±23.1 %, P=0.014), respectively (Table 6.3).
Table 6.3. Longer-term effect of PTCA on plasma and LDL lipid hydroperoxide levels, LDL
oxidation /n wfro, and LDL antioxidant levels.
VO (n=10")
P/asma and LDL //p/d hydroperox/ctes
Plasma
LDL
LDL ox/cfaffon
Lagtime
Dienes
Rate
LDL antfox/danfs
Total tocopherols''
5-Tocopherol
B+y-Tocopherol
a-Tocopherol
Total carotenoids'*
Lutein"
(3-Cryptoxanthin
Lycopene
a-Carotene
B-Carotene
Phytofluene"*
0.16 ±0.10
1.03 ±0.31
62.3 ±13.2
137.0 ±10.3
3.16 ±0.46
3882 ± 654
21 ± 7
367 ± 226
3495 ± 557
262 ± 133
41 ± 11
31 ± 17
81 ± 42
19 ± 18
90 ± 72
106 ±104
[n=13]
[0.17]
[1.05]
[63.5]
[138.0]
[3.35]
[3798]
[20]
[363]
[3414]
[250]
[40]
[30]
[76]
[18]
[87]
[99]
V3(n=10°)
0.15 ±0.08
1.12 ±0.38
62.5 ±13.0
136.5 ± 9.1
3.21 ±0.36
3757 ± 681
16 ± 4
271 ± 126
3470 ± 634
264 ± 130
40 ± 10
32 ± 16
81 ± 41
18 ± 18
93 + 70
108 ± 105
Change (AV)
-0.01 ± 0.07
0.09 ± 0.43
0.20 ± 6.05
-0.56 ± 4.50
0.05 ± 0.32
-125.4 ±317.2
-4.5 + 5.0 t
-96.2 ±109.7 f
-25.1 ±279.6
1.6 ± 18.6
-1.4 ± 3.9
0.5 ± 2.4
0.4 ± 7.5
-0.6 ± 0.6
2.4 ± 13.6
1.7 ± 10.6
On the morning of PTCA (V0) and two days thereafter (V3) a venous blood sample was taken, and the
changes (AV) in lipid hydroperoxide levels, LDL oxidation and antioxidant levels were calculated (for units,
see Table 6.1 and 6.2). Values are means ± SD. Values in brackets are means of all 13 LDL samples.
• n=9 [12] for LDL lipid hydroperoxides, and n=9 [13] for LDL oxidation parameters
*" see superscripts a-c in Table 6.2.
t , longer-term changes were analyzed by signed rank test, P<0.05.
98
and //p/d perox/daf/on
Comparison between venous and arterial samples
Spearman correlation coefficients between venous (V1) and arterial (A1) samples
taken just before PTCA were 0.76 for plasma lipid hydroperoxides (P=0.003, n=13),
and 0.55 for lipid hydroperoxides in LDL (P=0.067, n=12). For LDL oxidation
parameters, Spearman correlations ranged from 0.86 to 0.93 (P<0.0001, n=13), and
for LDL antioxidants from 0.90 to 1.00 (P<0.0001, n=13). Before PTCA, there were
also no significant differences between the mean venous and arterial levels for any of
the parameters studied (Tables 6.1 and 6.2).
DISCUSSION
Several studies have shown the formation of free radicals in animal models for
ischemia and reperfusion^, and after PTCA in humans^'™. Formation of lipid
hydroperoxides after PTCA due to free radical attack of polyunsaturated fatty acids,
however, could not be demonstrated in the present study. No increase in plasma lipid
hydroperoxide levels was noticed ten minutes after the first balloon inflation, nor 2
days thereafter.
The absence of increased levels of lipid hydroperoxides after PTCA is supported
by measurements of TBArs in coronary sinus plasma, two and ten minutes after the
last balloon inflation^. Other studies^'^, however, have suggested a transient release
of TBArs in coronary venous plasma immediately after PTCA, but this was not
confirmed by Steg ef a/.^. A release of TBArs, only detectable during the first minute
after PTCA, is further not supported by Blann ef a/.^, who found no increased levels
in coronary artery plasma at the time of balloon inflation, but levels were increased
after 10 minutes. These longer-lasting effects are in agreement with the reported
presence of free radicals in coronary sinus plasma for at least 10 minutes following
balloon inflations^. However, not all increases in TBArs reflect increased lipid
peroxidation^.
In the present study no increases in lipid hydroperoxides in LDL following PTCA
were noticed either. Levels were lower than those reported by El-Saadani ef a/.^,
who used an iodometric method to detect lipid hydroperoxides. They reported mean
Chapter 6
lipid hydroperoxide levels in native LDL of 5.4 ± 0.3 nmol/mg LDL (approx. 6
umol/mmol LDL cholesterol). In the present study, however, the amount of lipid
hydroperoxides in LDL was higher than the amount that could be detected in plasma,
and most lipid hydroperoxides in LDL were, therefore, probably formed during the
isolation of LDL, despite the protective presence of EDTA. This may also explain the
lack of correlation between lipid hydroperoxide levels in plasma and LDL.
To investigate whether free radicals formed during or after PTCA had modified
LDLs, copper-catalyzed oxidation of isolated LDL /n wfro and LDL antioxidant
concentrations were investigated. The lagtime and the maximum amount of dienes
during oxidation of LDL /n wfro, were not affected by PTCA. The unchanged lagtimes
indicate that the oxidation resistance of LDL was not affected, despite the changes in
antioxidant levels during the first ten minutes of PTCA. The remarkable longer-term
decreases in 5- and B+y-tocopherol also were not associated with diminished lagtimes.
Recently, it has been reported that the copper-catalyzed LDL oxidizability was
reduced in patients with coronary artery disease taking the B-blockers Atenolol or
Metoprolol, as compared with patients not taking any 13-blockers^. LDL oxidizability
was not affected by intake of acetylsalicylic acid, nitrates or calcium antagonists. In the
present study, however, average lipid peroxide levels and LDL oxidation parameters,
as well as responses during the study, were similar in the 6 patients receiving
B-blockers (1 patient used Atenolol, 4 patients Metoprolol, and 1 patient Bisoprolol)
and the 7 patients not taking B-blockers (results not shown). It is, therefore, unlikely
that the intake of B-blockers has prevented detection of PTCA-induced lipid
peroxidation. • -.
The maximum rate of oxidation decreased by 7-8% during the ten minutes after
the first balloon inflation, an effect observed in both venous and arterial samples.
Although it is apparent that the lagtime and amount of dienes reflect the LDL
antioxidant and PUFA concentration, factors affecting the maximum rate of oxidation
are unclear. Cominacini efa//*\ reported that the maximum rate of oxidation
decreased after a-tocopherol supplementation. It is unlikely, however, that changes
in LDL tocopherol or carotenoid levels affected the maximum rate of oxidation in this
study, since antioxidant responses in venous and arterial samples were opposite,
whereas the maximum rate of oxidation decreased in both. A change in (preformed)
lipid hydroperoxide levels in LDL could also not explain the decreased maximum rate
of oxidation, since there was no correlation between the short-term responses of these
parameters. Surprisingly, the maximum rate of oxidation just before PTCA (V1: 3.81
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dienes/min) was higher than the rate at baseline (VO: 3.35 dienes/min), indicating an
effect on the rate of oxidation not related to the ischemia or reperfusion during
angioplasty (Figure 6.2). Although it is possible that factors like the administered
heparin or lidocaine may have caused this initial increase in maximum rate of
oxidation, it is inconceivable that the effect of these factors diminished suddenly during
the short period of 10 minutes between V1, A1 and V2, A2. LDL from patients
receiving nitrates demonstrated similar copper-catalyzed oxidizability as compared with
LDL from patients not taking nitrates'^, but the effects of nitroglycerine and contrast
fluid, administered i.e. after V1 and A1, on the maximum rate of oxidation is unknown.
VO V1 V2 V3
Figure 6.2. Maximum rate of ;n vrtro oxidation of LDL from venous
samples (for further explanation see methods and Figure
6.1). Circles indicate individual values, and horizontal bars
indicate mean values. LDL-C = LDL cholesterol.
Apart from the change in maximum rate of oxidation of LDL /n v/fro, LDL
carotenoid levels decreased slightly in venous samples during the first ten minutes of
PTCA, and, unexpectedly, LDL antioxidant levels increased in arterial samples. This
latter observation does not agree with other studies, which showed decreased a-
tocopherol levels in heart tissue^"** and pulmonary artery plasma** after other
procedures associated with ischemia and reperfusion. However, the periods of
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ischemia in these studies were much longer than those used during PTCA in the
present study, and results may therefore not be comparable. The origin of the extra
antioxidants in LDL of arterial samples after ballooning in the present study is
unknown, however. In theory, it is possible that the transfer of a-tocopherol from LDL
to cells is inhibited due to heparin-induced release of lipoprotein lipase (LPL) from the
cells^, thereby causing a retainment of a-tocopherol in LDL. However, the
comparable decreases in plasma triglycerides levels in venous and arterial samples
(data not shown) indicate that the heparin-induced release of LPL was similar in
venous and arterial blood, whereas the a-tocopherol responses were not. Although
LDL S- and (3-Ky-tocopherol levels are low as compared with the large pool of a-
tocopherol, the decrease of almost 20% two days after PTCA indicates a selective loss
of these isomers. We cannot rule out, however, that the standard hospital meals may
have contained little 5- and 13+y-tocopherol.
In summary, we found no clear evidence for increased lipid peroxidation 10
minutes after the first balloon inflation during PTCA as measured by lipid
hydroperoxides levels, and the lagtime and maximum amount of dienes formed during
oxidation of LDL /n v/fro. There was a significant decrease of carotenoid levels in
venous LDL samples, but it was very small. Furthermore, the decrease in maximum
rate of diene formation during oxidation of LDL ;n viffro and the increased coronary
arterial levels of especially LDL-a-tocopherol rather indicate decreased lipid
peroxidation. It is unclear whether the almost 20% decrease in LDL 8- and
6+ytocopherol levels in venous samples two days after PTCA has any biological
significance.
In conclusion, our results do not support that PTCA in humans is associated with
oxidative stress-induced lipid peroxidation.
We are indebted to the health professionals of the Department of Cardiology of the
Academic Hospital Maastricht whose cooperation made this study possible, and to Mrs
Carin Wensing who assisted in collecting blood samples.
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GENERAL DISCUSSION
The aim of the studies described in this thesis was to investigate parameters of
lipid peroxidation and antioxidant status in situations in which the degree of oxidative
stress and/or antioxidative protection is altered. Firstly, we have increased the
availability of a major substrate for lipid peroxidation, polyunsaturated fatty acids
(PUFA), by supplementing the diet with highly unsaturated fish oil concentrates. At the
same time we have studied whether increasing the dietary intake of vitamin E, a chain-
breaking antioxidant, would be necessary to compensate for the increased availability
of substrate. In a second study this dietary manipulation was combined with exercise,
during which increased production of oxygen free radicals may exacerbate lipid
peroxidation. Thereafter, the antioxidant status was studied in pregnant women. During
the course of pregnancy, plasma (polyunsaturated) fatty acids levels increase. The
increased availability of substrate for lipid peroxidation may compromise antioxidant
defences. The antioxidant status was also studied in women with pregnancy-induced
hypertension (PIH), since it has been suggested that many of the clinical and
pathophysiological features of PIH might be explained by an inadequate antioxidant
status. Finally, lipid peroxidation and antioxidant status were studied during
revascularization of obstructed coronary arteries, a medical procedure associated with
increased production of oxygen free radicals.
The major parameters studied were oxidation of low density lipoproteins (LDL)
/n wfro and lipid soluble antioxidant concentrations in plasma. In subjects studied
during exercise, also various parameters linked to exercise or exercise performance
were examined.
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MAIN FINDINGS
Oxidation of LDL in vitro
F/s/7 o// supp/ementef/on
In the first study (Chapter 2), fish oil concentrates, with or without vitamin E, were
given to sedentary men for 3 weeks, and oxidation of LDL /n v/fro was compared with
a control group receiving no supplement. Already after the first week, an increase in
the /n wfro formation of conjugated dienes during oxidation of LDL (oxidizability) was
noticed in both groups receiving fish oil, as compared with controls. After three weeks,
these increases were significantly different from controls. These results support the
hypotheses that an increase in the average number of double bonds in fatty acids in
the diet increases the /'n wfro oxidizability of LDL, as was also found when the
proportion of dietary n-6 PUFA was increased at the expense of monounsaturated fatty
acids^'^'*. Furthermore, our results agree with studies showing an increase in the
formation of thiobarbituric acid reactive substance during cell- or copper-catalyzed
oxidation of LDL /n wfro^'^ after fish oil supplementation. However, in the second
study (Chapter 3), fish oil supplementation did not increase the oxidizability of LDL.
In both our studies a parallel design was used, and a control group was present
to correct for unknown drifts with time. Furthermore, samples from each of the three
experimental groups were present in each analytical run, and between-run artefacts
were therefore excluded. However, three apparent differences existed between the two
studies: (1) subjects were sedentary in the first study, and well-trained in the second
study, (2) although fish oil concentrates used in both studies were derived from natural
sources and gelatin covered, they were supplied by different manufacturers, (3) and
LDL for oxidation experiments were prepared by different methods.
With respect to the first two differences, both fish oil supplements increased the
degree of fatty acid unsaturation in the sedentary as well as the trained subjects. In
the sedentary subjects receiving fish oil (Chapter 2), the proportion of n-3 fatty acids
in plasma phospholipids increased from 4.7% to 9.7%. In the trained subjects (Chapter
3), n-3 fatty acids in red blood cell phospholipids increased from 5.2% to 7.3%, slightly
less than half the increase observed in plasma phospholipids in the first study.
However, it is known that n-3 fatty acid responses in red blood cells are less
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pronounced than responses in plasma^®^. Since dietary supplementations of n-3
fatty acids were comparable in both studies (study 1: 2.4 g/day; study 2: 2.1 g/day),
we expect that the LDL fatty acid composition also changed similarly. Unfortunately,
fatty acid compositions of LDL were not analyzed, but based on data from others
studies™ ° increases in the proportion of n-3 fatty acids in LDL of 3-5% might be
expected. Comparison of the two methods of LDL preparation (difference no. 3)
revealed no significant differences in LDL oxidation parameters in samples from not
supplemented sedentary subjects (results not shown). To investigate whether fish oil
supplementation may have had different effects on the two methods, a second study
was carried out in which 6 male sedentary subjects received Fish-EPA capsules (6
g/day, Orthica, Weesp, The Netherlands) and 6 received placebo capsules, for 3
weeks (Plat ef a/., results not yet published). The fish oil capsules were the same as
used in the second study (Chapter 3). For both methods, fish oil supplementation did
not increase the maximum amount of dienes, consistent with results shown in Chapter
3. In the first study (Chapter 2), the number of subjects was limited. Nonetheless, the
amount of dienes was consistently increased after 1, 2, and 3 weeks of
supplementation. Furthermore, dienes were increased by approximately 20% in both
groups receiving fish oil supplementation. Although currently we cannot explain why,
the discrepancy between the results reported in Chapter 2 and 3 may be related to the
kind of fish oil capsules. Since the fish oil capsules used in the first study were not
available anymore, we have not been able to verify this however.
In theory, an increase in fatty acid unsaturation of LDL, and thus of substrate for
lipid peroxidation, may decrease the lagtime before rapid onset of oxidation /n y/fro
due to accelerated depletion of antioxidants, and may increase the rate of oxidation
due to an increased number of lipid peroxidation chain-reactions. Indeed, in the first
study (Chapter 2), fish oil supplementation tended to decrease the lagtime in
agreement with recent studies in elderly hypertensive subjects^ and postmenopausal
women", but this was not confirmed in our second study (Chapter 3). Similar
inconsistent result were also found when the effects of dietary linoleic acid-rich diets
were compared with oleic acid-rich diets^*.
In the first study, fish oil supplementation did not significantly affect the rate of
oxidation. In contrast with our expectations, however, fish oil supplementation
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decreased the rate of oxidation in the second study, especially in combination with
vitamin E supplementation. A decrease in rate of oxidation after fish oil
supplementation was recently also found in elderly hypertensive subjects^ and
postmenopausal women". This appears to be in disagreement with studies in which
a linoleic acid-rich diet increased the rate of oxidation, as compared with an oleic acid-
rich diet^'*. Recently, Kleinveld ef a/.^ found that the rate of oxidation standardized
for LDL protein, correlated positively with the proportion of linoleic acid, and inversely
with the proportion of oleic acid and the oleic acid/linoleic acid ratio. However,
correlations with n-3 fatty acids were not studied. Furthermore, phospholipid fatty acid
analysis in plasma (Chapter 2) and erythrocytes (Chapter 3) indicated that fish oil
supplementation decreased the proportion of linoleic acid and increased the oleic
acid/linoleic acid ratio in both our studies, whereas a decrease in rate of oxidation was
only noticed in the second one. In other fish oil supplementation studies, the rate of
oxidation decreased while the oleic acid/linoleic acid ratio in LDlJ and plasma" did
not increase. The underlying mechanism for the possible effect of fish oil
supplementation on the rate of oxidation remains unexplained.
In conclusion, the first study indicated that fish oil supplementation may promote
oxidation of LDL, which is further supported by studies showing an increase in the
uptake of native^ and copper-oxidized^ LDL by macrophages after fish oil
supplementation. However, a reducing effect on the rate of copper-catalyzed oxidation
of LDL /n wYro was found in our second study. These contradictory results, and the
inconsistencies and apparent paradoxes reported by others, indicate that further
studies are needed before definite conclusions can be drawn about the effect of fish
oil supplementation on oxidation of LDL /n wfro.
F/s/7 o// p/t/s v/fa/n/n £ supp/emenfaf/on
In both studies described in Chapter 2 and 3, supplementation with 300 IU of
vitamin E, additionally to fish oil supplementation, almost doubled vitamin E levels in
LDL, and increased the lagtime, most likely by acting as a chain-breaking antioxidant
which terminates lipid peroxidation chain reactions until complete depletion of the
antioxidant(s)^. It should be noted that vitamin E only delayed oxidation, but that the
maximum amount of dienes formed was not affected, in agreement with results from
Wander ef a/.". On the other hand, this delay may also be important ;n v/Vo, since
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Regnstrom ef a/.™ showed an inverse relation between the lagtime for copper-
catalyzed LDL oxidation /n v/fro and quantitative estimates of global coronary
atherosclerosis in humans. As compared with fish oil supplementation alone, extra
vitamin E supplementation did not significantly affect the rate of oxidation, but recent
dose-response studies show that dietary dosages of 400 IU/day^ or 800 IU/day^
may be necessary to detect significant effects on the rate of oxidation. Nonetheless,
it is still unclear how vitamin E in high dietary dosages^^ may affect the rate of
oxidation, since all vitamin E is already consumed during the lag
With respect to LDL oxidation /n wfro, our studies (Chapter 2 and 3) do not provide
clear evidence that the intake of vitamin E should be increased during fish oil
supplementation. On the other hand, a fish oil-induced decrease in lagtime (Chapter
2, and refs 7 and 11), which was however not noticed in the study in Chapter 3, may
be counteracted by vitamin E supplementation (Chapter 2, and ref. 11). Croft ef a/.'"
even reported a prooxidative effect of vitamin E, since the cholesterol-standardized
vitamin E content of LDL correlated positively with the rate of oxidation and with the
amount of dienes formed during LDL oxidation /n w'fro. Similar correlations were found
for the protein-standardized vitamin E content^. However, in not supplemented
subjects, these correlations may be related to the PUFA content of LDL, since an
increase in PUFA is correlated with an increase in vitamin E^°, and an increase in
PUFA may also be con-elated with increases in rate of oxidation and the amount of
dienes (see above).
Endurance exerc/se
Strenuous endurance exercise did not affect the lagtime before onset of rapid
oxidation of LDL /n wfro or the rate of oxidation, but decreased the amount of
conjugated dienes formed (Chapter 3). This may indicate that the relative amounts of
PUFA in the native LDL had decreased^. Sumikawa ef a/.^ showed that exercise
decreased the proportion PUFA in red blood cell phospholipids of untrained subjects.
Although such a decrease may be a result of lipid peroxidation /n v/Vo, perhaps due
to decreased antioxidant protection (see below), alternative explanations cannot be
excluded. Therefore, additional studies are required for confirmation. Increasing the
supply of substrate for lipid peroxidation by fish oil supplementation, did not alter
exercise-induced changes in LDL oxidation.
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Percutaneous frans/um/na/coronary anaVop/asfy • .
LDL oxidation /n v/fro was also studied in patients undergoing percutaneous
transluminal coronary angioplasty (PTCA), a medical procedure in which blood flow
in an obstructed coronary artery is restored by ballooning (Chapter 6). The
reoxygenation, which may be associated with free radical production, did not affect the
lagtime and the maximum amount of dienes during oxidation of LDL /n w/ro. The
maximum rate of oxidation decreased during the ten minutes after the first balloon
inflation, an effect observed in both venous and coronary arterial samples. In addition,
no change in plasma lipid hydroperoxide levels were noticed, ten minutes after the first
ballooning. These results do not indicate that PTCA in humans increases LDL
oxidation /n wfro.
Extrapolation of copper-catalyzed oxidation of LDL in vitro to in vivo processes
Research in animals and humans has provided several supportive lines of
evidence for the occurrence of oxidation of LDL /n wVo, and for its role in
atherosclerosis as postulated by Steinberg ef a/, (see ref. 22, and refs therein).
However, due to ethical and logistical problems, development of /n v/fro techniques
was necessary in human studies. In our studies, the susceptibility of LDL to oxidation
was studied /n w/Yro with copper as prooxidant, and under conditions where the LDL
are not protected by all interacting (water-soluble) antioxidant systems normally
present in the human body. Nevertheless, ;n v/rro copper-oxidized LDL greatly
resembles LDL extracted from human and rabbit atherosclerotic lesions*^*, IgG
isolated from these lesions recognizes copper-oxidized LDL but not native LDL^,
and the degree of atherosclerosis in humans is correlated with copper-catalyzed
oxidation of LDL^. Although atherosclerosis is a multifactorial process, LDL oxidation
/n wfro may therefore prove a useful technique for future research in this field.
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Plasma lipid-soluble antioxidant levels
F/sn o//supp/emenfaf/on and endurance exerc/se v
Fish oil supplementation (Chapter 2 and 3) did not affect plasma lipid-soluble
antioxidant levels. Although only LDL-a-tocopherol levels were reported in the first
study (Chapter 2), the whole spectrum of lipid-soluble antioxidants were later analyzed
(not reported), in an attempt to find an explanation for the discrepancies between the
two fish oil supplementation studies. However, plasma lipid-soluble antioxidant levels
and responses were comparable. The increase in the amount of highly unsaturated
fatty acids apparently does not reduce lipid-soluble antioxidant levels, that is, at least
in plasma. Intense endurance exercise for 1 hour without intake of nutrients, on the
other hand, decreased plasma tocopherol and carotenoid levels adjusted for
hemoconcentration (Chapter 3). Although the decreases in antioxidants only provide
indirect supportive evidence for oxidative stress during exercise, we also noticed a
decrease in red blood cell deformability. Such a decrease has been associated with
oxidative stress as welP.
A/ornia/ pregnancy
During pregnancy, plasma levels of various lipids increase, and we therefore
studied whether the increase in PUFA contained in these lipids compromised
antioxidant defences (Chapter 4). However, plasma tocopherol and lutein levels
increased by more than 40% from the 1 st to the 3rd trimester, which was even more
than the increase in plasma unsaturation as estimated by the absolute phospholipid
PUFA unsaturation index ( U l ^ . Although plasma levels of most carotenoids
remained constant during pregnancy, there was a significant decline in (3-carotene
levels. Furthermore, since the U l ^ increased during pregnancy, carotenoid/Ulg^
ratios decreased. The different responses of the antioxidants during pregnancy
indicate that measurements of total tocopherol (vitamin E) or total carotenoid levels
may not provide an accurate reflection of lipid-soluble antioxidant responses. Besides
for 13-carotene, little information is available on the antioxidant capacity of other
carotenoids (for reviews, see refs 27, 28 and 29). Although carotenoid are
present in much lower concentrations than, for example a-tocopherol, Di Mascio
ef a/.^ ° showed that the higher singlet oxygen quenching capacity of carotenoids
compensates for this difference. However, the role of singlet oxygen in lipid
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peroxidation is still unclear", and effects observed in /n wtro models might not be
relevant /n wVo.
Remarkably, whereas most plasma antioxidant levels did not change from the 3rd
trimester to postpartum, there was a distinct decrease in 5-tocopherol and
6+Y-tocopherol levels (Chapter 4). The decrease in B+y-tocopherol levels was also
noticed in another group of pregnant women (Chapter 5). Future studies may indicate
whether this decline occurred during the last phase of pregnancy, or whether, for
example, oxidative stress during labor diminished plasma levels of the less abundant
tocopherol isomers. . ,
In neonates just after birth, plasma antioxidant levels were considerably lower than
levels found in adults (Chapter 4 and 5). Although plasma lipid levels were also lower
in neonates our data indicated that antioxidant levels adjusted for phospholipid or
phospholipid unsaturation are still lower in neonates. However, the plasma levels of
the most abundant lipid-soluble antioxidant, a-tocopherol, in neonates did not correlate
with levels in the mothers, and newborns from mothers with low plasma a-tocopherol
levels, had similar levels as well-nourished mothers (see discussion Chapter 4). This
indicates that supplementation of mothers with a-tocopherol will probably not improve
the neonatal antioxidant status. For several carotenoids, but certainly not for
phytofluene, neonatal levels appeared to be influenced by maternal levels, and this
observation may have implications for future studies in pregnant women and their
newboms.
Pregnancy comp//cated w/fh pregnancy-/nducecy nypertens/on
In pregnant women suffering from mild PIH, plasma lipid-soluble antioxidant levels
during the 3rd trimester of pregnancy were similar to 3rd trimester plasma levels in
women with uncomplicated pregnancies (Chapter 5). Others already found similar 3rd
trimester vitamin E (mainly a-tocopherol) levels in uncomplicated pregnancies and
pregnancies complicated with mild PIH^ '^ , but we showed that plasma levels of
the less abundant tocopherols and various carotenoids were also similar. Although
plasma antioxidant levels in women with PIH decreased from the 3rd trimester to
postpartum, plasma unsaturation, as estimated by the phospholipid PUFA unsaturation
index, decreased as well. Furthermore, neonatal plasma lipid-soluble antioxidant levels
were unaffected by maternal PIH. We, therefore, did not find a relation between the
plasma lipid-soluble antioxidant status and mild PIH. Studies in women with severe
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PIH, have presented inconsistent results with respect to plasma vitamin E
but the tendency to decreased antioxidant levels from the 3rd trimester to postpartum
in women with mild PIH in our study (Chapter 5) merits further investigation of lipid-
soluble antioxidant levels in severe PIH. On the other hand, a recent study showed
that dietary supplementation with 300 mg/day of vitamin E in women with PIH did not
affect fetal mortality"*. However, since vitamin E was given during the 3rd trimester
after diagnosis of PIH, this may have been too late to influence fetal outcome.
Percutaneous frans/um/na/ coronary ang/op/asfy
During the first ten minutes of PTCA, LDL tocopherol levels increased in coronary
arterial plasma, but not in venous samples (Chapter 6). In other procedures associated
with ischemia and reperfusion, decreased a-tocopherol levels in heart t issue^'^
and pulmonary artery plasma*" have been noticed. However, the periods of ischemia
in these studies were much longer than those used during PTCA in the present study,
and results may therefore not be comparable. Carotenoid levels also appeared to
increase in arterial samples, but decreased in venous samples. However, this
decrease was only small, and the increased coronary arterial antioxidant levels, the
decrease in rate of /n wfro oxidation of LDL, and absence of increased plasma levels
of lipid hydroperoxides do not support that PTCA in humans is associated with lipid
peroxidation shortly after the start of the procedure. Although LDL levels of the less
abundant tocopherol isomers were decreased two days after PTCA, this did not affect
LDL oxidation /n wfro or plasma lipid hydroperoxide levels.
Conclusions
In situations potentially subjected to oxidative stress (i.e. an imbalance between
prooxidants and antioxidants), like supplementation with highly unsaturated n-3 fatty
acids, exercise, pregnancy, mild PIH and PTCA, we found little or inconsistent
evidence for increased systemic lipid peroxidation. Although this may indicate that the
human body is sufficiently capable of counteracting (mild) oxidative stress, local effects
may not have been detectable in plasma. However, in most situations it is impossible
to study local events in humans. In the studies described, we have investigated lipid
peroxidation by using different techniques simultaneously, several of which have
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established meaning in lipid peroxidation research.
The method of copper-catalyzed oxidation of LDL /n wfro has provided the
opportunity to view the effects of moderate interventions on LDL oxidation
characteristics, which may be relevant for the /n wvo situation. By using the rapid
short-run isolation (Chapter 3) and gel filtration (Chapter 3 and 6) techniques, the
disadvantage of time-consuming preparation of LDL has been overcome, and a
reasonable number of samples can be analyzed within a short period. Furthermore,
the possible introduction of analytical artefacts, as during extensive preparation
procedures, is reduced. However, lipid peroxidation should not only be based on LDL
oxidation /n vrfro, but should simultaneously be estimated with other techniques as
well. The method of analysis of antioxidants in one single run, as developed by Hess
ef a/.^ ®, provides plasma concentrations of 10 lipid-soluble antioxidants within a short
period. It should be noted, however, that the antioxidant capacity of these molecules
is often based on ;"n wtto activity, and, especially with regard to the carotenoids and
retinol, needs more proof for their action /n v/Vo. Although lipid-soluble antioxidants
may be very important in lipid environments of, for example, membranes, other
antioxidant systems may also contribute to antioxidant defences.
Future research
Several 'indicators' have been developed to estimate the extent of lipid
peroxidation in the human body. The very simple assay based on the reaction with
thiobarbituric acid may be suitable for rough estimates of lipid peroxidation in patients,
but lacks sensitivity and specificity to detect small changes in healthy subjects (see
also Chapter 1). Recently introduced commercially available assays to easily and more
specifically measure lipid hydroperoxides concentrations in plasma or serum, however,
have detection limits of 2 nmol/l (LPO-CC, Kamiya Biomedical Company, Thousand
Oaks, CA, USA) and 2.5 nmol/l (LPO-586, Bioxytech, Bonneuil sur Maine, France),
and are therefore not suitable for plasmas of healthy subjects. A iodometric method,
developed for detection of lipid hydroperoxides in LDL^, was recently used for
plasma*°. We (results not shown) and others*^, however, could not detect lipid
hydroperoxides in plasma of healthy subjects using iodometry. A more sensitive,
method using HPLC and chemiluminescence detection, could detect free fatty acid and
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cholesterol ester hydroperoxides at picomole levels, but could not be used for
detection of phospholipid hydroperoxides, and is very laborious**. However, to study
lipid hydroperoxide concentrations in plasma of healthy subjects it seems inevitable
to develop and use very sensitive methods.
To include the influence of water-soluble antioxidants and antioxidant proteins,
assays that measure the total antioxidant capacity of serum or plasma in response to
a prooxidant /n v/fro have been developed. However, result obtained with these assays
should also be viewed with care. They may be affected by the medium in which the
assay is performed, and may depend on the kind of prooxidant the plasma or serum
has to inhibit. Furthermore, the antioxidant capacity assay may be affected by pure
antioxidant standards, but this does not mean that changes in plasma antioxidant
levels will be detected by the assay. For example, Rice-Evans and Milter'** showed
that antioxidants found in plasma, like a-tocopherol and vitamin C, when added as
pure substances, affected their recently developed assay for the total antioxidant
status in plasma and body fluids. However, they also showed that dietary
supplementation with 300 mg of a-tocopherol, 250 mg of vitamin C, or 15 mg
B-carotene per day for 8 weeks, increased plasma levels by 70%, 30%, and 250%,
respectively, but did not affect the 'total antioxidant status"^.
Recent studies have focussed again on LDL oxidation /n wvo. Virella ef a/.*®
detected antibodies against copper-oxidized LDL in human sera. They found that
antibody levels were similar in healthy subjects and subjects with coronary heart
disease. Holvoet ef a/.^ also measured similar plasma IgG autoantibody titers for
MDA-modified LDL in healthy subjects and subjects with chronic stable angina
pectoris, carotid atherosclerosis, or myocardial infarction. Using a murine monoclonal
antibody, they also detected MDA-modified LDL in carotid atherosclerotic lesions,
confirming previous research^'*®, but, in addition, demonstrated MDA-modified LDL
in plasma. With this new technique, they found similar plasma levels of MDA-modified
LDL in patients with chronic stable angina pectoris as compared with controls, but
higher levels in patients with carotid atherosclerosis, and in patients early after the
onset of myocardial infarction. Although these sophisticated techniques provide
important evidence for modification of LDL ;n wvo, they have only been used in
patients. It would be challenging to use these techniques to study effects of dietary
manipulations.
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Vrije zuurstof radicalen spelen een belangrijke rol in vele biologische processen
in de mens. Het zijn echter zeer reactieve deeltjes, waardoor schade aan weefsels kan
ontstaan. Antioxydantenzymen en andere antioxydantverbindingen in het lichaam
kunnen deze reactieve deeltjes weer onschadelijk maken. -
Meervoudig onverzadigde vetzuren (MOV) zijn zeer gevoelig voor aanvallen van
vrije zuurstof radicalen door de aanwezigheid van twee of meer dubbele bindingen
(Hoofdstuk 1). Deze gevoeligheid neemt toe bij een toename van het aantal dubbele
bindingen. Dit proces, en de daarop volgende peroxydatie van het vetzuur onder
invloed van zuurstof wordt 'lipidenperoxydatie' genoemd. Gedurende lipiden-
peroxydatie worden lipoperoxyden gevormd die op hun beurt andere vetzuren kunnen
aanvallen, en zo een ketting-reactie veroorzaken. Dit kan leiden tot beschadiging van
celmembranen, waarin deze MOV zich bevinden. De relatieve hoeveelheid en de soort
MOV in membranen wordt onder andere bepaald door de vetzuursamenstelling van
de voeding. Antioxydanten, zoals vitamine E uit de voeding, kunnen de ketting-reactie
van lipidenperoxydatie stoppen. Lipidenperoxydatie is dus afhankelijk van de vorming
van vrije zuurstof radicalen, van de beschikbaarheid van MOV, van de hoeveelheid
dubbele bindingen in de MOV, en van de aanwezigheid van antioxydanten.
Lipidenperoxydatie vindt niet alleen plaats in cellulaire membranen, maar ook in
bijvoorbeeld lipoproteinen. Resultaten van veel recente onderzoeken geven aan dat
het ontstaan en/of de progressie van atherosclerose mogelijk een oorzaak vinden in
lipidenperoxydatie van lage dichtheid lipoprotemen (LDL) (Hoofdstuk 1).
Aangezien lipidenperoxydatie afhankelijk is van de hoeveelheid beschikbare
dubbele bindingen in MOV, werd de invloed van een verhoging van de hoeveelheid
sterk onverzadigde MOV in de voeding op de oxydatie-gevoeligheid van LDL
onderzocht (Hoofdstuk 2). Gezonde proefpersonen kregen gedurende 3 weken een
supplement bij hun voeding, bestaande uit visolie, een olie met veel vetzuren met 5
en 6 dubbele bindingen. Indien men daama LDL isoleerde uit het bloed van die
proefpersonen, en het vervolgens oxydeerde met koper-ionen, dan werd er meer
oxydatie-produkt (geconjugeerde dienen) gevormd. In een groep die naast de visolie
tevens vitamine E ontving, duurde het langer voordat de oxydatie /n //fro op gang
kwam, maar de hoeveelheid dienen was uiteindelijk even sterk verhoogd als bij de
119
Samenvaff/ng
proefpersonen die alleen visolie kregen. Uit deze proef werd geconcludeerd dat de
sterk onverzadigde vetzuren uit visolie de /n wfro oxydeerbaarheid van LDL verhogen,
maar dat vitamine E in de voeding de weerstand tegen dit proces verbetert.
Er zijn aanwijzingen dat visolie een positieve invloed heeft op het fysieke
prestatievermogen. Inbouw van de vetzuren uit visolie in membranen van rode
bloedcellen zou de flexibiliteit van deze cellen kunnen bevorderen, en daarmee de
voorziening van zuurstof aan de spieren. Echter fysieke inspanning verhoogd de
vorming van zuurstof radicalen, en een extra verhoging van de mate van lipiden-
peroxydatie door visolie, zoals waargenomen in Hoofdstuk 2, zou niet wenselijk zijn.
Om het effect van inspanning per se te bepalen werd eerst het fysieke prestatie-
vermogen, de flexibiliteit van rode bloedcellen en de mate van lipidenperoxydatie
gemeten in 24 getrainde atleten voor dat deze een supplement kregen (Hoofdstuk 3).
Een tijdrit van 1 uur op een fiets-ergometer resulteerde in een daling van de flexibiliteit
van de rode bloedcellen. Gedurende de tijdrit daalde ook de hoeveelheid
antioxydanten (tocoferolen en carotenolden) in plasma, maar onduidelijk is of dit
gerelateerd is aan lipidenperoxydatie, aan een verschuiving van antioxydanten van het
plasma naar weefsels, of aan een combinatie hiervan. Het meten van meer
parameters van lipidenperoxydatie zal daarom noodzakelijk zijn.
Gedurende 3 weken ontvingen vervolgens twee groepen van 8 atleten een
dagelijks supplement bestaande uit visolie, en van die twee groepen kreeg een groep
van 8 tevens vitamine E. De derde groep van 8 ontving een placebo supplement.
Suppletie met visolie veroorzaakte echter geen verandering van de flexibiliteit van de
rode bloedcellen. In tegenstelling tot de bevindingen in Hoofdstuk 2 veroorzaakte
suppletie met visolie bij de atleten (Hoofdstuk 3) geen stijging van de vorming van
geconjugeerde dienen tijdens oxydatie van LDL /n wfro. Voor de tegenstrijdige
resultaten van Hoofdstuk 2 en 3, met betrekking tot LDL oxydatie /n wfro, is tot op
heden echter nog geen verklaring gevonden. Na suppletie met visolie werd er geen
verbetering van de prestatie waargenomen, maar waren er ook geen aanwijzingen dat
de combinatie van inspanning en visolie-suppletie de mate van lipidenperoxydatie
extra verhoogt.
Gedurende de zwangerschap stijgen de plasma concentraties van lipiden.
Aangezien de hoeveelheid MOV in plasma dan ook stijgt, werd onderzocht of de
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hoeveelheid antioxydanten in plasma zich aanpast aan de verhoogde concentratie
MOV (Hoofdstuk 4). Verder werd ook gekeken naar de plasma antioxydant
concentraties van de pasgeborenen, omdat andere onderzoeken hebben aangetoond
dat de plasma vitamin E concentratie veel lager is dan die van de moeder. Alhoewel
ook de plasma concentratie van veel lipiden lager is dan bij de moeder, is de relatieve
bijdrage van sterk onverzadigde en oxydatie-gevoelige MOV in fosfolipiden groter.
Van het eerste naar het derde trimester van de zwangerschap stegen de plasma
concentraties van tocoferolen en de carotenoTd luteine met meer dan 40%. Dit was
meer dan de stijging van de mate van onverzadiging van het plasma, berekend aan
de hand van de stijging van MOV in fosfolipiden en het aantal dubbele bindingen in
die MOV. De R-caroteen concentratie in plasma daalde echter met 19%, terwijl de
concentraties van de andere carotenoVden constant bleven gedurende de
zwangerschap. Hierdoor daalde, van het eerste naar het derde trimester, de ratio van
deze carotenolden ten opzichte van de mate van onverzadiging.
Na de bevalling waren de plasma concentraties van oc-tocoferol en de carotenolden
vergelijkbaar met die in het derde trimester. De plasma concentraties van 5- en
B+y-tocoferol waren echter significant lager na de bevalling ten opzichte van waarden
in derde trimester. Het is onduidelijk of dit effect optreedt gedurende de laatste fase
van de zwangerschap, of dat de (oxydatieve) stress gedurende de bevalling hierop
van invloed is.
In pasgeborenen waren de plasma antioxydant concentraties veel lager dan die
van de moeder. Plasma concentraties van tocoferolen en carotenolden waren ook
significant lager indien ze gecorrigeerd werden voor de lagere mate van onverzadiging
van het neonatale plasma. Er werd nagenoeg geen fytoflueen aangetroffen in plasma
van pasgeborenen. Deze carotenoTd wordt dus tijdens de zwangerschap niet van de
moeder op het kind overgebracht. Verder bleek dat 6+y-tocoferol en veel carotenoTd
concentraties in neonataal plasma correleerden met die in moederlijk plasma, maar
dat dit niet gold voor 8-tocoferol, a-tocoferol, lycopeen en retinol.
Deze studie heeft getoond dat de stijging van de plasma concentraties oxydatie-
gevoelige MOV gedurende de zwangerschap, gepaard gaat met een stijging van de
concentraties van tocoferol en luteine. In hoeverre de stijging van deze antioxydanten
een potentiele stijging van lipidenperoxydatie kunnen voorkomen, zal additioneel
onderzoek moeten uitwijzen. Alhoewel de rol van carotenolden als antioxydanten
/n v/Vo ter discussie staat, kan de daling van de plasma B-caroteen concentratie
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tijdens de zwangerschap van biologische belang zijn. De daling van bepaalde tocoferol
isomeren na de bevalling, en de iage neonatale plasma concentraties van tocoferolen
en carotenoTden geven aan dat onderzoek naar parameters van lipidenperoxydatie
rond de tijd van bevalling noodzakelijk is.
Resultaten van recente onderzoeken duiden erop dat kenmerken van
zwangerschapshypertensie mede verklaard zouden kunnen worden door een
verstoorde balans tussen lipidenperoxydatie en antioxydant status. Vooral de rol van
vetoplosbare antioxydanten, zoals vitamine E, werd hierbij benadrukt. Echter niet in
alle onderzoeken werden verlaagde plasma vitamine E concentraties gevonden bij
zwangerschapshypertensie. Verder werd er geen rekening gehouden met
veranderingen in de vetzuur-status. Daarom werden de concentraties van
verschillende vetoplosbare antioxydanten gemeten in plasma van 23 vrouwen met
zwangerschapshypertensie gedurende het derde trimester en postpartum, en
vergeleken met 23 zwangere vrouwen zonder zwangerschapshypertensie (Hoofdstuk
5). Tevens werd onderzocht of de zwangerschapshypertensie bij de moeder van
invloed was op de antioxydant status van de pasgeborene. Plasma antioxydant
concentraties werden gerelateerd aan de mate van onverzadiging van fosfolipiden om
te corrigeren voor veranderingen in MOV-status, en omdat de hoge mate van
onverzadiging van fosfolipiden, membranen mogelijk gevoelig maakt voor lipiden-
peroxydatie. Er zijn aanwijzingen dat beschadiging van endotheliale cellen een rol
speelt in de pathogenese van zwangerschapshypertensie.
In het derde trimester waren de plasma concentraties van de gemeten tocoferolen,
carotenoTden en retinol vergelijkbaar in vrouwen met of zonder zwangerschaps-
hypertensie. Na de bevalling was de plasma concentratie van (3+y-tocoferol in de
controle groep 5% lager dan die in het derde trimester, een effect dat ook werd
waargenomen in de studie beschreven in Hoofdstuk 4. In de groep vrouwen met
zwangerschapshypertensie waren de postpartum plasma concentraties van
verscheidene antioxydanten 15 tot 26 percent lager dan de concentraties in het derde
trimester, hetgeen niet werd waargenomen in de controle groep. Na correctie voor
veranderingen in de mate van onverzadiging, die verschillend waren in de twee
groepen, was er echter geen onderscheid meer tussen de twee groepen. Uit onze
studie bleek ook dat de antioxydant status van de pasgeborenen niet beinvloed werd
door de milde zwangerschapshypertensie van de moeder. Deze resultaten
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onderschrijven daarom niet dat zwangerschapshypertensie gepaard gaat met een
verslechterde antioxydant status van moeder of kind. De vrouwen met zwangerschaps-
hypertensie in onze studie hadden een relatief milde vorm van deze aandoening. Het
is daarom mogelijk dat bij een zware vorm van zwangerschapshypertensie de
antioxydant status sterker afwijkt van een controle groep.
Gedurende veel operatieve ingrepen worden arterien tijdelijk afgesloten. Resultaten
uit proeven met dieren geven aan dat de hemieuwde toevoer van bloed (reperfusie),
en dus van zuurstof, naar het voorheen ischemische deel van de arterie een overmaat
aan vrije zuurstof radicalen veroorzaakt, en dus mogelijk gevolgen heeft voor de mate
van lipidenperoxydatie. In dieren werd aangetoond dat het toedienen van
antioxydanten het herstel van de hartfunctie na ischemie/reperfusie bespoedigt.
Echter, metingen van verschillende indicatoren voor lipidenperoxydatie leverden
tegenstrijdige resultaten op.
In mensen is oxydatieve stress na ischemie/reperfusie voomamelijk onderzocht
gedurende operatieve ingrepen onder zeer variabele condities. Percutane
transluminale coronaire angioplastiek (PTCA) is een routinematig uitgevoerde
medische handeling onder goed-gestandaardiseerde omstandigheden, en zou dus een
bruikbaar ischemie/reperfusie model voor oxydatieve stress in de mens kunnen zijn.
Bij PTCA wordt een vemauwing in een kransslagader verwijd met behulp van een
ballon-catheter. Deze procedure wordt gewoonlijk aangeduid met 'dotteren'.
In eerdere onderzoeken werd lipidenperoxydatie tijdens PTCA in mensen meestal
onderzocht door het meten van produkten in plasma die reageren met
thiobarbituurzuur (TBArs). Deze indirecte methode is echter kwalitatief en kwantitatief
niet zeer betrouwbaar, hetgeen mogelijk de tegenstrijdige resultaten zou kunnen
verklaren. Daarom werd in 13 patienten, voor en na PTCA, de plasma concentratie
lipoperoxyden gemeten met een directe methode. Aangezien zuurstof radicalen
kunnen reageren met MOV in LDL, zou modificatie van het LDL-deeltje een indicatie
zijn voor het optreden van oxydatieve stress. Daarom werd de oxydatieve modificatie
gemeten aan de hand van de lipoperoxyde en antioxydant concentratie van LDL, en
de koper-geinduceerde oxydatie-gevoeligheid van het deeltje (Hoofdstuk 6).
Tien minuten na de eerste verwijding (dilatatie) --soms zijn meer pogingen nodig
om een klinisch acceptabel resultaat te krijgen--, waren de lipoperoxyde concentraties
in plasma en LDL vergelijkbaar met concentraties voor het dotteren, zowel in veneuze
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monsters als in monsters uit de coronaire arterie. In het arteriele LDL stegen de
antioxydant-concentraties (vooral a-tocoferol), terwijl in veneus LDL de concentrates
onveranderd bleven (tocoferolen) of licht daalden (carotenoTden). Tijdens de oxydatie
van LDL ;n wfro kwam de oxydatie even snel op gang in monster verzameld kort voor
PTCA als in monsters verzameld 10 minuten na de eerste dilatatie. Alhoewel deze
inloop periode, onder andere, bepaald wordt door de antioxydant concentratie in LDL,
hadden de waargenomen veranderingen in de antioxydant concentratie dus geen
statistisch significant effect op deze periode. Na de inloop periode treedt snelle
oxydatie van vetzuren op. Na de eerste 10 minuten van de dotter-procedure verliep
deze oxydatie langzamer dan ervoor. De hoeveelheid geconjugeerde dienen die
gevormd werd wijzigde echter niet. Twee dagen na PTCA waren de meeste
parameters vergelijkbaar met waarden enkele uren voor de PTCA, behalve de
ongeveer 17% lagere S-tocoferol en B+y-tocoferol concentraties in LDL. Desalniettemin
zijn er weinig aanwijzingen gevonden dat er een verhoogde mate van lipiden-
peroxydatie optreedt tijdens PTCA.
In de algemene discussie (Hoofdstuk 7) worden de belangrijkste bevindingen van
de studies in Hoofdstukken 2-6 kort uiteengezet. Geconcludeerd kan worden dat,
ondanks het feit dat meerdere technieken tegelijkertijd werden gehanteerd die tevens
reeds eerder succesvol zijn gebruikt voor het meten van lipidenperoxydatie, in de
beschreven situaties van potentieel toegenomen oxydatieve stress slechts weinig
aanwijzingen voor toegenomen lipidenperoxydatie zijn waargenomen. Interessant zou
zijn of nieuwe '/n wvo'-technieken, zoals het meten van plasma antistoffen tegen
geoxydeerd LDL dit zouden bevestigen, en of deze technieken in de toekomst
bruikbaar zijn voor voedingsinterventie-studies.
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The aim of the studies described in this thesis was to investigate
parameters of lipid peroxidation and antioxidant status in situations in
which the degree of oxidative stress and/or antioxidative protection is
altered.
Increasing the availability of a major substrate for lipid peroxidation,
polyunsaturated fatty acids (PUFA), by supplementing the diet with highly
unsaturated fish oil concentrates, increased the /n wfra oxidation of low
density lipoproteins in a first study. However, in a second, larger, study
this effect was not confirmed. During exhaustive exercise plasma
antioxidant levels and the deformability of red blood cells decreased.
Although this may indicate increased oxidative stress, additional
parameters of lipid peroxidation have to be measured to substantiate
this. A combination of fish oil supplementation and exercise did not
augment the effects observed during pre-supplementation exercise. The
large increase in fatty acids levels during pregnancy was accompanied
by a similar increase in plasma tocopherols levels, which might prevent
oxidative stress due to the increase in plasma unsaturation. However,
plasma carotenoid and retinol levels did not increase, but their role as
antioxidants is sometimes disputed. Mild pregnancy-induced
hypertension (PIH) did not affect plasma antioxidant levels, although
some levels appear to decrease from the third trimester to postpartum,
as compared with normotensive pregnant women. Nonetheless, the
plasma antioxidant levels of the neonate were not affected by mild PIH
of the mother. Also, in patients undergoing percutaneous transluminal
coronary angioplasty (PTCA), there was no clear evidence indicating
increased lipid peroxidation after this medical procedure associated with
the production of oxygen free radicals.
It is concluded that under the investigated conditions of potentially
increased oxidative stress, little or inconsistent evidence for increased
systemic lipid peroxidation was present.
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